<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE html><html xmlns="http://www.w3.org/1999/xhtml" xmlns:art="http://www.rsc.org/schema/rscart38" xmlns:epub="http://www.idpf.org/2007/ops" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rsc="urn:rsc.org" xml:lang="en" lang="en"><head><!--Google Tag Manager--><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&amp;l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-56FZ7G');</script><!--End Google Tag Manager--><title>Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy  - Biomaterials Science (RSC Publishing) DOI:10.1039/D1BM00317H</title><link rel="canonical" href="https://pubs.rsc.org/en/content/articlehtml/2022/bm/d1bm00317h"/><meta http-equiv="content-type" content="application/xhtml+xml; charset=utf-8"/><script type="text/javascript">window.NREUM||(NREUM={});NREUM.info = {"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"NRJS-aaa897feae8feeca979","applicationID":"1313546638","transactionName":"M1wANxQFCEcDVU0PWgoWLzUlSyVbDEJcCEEnVgwXFAsKWAdEFgdHEFABDwMMElkO","queueTime":0,"applicationTime":64,"agent":"","atts":""}</script><script type="text/javascript">(window.NREUM||(NREUM={})).init={privacy:{cookies_enabled:true},ajax:{deny_list:["bam.nr-data.net"]},distributed_tracing:{enabled:true}};(window.NREUM||(NREUM={})).loader_config={agentID:"1386013924",accountID:"2851366",trustKey:"1029994",xpid:"Vg4CUFVVDhABV1BRAgUBUFcJ",licenseKey:"NRJS-aaa897feae8feeca979",applicationID:"1313546638"};;/*! For license information please see nr-loader-spa-1.236.0.min.js.LICENSE.txt */
(()=>{"use strict";var e,t,r={5763:(e,t,r)=>{r.d(t,{P_:()=>l,Mt:()=>g,C5:()=>s,DL:()=>v,OP:()=>T,lF:()=>D,Yu:()=>y,Dg:()=>h,CX:()=>c,GE:()=>b,sU:()=>_});var n=r(8632),i=r(9567);const o={beacon:n.ce.beacon,errorBeacon:n.ce.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function c(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.D)(t,o),(0,n.Qy)(e,a[e],"info")}var u=r(7056);const d=()=>{const e={blockSelector:"[data-nr-block]",maskInputOptions:{password:!0}};return{allow_bfcache:!0,privacy:{cookies_enabled:!0},ajax:{deny_list:void 0,enabled:!0,harvestTimeSeconds:10},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},session:{domain:void 0,expiresMs:u.oD,inactiveMs:u.Hb},ssl:void 0,obfuscate:void 0,jserrors:{enabled:!0,harvestTimeSeconds:10},metrics:{enabled:!0},page_action:{enabled:!0,harvestTimeSeconds:30},page_view_event:{enabled:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,long_task:!1},session_trace:{enabled:!0,harvestTimeSeconds:10},harvest:{tooManyRequestsDelay:60},session_replay:{enabled:!1,harvestTimeSeconds:60,sampleRate:.1,errorSampleRate:.1,maskTextSelector:"*",maskAllInputs:!0,get blockClass(){return"nr-block"},get ignoreClass(){return"nr-ignore"},get maskTextClass(){return"nr-mask"},get blockSelector(){return e.blockSelector},set blockSelector(t){e.blockSelector+=",".concat(t)},get maskInputOptions(){return e.maskInputOptions},set maskInputOptions(t){e.maskInputOptions={...t,password:!0}}},spa:{enabled:!0,harvestTimeSeconds:10}}},f={};function l(e){if(!e)throw new Error("All configuration objects require an agent identifier!");if(!f[e])throw new Error("Configuration for ".concat(e," was never set"));return f[e]}function h(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");f[e]=(0,i.D)(t,d()),(0,n.Qy)(e,f[e],"config")}function g(e,t){if(!e)throw new Error("All configuration objects require an agent identifier!");var r=l(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}const p={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},m={};function v(e){if(!e)throw new Error("All loader-config objects require an agent identifier!");if(!m[e])throw new Error("LoaderConfig for ".concat(e," was never set"));return m[e]}function b(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");m[e]=(0,i.D)(t,p),(0,n.Qy)(e,m[e],"loader_config")}const y=(0,n.mF)().o;var w=r(385),x=r(6818);const A={buildEnv:x.Re,bytesSent:{},queryBytesSent:{},customTransaction:void 0,disabled:!1,distMethod:x.gF,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,offset:Math.floor(w._A?.performance?.timeOrigin||w._A?.performance?.timing?.navigationStart||Date.now()),onerror:void 0,origin:""+w._A.location,ptid:void 0,releaseIds:{},session:void 0,xhrWrappable:"function"==typeof w._A.XMLHttpRequest?.prototype?.addEventListener,version:x.q4},E={};function T(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!E[e])throw new Error("Runtime for ".concat(e," was never set"));return E[e]}function _(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");E[e]=(0,i.D)(t,A),(0,n.Qy)(e,E[e],"runtime")}function D(e){return function(e){try{const t=s(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}(e)}},9567:(e,t,r)=>{r.d(t,{D:()=>i});var n=r(50);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.Z)("Setting a Configurable requires an object as input");if(!t||"object"!=typeof t)return(0,n.Z)("Setting a Configurable requires a model to set its initial properties");const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.Z)("An error occurred while setting a property of a Configurable",e)}return r}catch(e){(0,n.Z)("An error occured while setting a Configurable",e)}}},6818:(e,t,r)=>{r.d(t,{Re:()=>i,gF:()=>o,q4:()=>n});const n="1.236.0",i="PROD",o="CDN"},385:(e,t,r)=>{r.d(t,{FN:()=>a,IF:()=>u,Nk:()=>f,Tt:()=>s,_A:()=>o,il:()=>n,pL:()=>c,v6:()=>i,w1:()=>d});const n="undefined"!=typeof window&&!!window.document,i="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),o=n?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),a=""+o?.location,s=/iPad|iPhone|iPod/.test(navigator.userAgent),c=s&&"undefined"==typeof SharedWorker,u=(()=>{const e=navigator.userAgent.match(/Firefox[/\s](\d+\.\d+)/);return Array.isArray(e)&&e.length>=2?+e[1]:0})(),d=Boolean(n&&window.document.documentMode),f=!!navigator.sendBeacon},1117:(e,t,r)=>{r.d(t,{w:()=>o});var n=r(50);const i={agentIdentifier:"",ee:void 0};class o{constructor(e){try{if("object"!=typeof e)return(0,n.Z)("shared context requires an object as input");this.sharedContext={},Object.assign(this.sharedContext,i),Object.entries(e).forEach((e=>{let[t,r]=e;Object.keys(i).includes(t)&&(this.sharedContext[t]=r)}))}catch(e){(0,n.Z)("An error occured while setting SharedContext",e)}}}},8e3:(e,t,r)=>{r.d(t,{L:()=>d,R:()=>c});var n=r(2177),i=r(1284),o=r(4322),a=r(3325);const s={};function c(e,t){const r={staged:!1,priority:a.p[t]||0};u(e),s[e].get(t)||s[e].set(t,r)}function u(e){e&&(s[e]||(s[e]=new Map))}function d(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:"",t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:"feature";if(u(e),!e||!s[e].get(t))return a(t);s[e].get(t).staged=!0;const r=[...s[e]];function a(t){const r=e?n.ee.get(e):n.ee,a=o.X.handlers;if(r.backlog&&a){var s=r.backlog[t],c=a[t];if(c){for(var u=0;s&&u<s.length;++u)f(s[u],c);(0,i.D)(c,(function(e,t){(0,i.D)(t,(function(t,r){r[0].on(e,r[1])}))}))}delete a[t],r.backlog[t]=null,r.emit("drain-"+t,[])}}r.every((e=>{let[t,r]=e;return r.staged}))&&(r.sort(((e,t)=>e[1].priority-t[1].priority)),r.forEach((e=>{let[t]=e;a(t)})))}function f(e,t){var r=e[1];(0,i.D)(t[r],(function(t,r){var n=e[0];if(r[0]===n){var i=r[1],o=e[3],a=e[2];i.apply(o,a)}}))}},2177:(e,t,r)=>{r.d(t,{c:()=>f,ee:()=>u});var n=r(8632),i=r(2210),o=r(1284),a=r(5763),s="nr@context";let c=(0,n.fP)();var u;function d(){}function f(e){return(0,i.X)(e,s,l)}function l(){return new d}function h(){u.aborted=!0,u.backlog={}}c.ee?u=c.ee:(u=function e(t,r){var n={},c={},f={},g=!1;try{g=16===r.length&&(0,a.OP)(r).isolatedBacklog}catch(e){}var p={on:b,addEventListener:b,removeEventListener:y,emit:v,get:x,listeners:w,context:m,buffer:A,abort:h,aborted:!1,isBuffering:E,debugId:r,backlog:g?{}:t&&"object"==typeof t.backlog?t.backlog:{}};return p;function m(e){return e&&e instanceof d?e:e?(0,i.X)(e,s,l):l()}function v(e,r,n,i,o){if(!1!==o&&(o=!0),!u.aborted||i){t&&o&&t.emit(e,r,n);for(var a=m(n),s=w(e),d=s.length,f=0;f<d;f++)s[f].apply(a,r);var l=T()[c[e]];return l&&l.push([p,e,r,a]),a}}function b(e,t){n[e]=w(e).concat(t)}function y(e,t){var r=n[e];if(r)for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)}function w(e){return n[e]||[]}function x(t){return f[t]=f[t]||e(p,t)}function A(e,t){var r=T();p.aborted||(0,o.D)(e,(function(e,n){t=t||"feature",c[n]=t,t in r||(r[t]=[])}))}function E(e){return!!T()[c[e]]}function T(){return p.backlog}}(void 0,"globalEE"),c.ee=u)},5546:(e,t,r)=>{r.d(t,{E:()=>n,p:()=>i});var n=r(2177).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},4322:(e,t,r)=>{r.d(t,{X:()=>o});var n=r(5546);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.E,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.E);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3239:(e,t,r)=>{r.d(t,{bP:()=>s,iz:()=>c,m$:()=>a});var n=r(385);let i=!1,o=!1;try{const e={get passive(){return i=!0,!1},get signal(){return o=!0,!1}};n._A.addEventListener("test",null,e),n._A.removeEventListener("test",null,e)}catch(e){}function a(e,t){return i||o?{capture:!!e,passive:i,signal:t}:!!e}function s(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;window.addEventListener(e,t,a(r,n))}function c(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2],n=arguments.length>3?arguments[3]:void 0;document.addEventListener(e,t,a(r,n))}},4402:(e,t,r)=>{r.d(t,{Ht:()=>u,M:()=>c,Rl:()=>a,ky:()=>s});var n=r(385);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n._A?.crypto||n._A?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(31))),i.split("").map((e=>"x"===e?o(t,++r).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n._A?.crypto||n._A?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(31)));const a=[];for(var s=0;s<e;s++)a.push(o(r,++i).toString(16));return a.join("")}function c(){return s(16)}function u(){return s(32)}},7056:(e,t,r)=>{r.d(t,{Bq:()=>n,Hb:()=>o,oD:()=>i});const n="NRBA",i=144e5,o=18e5},7894:(e,t,r)=>{function n(){return Math.round(performance.now())}r.d(t,{z:()=>n})},7243:(e,t,r)=>{r.d(t,{e:()=>o});var n=r(385),i={};function o(e){if(e in i)return i[e];if(0===(e||"").indexOf("data:"))return{protocol:"data"};let t;var r=n._A?.location,o={};if(n.il)t=document.createElement("a"),t.href=e;else try{t=new URL(e,r.href)}catch(e){return o}o.port=t.port;var a=t.href.split("://");!o.port&&a[1]&&(o.port=a[1].split("/")[0].split("@").pop().split(":")[1]),o.port&&"0"!==o.port||(o.port="https"===a[0]?"443":"80"),o.hostname=t.hostname||r.hostname,o.pathname=t.pathname,o.protocol=a[0],"/"!==o.pathname.charAt(0)&&(o.pathname="/"+o.pathname);var s=!t.protocol||":"===t.protocol||t.protocol===r.protocol,c=t.hostname===r.hostname&&t.port===r.port;return o.sameOrigin=s&&(!t.hostname||c),"/"===o.pathname&&(i[e]=o),o}},50:(e,t,r)=>{function n(e,t){"function"==typeof console.warn&&(console.warn("New Relic: ".concat(e)),t&&console.warn(t))}r.d(t,{Z:()=>n})},2587:(e,t,r)=>{r.d(t,{N:()=>c,T:()=>u});var n=r(2177),i=r(5546),o=r(8e3),a=r(3325);const s={stn:[a.D.sessionTrace],err:[a.D.jserrors,a.D.metrics],ins:[a.D.pageAction],spa:[a.D.spa],sr:[a.D.sessionReplay,a.D.sessionTrace]};function c(e,t){const r=n.ee.get(t);e&&"object"==typeof e&&(Object.entries(e).forEach((e=>{let[t,n]=e;void 0===u[t]&&(s[t]?s[t].forEach((e=>{n?(0,i.p)("feat-"+t,[],void 0,e,r):(0,i.p)("block-"+t,[],void 0,e,r),(0,i.p)("rumresp-"+t,[Boolean(n)],void 0,e,r)})):n&&(0,i.p)("feat-"+t,[],void 0,void 0,r),u[t]=Boolean(n))})),Object.keys(s).forEach((e=>{void 0===u[e]&&(s[e]?.forEach((t=>(0,i.p)("rumresp-"+e,[!1],void 0,t,r))),u[e]=!1)})),(0,o.L)(t,a.D.pageViewEvent))}const u={}},2210:(e,t,r)=>{r.d(t,{X:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},1284:(e,t,r)=>{r.d(t,{D:()=>n});const n=(e,t)=>Object.entries(e||{}).map((e=>{let[r,n]=e;return t(r,n)}))},4351:(e,t,r)=>{r.d(t,{P:()=>o});var n=r(2177);const i=()=>{const e=new WeakSet;return(t,r)=>{if("object"==typeof r&&null!==r){if(e.has(r))return;e.add(r)}return r}};function o(e){try{return JSON.stringify(e,i())}catch(e){try{n.ee.emit("internal-error",[e])}catch(e){}}}},3960:(e,t,r)=>{r.d(t,{K:()=>a,b:()=>o});var n=r(3239);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.bP)("load",e,t)}function a(e){if(i())return e();(0,n.iz)("DOMContentLoaded",e)}},8632:(e,t,r)=>{r.d(t,{EZ:()=>u,Qy:()=>c,ce:()=>o,fP:()=>a,gG:()=>d,mF:()=>s});var n=r(7894),i=r(385);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return i._A.NREUM||(i._A.NREUM={}),void 0===i._A.newrelic&&(i._A.newrelic=i._A.NREUM),i._A.NREUM}function s(){let e=a();return e.o||(e.o={ST:i._A.setTimeout,SI:i._A.setImmediate,CT:i._A.clearTimeout,XHR:i._A.XMLHttpRequest,REQ:i._A.Request,EV:i._A.Event,PR:i._A.Promise,MO:i._A.MutationObserver,FETCH:i._A.fetch}),e}function c(e,t,r){let i=a();const o=i.initializedAgents||{},s=o[e]||{};return Object.keys(s).length||(s.initializedAt={ms:(0,n.z)(),date:new Date}),i.initializedAgents={...o,[e]:{...s,[r]:t}},i}function u(e,t){a()[e]=t}function d(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},7956:(e,t,r)=>{r.d(t,{N:()=>i});var n=r(3239);function i(e){let t=arguments.length>1&&void 0!==arguments[1]&&arguments[1],r=arguments.length>2?arguments[2]:void 0,i=arguments.length>3?arguments[3]:void 0;return void(0,n.iz)("visibilitychange",(function(){if(t)return void("hidden"==document.visibilityState&&e());e(document.visibilityState)}),r,i)}},1214:(e,t,r)=>{r.d(t,{em:()=>v,u5:()=>N,QU:()=>S,_L:()=>I,Gm:()=>L,Lg:()=>M,gy:()=>U,BV:()=>Q,Kf:()=>ee});var n=r(2177);const i="nr@original";var o=Object.prototype.hasOwnProperty,a=!1;function s(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");var a,s,c,u="-"===n.charAt(0);for(c=0;c<t.length;c++)d(a=e[s=t[c]])||(e[s]=r(a,u?s+n:n,i,s,o))},r.flag=i,r;function r(t,r,n,a,s){return d(t)?t:(r||(r=""),nrWrapper[i]=t,u(t,nrWrapper,e),nrWrapper);function nrWrapper(){var i,u,d,f;try{u=this,i=[...arguments],d="function"==typeof n?n(i,u):n||{}}catch(t){c([t,"",[i,u,a],d],e)}o(r+"start",[i,u,a],d,s);try{return f=t.apply(u,i)}catch(e){throw o(r+"err",[i,u,e],d,s),e}finally{o(r+"end",[i,u,f],d,s)}}}function o(r,n,i,o){if(!a||t){var s=a;a=!0;try{e.emit(r,n,i,t,o)}catch(t){c([t,r,n,i],e)}a=s}}}function c(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function u(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){c([e],r)}for(var n in e)o.call(e,n)&&(t[n]=e[n]);return t}function d(e){return!(e&&e instanceof Function&&e.apply&&!e[i])}var f=r(2210),l=r(385);const h={},g=XMLHttpRequest,p="addEventListener",m="removeEventListener";function v(e){var t=function(e){return(e||n.ee).get("events")}(e);if(h[t.debugId]++)return t;h[t.debugId]=1;var r=s(t,!0);function i(e){r.inPlace(e,[p,m],"-",o)}function o(e,t){return e[1]}return"getPrototypeOf"in Object&&(l.il&&b(document,i),b(l._A,i),b(g.prototype,i)),t.on(p+"-start",(function(e,t){var n=e[1];if(null!==n&&("function"==typeof n||"object"==typeof n)){var i=(0,f.X)(n,"nr@wrapped",(function(){var e={object:function(){if("function"!=typeof n.handleEvent)return;return n.handleEvent.apply(n,arguments)},function:n}[typeof n];return e?r(e,"fn-",null,e.name||"anonymous"):n}));this.wrapped=e[1]=i}})),t.on(m+"-start",(function(e){e[1]=this.wrapped||e[1]})),t}function b(e,t){let r=e;for(;"object"==typeof r&&!Object.prototype.hasOwnProperty.call(r,p);)r=Object.getPrototypeOf(r);for(var n=arguments.length,i=new Array(n>2?n-2:0),o=2;o<n;o++)i[o-2]=arguments[o];r&&t(r,...i)}var y="fetch-",w=y+"body-",x=["arrayBuffer","blob","json","text","formData"],A=l._A.Request,E=l._A.Response,T="prototype",_="nr@context";const D={};function N(e){const t=function(e){return(e||n.ee).get("fetch")}(e);if(!(A&&E&&l._A.fetch))return t;if(D[t.debugId]++)return t;function r(e,r,n){var i=e[r];"function"==typeof i&&(e[r]=function(){var e,r=[...arguments],o={};t.emit(n+"before-start",[r],o),o[_]&&o[_].dt&&(e=o[_].dt);var a=i.apply(this,r);return t.emit(n+"start",[r,e],a),a.then((function(e){return t.emit(n+"end",[null,e],a),e}),(function(e){throw t.emit(n+"end",[e],a),e}))})}return D[t.debugId]=1,x.forEach((e=>{r(A[T],e,w),r(E[T],e,w)})),r(l._A,"fetch",y),t.on(y+"end",(function(e,r){var n=this;if(r){var i=r.headers.get("content-length");null!==i&&(n.rxSize=i),t.emit(y+"done",[null,r],n)}else t.emit(y+"done",[e],n)})),t}const O={},j=["pushState","replaceState"];function S(e){const t=function(e){return(e||n.ee).get("history")}(e);return!l.il||O[t.debugId]++||(O[t.debugId]=1,s(t).inPlace(window.history,j,"-")),t}var P=r(3239);const C={},R=["appendChild","insertBefore","replaceChild"];function I(e){const t=function(e){return(e||n.ee).get("jsonp")}(e);if(!l.il||C[t.debugId])return t;C[t.debugId]=!0;var r=s(t),i=/[?&](?:callback|cb)=([^&#]+)/,o=/(.*)\.([^.]+)/,a=/^(\w+)(\.|$)(.*)$/;function c(e,t){var r=e.match(a),n=r[1],i=r[3];return i?c(i,t[n]):t[n]}return r.inPlace(Node.prototype,R,"dom-"),t.on("dom-start",(function(e){!function(e){if(!e||"string"!=typeof e.nodeName||"script"!==e.nodeName.toLowerCase())return;if("function"!=typeof e.addEventListener)return;var n=(a=e.src,s=a.match(i),s?s[1]:null);var a,s;if(!n)return;var u=function(e){var t=e.match(o);if(t&&t.length>=3)return{key:t[2],parent:c(t[1],window)};return{key:e,parent:window}}(n);if("function"!=typeof u.parent[u.key])return;var d={};function f(){t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}function l(){t.emit("jsonp-error",[],d),t.emit("jsonp-end",[],d),e.removeEventListener("load",f,(0,P.m$)(!1)),e.removeEventListener("error",l,(0,P.m$)(!1))}r.inPlace(u.parent,[u.key],"cb-",d),e.addEventListener("load",f,(0,P.m$)(!1)),e.addEventListener("error",l,(0,P.m$)(!1)),t.emit("new-jsonp",[e.src],d)}(e[0])})),t}var k=r(5763);const H={};function L(e){const t=function(e){return(e||n.ee).get("mutation")}(e);if(!l.il||H[t.debugId])return t;H[t.debugId]=!0;var r=s(t),i=k.Yu.MO;return i&&(window.MutationObserver=function(e){return this instanceof i?new i(r(e,"fn-")):i.apply(this,arguments)},MutationObserver.prototype=i.prototype),t}const z={};function M(e){const t=function(e){return(e||n.ee).get("promise")}(e);if(z[t.debugId])return t;z[t.debugId]=!0;var r=n.c,o=s(t),a=k.Yu.PR;return a&&function(){function e(r){var n=t.context(),i=o(r,"executor-",n,null,!1);const s=Reflect.construct(a,[i],e);return t.context(s).getCtx=function(){return n},s}l._A.Promise=e,Object.defineProperty(e,"name",{value:"Promise"}),e.toString=function(){return a.toString()},Object.setPrototypeOf(e,a),["all","race"].forEach((function(r){const n=a[r];e[r]=function(e){let i=!1;[...e||[]].forEach((e=>{this.resolve(e).then(a("all"===r),a(!1))}));const o=n.apply(this,arguments);return o;function a(e){return function(){t.emit("propagate",[null,!i],o,!1,!1),i=i||!e}}}})),["resolve","reject"].forEach((function(r){const n=a[r];e[r]=function(e){const r=n.apply(this,arguments);return e!==r&&t.emit("propagate",[e,!0],r,!1,!1),r}})),e.prototype=a.prototype;const n=a.prototype.then;a.prototype.then=function(){var e=this,i=r(e);i.promise=e;for(var a=arguments.length,s=new Array(a),c=0;c<a;c++)s[c]=arguments[c];s[0]=o(s[0],"cb-",i,null,!1),s[1]=o(s[1],"cb-",i,null,!1);const u=n.apply(this,s);return i.nextPromise=u,t.emit("propagate",[e,!0],u,!1,!1),u},a.prototype.then[i]=n,t.on("executor-start",(function(e){e[0]=o(e[0],"resolve-",this,null,!1),e[1]=o(e[1],"resolve-",this,null,!1)})),t.on("executor-err",(function(e,t,r){e[1](r)})),t.on("cb-end",(function(e,r,n){t.emit("propagate",[n,!0],this.nextPromise,!1,!1)})),t.on("propagate",(function(e,r,n){this.getCtx&&!r||(this.getCtx=function(){if(e instanceof Promise)var r=t.context(e);return r&&r.getCtx?r.getCtx():this})}))}(),t}const B={},F="requestAnimationFrame";function U(e){const t=function(e){return(e||n.ee).get("raf")}(e);if(!l.il||B[t.debugId]++)return t;B[t.debugId]=1;var r=s(t);return r.inPlace(window,[F],"raf-"),t.on("raf-start",(function(e){e[0]=r(e[0],"fn-")})),t}const q={},G="setTimeout",V="setInterval",X="clearTimeout",W="-start",Z="-",$=[G,"setImmediate",V,X,"clearImmediate"];function Q(e){const t=function(e){return(e||n.ee).get("timer")}(e);if(q[t.debugId]++)return t;q[t.debugId]=1;var r=s(t);return r.inPlace(l._A,$.slice(0,2),G+Z),r.inPlace(l._A,$.slice(2,3),V+Z),r.inPlace(l._A,$.slice(3),X+Z),t.on(V+W,(function(e,t,n){e[0]=r(e[0],"fn-",null,n)})),t.on(G+W,(function(e,t,n){this.method=n,this.timerDuration=isNaN(e[1])?0:+e[1],e[0]=r(e[0],"fn-",this,n)})),t}var Y=r(50);const K={},J=["open","send"];function ee(e){var t=e||n.ee;const r=function(e){return(e||n.ee).get("xhr")}(t);if(K[r.debugId]++)return r;K[r.debugId]=1,v(t);var i=s(r),o=k.Yu.XHR,a=k.Yu.MO,c=k.Yu.PR,u=k.Yu.SI,d="readystatechange",f=["onload","onerror","onabort","onloadstart","onloadend","onprogress","ontimeout"],h=[],g=l._A.XMLHttpRequest.listeners,p=l._A.XMLHttpRequest=function(e){var t=new o(e);function n(){try{r.emit("new-xhr",[t],t),t.addEventListener(d,b,(0,P.m$)(!1))}catch(e){(0,Y.Z)("An error occured while intercepting XHR",e);try{r.emit("internal-error",[e])}catch(e){}}}return this.listeners=g?[...g,n]:[n],this.listeners.forEach((e=>e())),t};function m(e,t){i.inPlace(t,["onreadystatechange"],"fn-",E)}function b(){var e=this,t=r.context(e);e.readyState>3&&!t.resolved&&(t.resolved=!0,r.emit("xhr-resolved",[],e)),i.inPlace(e,f,"fn-",E)}if(function(e,t){for(var r in e)t[r]=e[r]}(o,p),p.prototype=o.prototype,i.inPlace(p.prototype,J,"-xhr-",E),r.on("send-xhr-start",(function(e,t){m(e,t),function(e){h.push(e),a&&(y?y.then(A):u?u(A):(w=-w,x.data=w))}(t)})),r.on("open-xhr-start",m),a){var y=c&&c.resolve();if(!u&&!c){var w=1,x=document.createTextNode(w);new a(A).observe(x,{characterData:!0})}}else t.on("fn-end",(function(e){e[0]&&e[0].type===d||A()}));function A(){for(var e=0;e<h.length;e++)m(0,h[e]);h.length&&(h=[])}function E(e,t){return t}return r}},7825:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.ajax},6660:(e,t,r)=>{r.d(t,{A:()=>i,t:()=>n});const n=r(3325).D.jserrors,i="nr@seenError"},3081:(e,t,r)=>{r.d(t,{gF:()=>o,mY:()=>i,t9:()=>n,vz:()=>s,xS:()=>a});const n=r(3325).D.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},4649:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageAction},7633:(e,t,r)=>{r.d(t,{Dz:()=>i,OJ:()=>a,qw:()=>o,t9:()=>n});const n=r(3325).D.pageViewEvent,i="firstbyte",o="domcontent",a="windowload"},9251:(e,t,r)=>{r.d(t,{t:()=>n});const n=r(3325).D.pageViewTiming},3614:(e,t,r)=>{r.d(t,{BST_RESOURCE:()=>i,END:()=>s,FEATURE_NAME:()=>n,FN_END:()=>u,FN_START:()=>c,PUSH_STATE:()=>d,RESOURCE:()=>o,START:()=>a});const n=r(3325).D.sessionTrace,i="bstResource",o="resource",a="-start",s="-end",c="fn"+a,u="fn"+s,d="pushState"},7836:(e,t,r)=>{r.d(t,{BODY:()=>A,CB_END:()=>E,CB_START:()=>u,END:()=>x,FEATURE_NAME:()=>i,FETCH:()=>_,FETCH_BODY:()=>v,FETCH_DONE:()=>m,FETCH_START:()=>p,FN_END:()=>c,FN_START:()=>s,INTERACTION:()=>l,INTERACTION_API:()=>d,INTERACTION_EVENTS:()=>o,JSONP_END:()=>b,JSONP_NODE:()=>g,JS_TIME:()=>T,MAX_TIMER_BUDGET:()=>a,REMAINING:()=>f,SPA_NODE:()=>h,START:()=>w,originalSetTimeout:()=>y});var n=r(5763);const i=r(3325).D.spa,o=["click","submit","keypress","keydown","keyup","change"],a=999,s="fn-start",c="fn-end",u="cb-start",d="api-ixn-",f="remaining",l="interaction",h="spaNode",g="jsonpNode",p="fetch-start",m="fetch-done",v="fetch-body-",b="jsonp-end",y=n.Yu.ST,w="-start",x="-end",A="-body",E="cb"+x,T="jsTime",_="fetch"},5938:(e,t,r)=>{r.d(t,{W:()=>o});var n=r(5763),i=r(2177);class o{constructor(e,t,r){this.agentIdentifier=e,this.aggregator=t,this.ee=i.ee.get(e,(0,n.OP)(this.agentIdentifier).isolatedBacklog),this.featureName=r,this.blocked=!1}}},9144:(e,t,r)=>{r.d(t,{j:()=>m});var n=r(3325),i=r(5763),o=r(5546),a=r(2177),s=r(7894),c=r(8e3),u=r(3960),d=r(385),f=r(50),l=r(3081),h=r(8632);function g(){const e=(0,h.gG)();["setErrorHandler","finished","addToTrace","inlineHit","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId"].forEach((t=>{e[t]=function(){for(var r=arguments.length,n=new Array(r),i=0;i<r;i++)n[i]=arguments[i];return function(t){for(var r=arguments.length,n=new Array(r>1?r-1:0),i=1;i<r;i++)n[i-1]=arguments[i];let o=[];return Object.values(e.initializedAgents).forEach((e=>{e.exposed&&e.api[t]&&o.push(e.api[t](...n))})),o.length>1?o:o[0]}(t,...n)}}))}var p=r(2587);function m(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:{},m=arguments.length>2?arguments[2]:void 0,v=arguments.length>3?arguments[3]:void 0,{init:b,info:y,loader_config:w,runtime:x={loaderType:m},exposed:A=!0}=t;const E=(0,h.gG)();y||(b=E.init,y=E.info,w=E.loader_config),(0,i.Dg)(e,b||{}),(0,i.GE)(e,w||{}),(0,i.sU)(e,x),y.jsAttributes??={},d.v6&&(y.jsAttributes.isWorker=!0),(0,i.CX)(e,y),g();const T=function(e,t){t||(0,c.R)(e,"api");const h={};var g=a.ee.get(e),p=g.get("tracer"),m="api-",v=m+"ixn-";function b(t,r,n,o){const a=(0,i.C5)(e);return null===r?delete a.jsAttributes[t]:(0,i.CX)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),x(m,n,!0,o||null===r?"session":void 0)(t,r)}function y(){}["setErrorHandler","finished","addToTrace","inlineHit","addRelease"].forEach((e=>h[e]=x(m,e,!0,"api"))),h.addPageAction=x(m,"addPageAction",!0,n.D.pageAction),h.setCurrentRouteName=x(m,"routeName",!0,n.D.spa),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,i.OP)(e).customTransaction=(r||"http://custom.transaction")+t,x(m,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t){let r=arguments.length>2&&void 0!==arguments[2]&&arguments[2];if("string"==typeof e){if(["string","number"].includes(typeof t)||null===t)return b(e,t,"setCustomAttribute",r);(0,f.Z)("Failed to execute setCustomAttribute.\nNon-null value must be a string or number type, but a type of <".concat(typeof t,"> was provided."))}else(0,f.Z)("Failed to execute setCustomAttribute.\nName must be a string type, but a type of <".concat(typeof e,"> was provided."))},h.setUserId=function(e){if("string"==typeof e||null===e)return b("enduser.id",e,"setUserId",!0);(0,f.Z)("Failed to execute setUserId.\nNon-null value must be a string type, but a type of <".concat(typeof e,"> was provided."))},h.interaction=function(){return(new y).get()};var w=y.prototype={createTracer:function(e,t){var r={},i=this,a="function"==typeof t;return(0,o.p)(v+"tracer",[(0,s.z)(),e,r],i,n.D.spa,g),function(){if(p.emit((a?"":"no-")+"fn-start",[(0,s.z)(),i,a],r),a)try{return t.apply(this,arguments)}catch(e){throw p.emit("fn-err",[arguments,this,"string"==typeof e?new Error(e):e],r),e}finally{p.emit("fn-end",[(0,s.z)()],r)}}}};function x(e,t,r,i){return function(){return(0,o.p)(l.xS,["API/"+t+"/called"],void 0,n.D.metrics,g),i&&(0,o.p)(e+t,[(0,s.z)(),...arguments],r?null:this,i,g),r?void 0:this}}function A(){r.e(439).then(r.bind(r,7438)).then((t=>{let{setAPI:r}=t;r(e),(0,c.L)(e,"api")})).catch((()=>(0,f.Z)("Downloading runtime APIs failed...")))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{w[e]=x(v,e,void 0,n.D.spa)})),h.noticeError=function(e,t){"string"==typeof e&&(e=new Error(e)),(0,o.p)(l.xS,["API/noticeError/called"],void 0,n.D.metrics,g),(0,o.p)("err",[e,(0,s.z)(),!1,t],void 0,n.D.jserrors,g)},d.il?(0,u.b)((()=>A()),!0):A(),h}(e,v);return(0,h.Qy)(e,T,"api"),(0,h.Qy)(e,A,"exposed"),(0,h.EZ)("activatedFeatures",p.T),T}},3325:(e,t,r)=>{r.d(t,{D:()=>n,p:()=>i});const n={ajax:"ajax",jserrors:"jserrors",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.ajax]:5,[n.sessionTrace]:6,[n.pageAction]:7,[n.spa]:8,[n.sessionReplay]:9}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>(({78:"page_action-aggregate",147:"metrics-aggregate",242:"session-manager",317:"jserrors-aggregate",348:"page_view_timing-aggregate",412:"lazy-feature-loader",439:"async-api",538:"recorder",590:"session_replay-aggregate",675:"compressor",733:"session_trace-aggregate",786:"page_view_event-aggregate",873:"spa-aggregate",898:"ajax-aggregate"}[e]||e)+"."+{78:"ac76d497",147:"3dc53903",148:"1a20d5fe",242:"2a64278a",317:"49e41428",348:"bd6de33a",412:"2f55ce66",439:"30bd804e",538:"1b18459f",590:"cf0efb30",675:"ae9f91a8",733:"83105561",786:"06482edd",860:"03a8b7a5",873:"e6b09d52",898:"998ef92b"}[e]+"-1.236.0.min.js"),i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var f=u[d];if(f.getAttribute("src")==r||f.getAttribute("data-webpack")==t+o){s=f;break}}s||(c=!0,(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r),e[r]=[n];var l=(t,n)=>{s.onerror=s.onload=null,clearTimeout(h);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},h=setTimeout(l.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=l.bind(null,s.onerror),s.onload=l.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.j=364,i.p="https://js-agent.newrelic.com/",(()=>{var e={364:0,953:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=window.webpackChunkNRBA=window.webpackChunkNRBA||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})();var o={};(()=>{i.r(o);var e=i(3325),t=i(5763);const r=Object.values(e.D);function n(e){const n={};return r.forEach((r=>{n[r]=function(e,r){return!1!==(0,t.Mt)(r,"".concat(e,".enabled"))}(r,e)})),n}var a=i(9144);var s=i(5546),c=i(385),u=i(8e3),d=i(5938),f=i(3960),l=i(50);class h extends d.W{constructor(e,t,r){let n=!(arguments.length>3&&void 0!==arguments[3])||arguments[3];super(e,t,r),this.auto=n,this.abortHandler,this.featAggregate,this.onAggregateImported,n&&(0,u.R)(e,r)}importAggregator(){let e=arguments.length>0&&void 0!==arguments[0]?arguments[0]:{};if(this.featAggregate||!this.auto)return;const r=c.il&&!0===(0,t.Mt)(this.agentIdentifier,"privacy.cookies_enabled");let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let t;try{if(r){const{setupAgentSession:e}=await Promise.all([i.e(860),i.e(242)]).then(i.bind(i,3228));t=e(this.agentIdentifier)}}catch(e){(0,l.Z)("A problem occurred when starting up session manager. This page will not start or extend any session.",e)}try{if(!this.shouldImportAgg(this.featureName,t))return void(0,u.L)(this.agentIdentifier,this.featureName);const{lazyFeatureLoader:r}=await i.e(412).then(i.bind(i,8582)),{Aggregate:o}=await r(this.featureName,"aggregate");this.featAggregate=new o(this.agentIdentifier,this.aggregator,e),n(!0)}catch(e){(0,l.Z)("Downloading and initializing ".concat(this.featureName," failed..."),e),this.abortHandler?.(),n(!1)}};c.il?(0,f.b)((()=>o()),!0):o()}shouldImportAgg(r,n){return r!==e.D.sessionReplay||!1!==(0,t.Mt)(this.agentIdentifier,"session_trace.enabled")&&(!!n?.isNew||!!n?.state.sessionReplay)}}var g=i(7633),p=i(7894);class m extends h{static featureName=g.t9;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];if(super(r,n,g.t9,i),("undefined"==typeof PerformanceNavigationTiming||c.Tt)&&"undefined"!=typeof PerformanceTiming){const n=(0,t.OP)(r);n[g.Dz]=Math.max(Date.now()-n.offset,0),(0,f.K)((()=>n[g.qw]=Math.max((0,p.z)()-n[g.Dz],0))),(0,f.b)((()=>{const t=(0,p.z)();n[g.OJ]=Math.max(t-n[g.Dz],0),(0,s.p)("timing",["load",t],void 0,e.D.pageViewTiming,this.ee)}))}this.importAggregator()}}var v=i(1117),b=i(1284);class y extends v.w{constructor(e){super(e),this.aggregatedData={}}store(e,t,r,n,i){var o=this.getBucket(e,t,r,i);return o.metrics=function(e,t){t||(t={count:0});return t.count+=1,(0,b.D)(e,(function(e,r){t[e]=w(r,t[e])})),t}(n,o.metrics),o}merge(e,t,r,n,i){var o=this.getBucket(e,t,n,i);if(o.metrics){var a=o.metrics;a.count+=r.count,(0,b.D)(r,(function(e,t){if("count"!==e){var n=a[e],i=r[e];i&&!i.c?a[e]=w(i.t,n):a[e]=function(e,t){if(!t)return e;t.c||(t=x(t.t));return t.min=Math.min(e.min,t.min),t.max=Math.max(e.max,t.max),t.t+=e.t,t.sos+=e.sos,t.c+=e.c,t}(i,a[e])}}))}else o.metrics=r}storeMetric(e,t,r,n){var i=this.getBucket(e,t,r);return i.stats=w(n,i.stats),i}getBucket(e,t,r,n){this.aggregatedData[e]||(this.aggregatedData[e]={});var i=this.aggregatedData[e][t];return i||(i=this.aggregatedData[e][t]={params:r||{}},n&&(i.custom=n)),i}get(e,t){return t?this.aggregatedData[e]&&this.aggregatedData[e][t]:this.aggregatedData[e]}take(e){for(var t={},r="",n=!1,i=0;i<e.length;i++)t[r=e[i]]=A(this.aggregatedData[r]),t[r].length&&(n=!0),delete this.aggregatedData[r];return n?t:null}}function w(e,t){return null==e?function(e){e?e.c++:e={c:1};return e}(t):t?(t.c||(t=x(t.t)),t.c+=1,t.t+=e,t.sos+=e*e,e>t.max&&(t.max=e),e<t.min&&(t.min=e),t):{t:e}}function x(e){return{t:e,min:e,max:e,sos:e*e,c:1}}function A(e){return"object"!=typeof e?[]:(0,b.D)(e,E)}function E(e,t){return t}var T=i(8632),_=i(4402),D=i(4351);var N=i(7956),O=i(3239),j=i(9251);class S extends h{static featureName=j.t;constructor(e,r){let n=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,r,j.t,n),c.il&&((0,t.OP)(e).initHidden=Boolean("hidden"===document.visibilityState),(0,N.N)((()=>(0,s.p)("docHidden",[(0,p.z)()],void 0,j.t,this.ee)),!0),(0,O.bP)("pagehide",(()=>(0,s.p)("winPagehide",[(0,p.z)()],void 0,j.t,this.ee))),this.importAggregator())}}var P=i(3081);class C extends h{static featureName=P.t9;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,P.t9,r),this.importAggregator()}}var R,I=i(2210),k=i(1214),H=i(2177),L={};try{R=localStorage.getItem("__nr_flags").split(","),console&&"function"==typeof console.log&&(L.console=!0,-1!==R.indexOf("dev")&&(L.dev=!0),-1!==R.indexOf("nr_dev")&&(L.nrDev=!0))}catch(e){}function z(e){try{L.console&&z(e)}catch(e){}}L.nrDev&&H.ee.on("internal-error",(function(e){z(e.stack)})),L.dev&&H.ee.on("fn-err",(function(e,t,r){z(r.stack)})),L.dev&&(z("NR AGENT IN DEVELOPMENT MODE"),z("flags: "+(0,b.D)(L,(function(e,t){return e})).join(", ")));var M=i(6660);class B extends h{static featureName=M.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,M.t,i),this.skipNext=0;try{this.removeOnAbort=new AbortController}catch(e){}const o=this;o.ee.on("fn-start",(function(e,t,r){o.abortHandler&&(o.skipNext+=1)})),o.ee.on("fn-err",(function(t,r,n){o.abortHandler&&!n[M.A]&&((0,I.X)(n,M.A,(function(){return!0})),this.thrown=!0,(0,s.p)("err",[n,(0,p.z)()],void 0,e.D.jserrors,o.ee))})),o.ee.on("fn-end",(function(){o.abortHandler&&!this.thrown&&o.skipNext>0&&(o.skipNext-=1)})),o.ee.on("internal-error",(function(t){(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,o.ee)})),this.origOnerror=c._A.onerror,c._A.onerror=this.onerrorHandler.bind(this),c._A.addEventListener("unhandledrejection",(t=>{const r=function(e){let t="Unhandled Promise Rejection: ";if(e instanceof Error)try{return e.message=t+e.message,e}catch(t){return e}if(void 0===e)return new Error(t);try{return new Error(t+(0,D.P)(e))}catch(e){return new Error(t)}}(t.reason);(0,s.p)("err",[r,(0,p.z)(),!1,{unhandledPromiseRejection:1}],void 0,e.D.jserrors,this.ee)}),(0,O.m$)(!1,this.removeOnAbort?.signal)),(0,k.gy)(this.ee),(0,k.BV)(this.ee),(0,k.em)(this.ee),(0,t.OP)(r).xhrWrappable&&(0,k.Kf)(this.ee),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}onerrorHandler(t,r,n,i,o){"function"==typeof this.origOnerror&&this.origOnerror(...arguments);try{this.skipNext?this.skipNext-=1:(0,s.p)("err",[o||new F(t,r,n),(0,p.z)()],void 0,e.D.jserrors,this.ee)}catch(t){try{(0,s.p)("ierr",[t,(0,p.z)(),!0],void 0,e.D.jserrors,this.ee)}catch(e){}}return!1}}function F(e,t,r){this.message=e||"Uncaught error with no additional information",this.sourceURL=t,this.line=r}let U=1;const q="nr@id";function G(e){const t=typeof e;return!e||"object"!==t&&"function"!==t?-1:e===c._A?0:(0,I.X)(e,q,(function(){return U++}))}function V(e){if("string"==typeof e&&e.length)return e.length;if("object"==typeof e){if("undefined"!=typeof ArrayBuffer&&e instanceof ArrayBuffer&&e.byteLength)return e.byteLength;if("undefined"!=typeof Blob&&e instanceof Blob&&e.size)return e.size;if(!("undefined"!=typeof FormData&&e instanceof FormData))try{return(0,D.P)(e).length}catch(e){return}}}var X=i(7243);class W{constructor(e){this.agentIdentifier=e,this.generateTracePayload=this.generateTracePayload.bind(this),this.shouldGenerateTrace=this.shouldGenerateTrace.bind(this)}generateTracePayload(e){if(!this.shouldGenerateTrace(e))return null;var r=(0,t.DL)(this.agentIdentifier);if(!r)return null;var n=(r.accountID||"").toString()||null,i=(r.agentID||"").toString()||null,o=(r.trustKey||"").toString()||null;if(!n||!i)return null;var a=(0,_.M)(),s=(0,_.Ht)(),c=Date.now(),u={spanId:a,traceId:s,timestamp:c};return(e.sameOrigin||this.isAllowedOrigin(e)&&this.useTraceContextHeadersForCors())&&(u.traceContextParentHeader=this.generateTraceContextParentHeader(a,s),u.traceContextStateHeader=this.generateTraceContextStateHeader(a,c,n,i,o)),(e.sameOrigin&&!this.excludeNewrelicHeader()||!e.sameOrigin&&this.isAllowedOrigin(e)&&this.useNewrelicHeaderForCors())&&(u.newrelicHeader=this.generateTraceHeader(a,s,c,n,i,o)),u}generateTraceContextParentHeader(e,t){return"00-"+t+"-"+e+"-01"}generateTraceContextStateHeader(e,t,r,n,i){return i+"@nr=0-1-"+r+"-"+n+"-"+e+"----"+t}generateTraceHeader(e,t,r,n,i,o){if(!("function"==typeof c._A?.btoa))return null;var a={v:[0,1],d:{ty:"Browser",ac:n,ap:i,id:e,tr:t,ti:r}};return o&&n!==o&&(a.d.tk=o),btoa((0,D.P)(a))}shouldGenerateTrace(e){return this.isDtEnabled()&&this.isAllowedOrigin(e)}isAllowedOrigin(e){var r=!1,n={};if((0,t.Mt)(this.agentIdentifier,"distributed_tracing")&&(n=(0,t.P_)(this.agentIdentifier).distributed_tracing),e.sameOrigin)r=!0;else if(n.allowed_origins instanceof Array)for(var i=0;i<n.allowed_origins.length;i++){var o=(0,X.e)(n.allowed_origins[i]);if(e.hostname===o.hostname&&e.protocol===o.protocol&&e.port===o.port){r=!0;break}}return r}isDtEnabled(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.enabled}excludeNewrelicHeader(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.exclude_newrelic_header}useNewrelicHeaderForCors(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!1!==e.cors_use_newrelic_header}useTraceContextHeadersForCors(){var e=(0,t.Mt)(this.agentIdentifier,"distributed_tracing");return!!e&&!!e.cors_use_tracecontext_headers}}var Z=i(7825),$=["load","error","abort","timeout"],Q=$.length,Y=t.Yu.REQ,K=c._A.XMLHttpRequest;class J extends h{static featureName=Z.t;constructor(r,n){let i=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(r,n,Z.t,i),(0,t.OP)(r).xhrWrappable&&(this.dt=new W(r),this.handler=(e,t,r,n)=>(0,s.p)(e,t,r,n,this.ee),(0,k.u5)(this.ee),(0,k.Kf)(this.ee),function(r,n,i,o){function a(e){var t=this;t.totalCbs=0,t.called=0,t.cbTime=0,t.end=E,t.ended=!1,t.xhrGuids={},t.lastSize=null,t.loadCaptureCalled=!1,t.params=this.params||{},t.metrics=this.metrics||{},e.addEventListener("load",(function(r){_(t,e)}),(0,O.m$)(!1)),c.IF||e.addEventListener("progress",(function(e){t.lastSize=e.loaded}),(0,O.m$)(!1))}function s(e){this.params={method:e[0]},T(this,e[1]),this.metrics={}}function u(e,n){var i=(0,t.DL)(r);i.xpid&&this.sameOrigin&&n.setRequestHeader("X-NewRelic-ID",i.xpid);var a=o.generateTracePayload(this.parsedOrigin);if(a){var s=!1;a.newrelicHeader&&(n.setRequestHeader("newrelic",a.newrelicHeader),s=!0),a.traceContextParentHeader&&(n.setRequestHeader("traceparent",a.traceContextParentHeader),a.traceContextStateHeader&&n.setRequestHeader("tracestate",a.traceContextStateHeader),s=!0),s&&(this.dt=a)}}function d(e,t){var r=this.metrics,i=e[0],o=this;if(r&&i){var a=V(i);a&&(r.txSize=a)}this.startTime=(0,p.z)(),this.listener=function(e){try{"abort"!==e.type||o.loadCaptureCalled||(o.params.aborted=!0),("load"!==e.type||o.called===o.totalCbs&&(o.onloadCalled||"function"!=typeof t.onload)&&"function"==typeof o.end)&&o.end(t)}catch(e){try{n.emit("internal-error",[e])}catch(e){}}};for(var s=0;s<Q;s++)t.addEventListener($[s],this.listener,(0,O.m$)(!1))}function f(e,t,r){this.cbTime+=e,t?this.onloadCalled=!0:this.called+=1,this.called!==this.totalCbs||!this.onloadCalled&&"function"==typeof r.onload||"function"!=typeof this.end||this.end(r)}function l(e,t){var r=""+G(e)+!!t;this.xhrGuids&&!this.xhrGuids[r]&&(this.xhrGuids[r]=!0,this.totalCbs+=1)}function h(e,t){var r=""+G(e)+!!t;this.xhrGuids&&this.xhrGuids[r]&&(delete this.xhrGuids[r],this.totalCbs-=1)}function g(){this.endTime=(0,p.z)()}function m(e,t){t instanceof K&&"load"===e[0]&&n.emit("xhr-load-added",[e[1],e[2]],t)}function v(e,t){t instanceof K&&"load"===e[0]&&n.emit("xhr-load-removed",[e[1],e[2]],t)}function b(e,t,r){t instanceof K&&("onload"===r&&(this.onload=!0),("load"===(e[0]&&e[0].type)||this.onload)&&(this.xhrCbStart=(0,p.z)()))}function y(e,t){this.xhrCbStart&&n.emit("xhr-cb-time",[(0,p.z)()-this.xhrCbStart,this.onload,t],t)}function w(e){var t,r=e[1]||{};"string"==typeof e[0]?t=e[0]:e[0]&&e[0].url?t=e[0].url:c._A?.URL&&e[0]&&e[0]instanceof URL&&(t=e[0].href),t&&(this.parsedOrigin=(0,X.e)(t),this.sameOrigin=this.parsedOrigin.sameOrigin);var n=o.generateTracePayload(this.parsedOrigin);if(n&&(n.newrelicHeader||n.traceContextParentHeader))if("string"==typeof e[0]||c._A?.URL&&e[0]&&e[0]instanceof URL){var i={};for(var a in r)i[a]=r[a];i.headers=new Headers(r.headers||{}),s(i.headers,n)&&(this.dt=n),e.length>1?e[1]=i:e.push(i)}else e[0]&&e[0].headers&&s(e[0].headers,n)&&(this.dt=n);function s(e,t){var r=!1;return t.newrelicHeader&&(e.set("newrelic",t.newrelicHeader),r=!0),t.traceContextParentHeader&&(e.set("traceparent",t.traceContextParentHeader),t.traceContextStateHeader&&e.set("tracestate",t.traceContextStateHeader),r=!0),r}}function x(e,t){this.params={},this.metrics={},this.startTime=(0,p.z)(),this.dt=t,e.length>=1&&(this.target=e[0]),e.length>=2&&(this.opts=e[1]);var r,n=this.opts||{},i=this.target;"string"==typeof i?r=i:"object"==typeof i&&i instanceof Y?r=i.url:c._A?.URL&&"object"==typeof i&&i instanceof URL&&(r=i.href),T(this,r);var o=(""+(i&&i instanceof Y&&i.method||n.method||"GET")).toUpperCase();this.params.method=o,this.txSize=V(n.body)||0}function A(t,r){var n;this.endTime=(0,p.z)(),this.params||(this.params={}),this.params.status=r?r.status:0,"string"==typeof this.rxSize&&this.rxSize.length>0&&(n=+this.rxSize);var o={txSize:this.txSize,rxSize:n,duration:(0,p.z)()-this.startTime};i("xhr",[this.params,o,this.startTime,this.endTime,"fetch"],this,e.D.ajax)}function E(t){var r=this.params,n=this.metrics;if(!this.ended){this.ended=!0;for(var o=0;o<Q;o++)t.removeEventListener($[o],this.listener,!1);r.aborted||(n.duration=(0,p.z)()-this.startTime,this.loadCaptureCalled||4!==t.readyState?null==r.status&&(r.status=0):_(this,t),n.cbTime=this.cbTime,i("xhr",[r,n,this.startTime,this.endTime,"xhr"],this,e.D.ajax))}}function T(e,t){var r=(0,X.e)(t),n=e.params;n.hostname=r.hostname,n.port=r.port,n.protocol=r.protocol,n.host=r.hostname+":"+r.port,n.pathname=r.pathname,e.parsedOrigin=r,e.sameOrigin=r.sameOrigin}function _(e,t){e.params.status=t.status;var r=function(e,t){var r=e.responseType;return"json"===r&&null!==t?t:"arraybuffer"===r||"blob"===r||"json"===r?V(e.response):"text"===r||""===r||void 0===r?V(e.responseText):void 0}(t,e.lastSize);if(r&&(e.metrics.rxSize=r),e.sameOrigin){var n=t.getResponseHeader("X-NewRelic-App-Data");n&&(e.params.cat=n.split(", ").pop())}e.loadCaptureCalled=!0}n.on("new-xhr",a),n.on("open-xhr-start",s),n.on("open-xhr-end",u),n.on("send-xhr-start",d),n.on("xhr-cb-time",f),n.on("xhr-load-added",l),n.on("xhr-load-removed",h),n.on("xhr-resolved",g),n.on("addEventListener-end",m),n.on("removeEventListener-end",v),n.on("fn-end",y),n.on("fetch-before-start",w),n.on("fetch-start",x),n.on("fn-start",b),n.on("fetch-done",A)}(r,this.ee,this.handler,this.dt),this.importAggregator())}}var ee=i(3614);const{BST_RESOURCE:te,RESOURCE:re,START:ne,END:ie,FEATURE_NAME:oe,FN_END:ae,FN_START:se,PUSH_STATE:ce}=ee;var ue=i(7836);const{FEATURE_NAME:de,START:fe,END:le,BODY:he,CB_END:ge,JS_TIME:pe,FETCH:me,FN_START:ve,CB_START:be,FN_END:ye}=ue;var we=i(4649);class xe extends h{static featureName=we.t;constructor(e,t){let r=!(arguments.length>2&&void 0!==arguments[2])||arguments[2];super(e,t,we.t,r),this.importAggregator()}}new class{constructor(e){let t=arguments.length>1&&void 0!==arguments[1]?arguments[1]:(0,_.ky)(16);c._A?(this.agentIdentifier=t,this.sharedAggregator=new y({agentIdentifier:this.agentIdentifier}),this.features={},this.desiredFeatures=new Set(e.features||[]),this.desiredFeatures.add(m),Object.assign(this,(0,a.j)(this.agentIdentifier,e,e.loaderType||"agent")),this.start()):(0,l.Z)("Failed to initial the agent. Could not determine the runtime environment.")}get config(){return{info:(0,t.C5)(this.agentIdentifier),init:(0,t.P_)(this.agentIdentifier),loader_config:(0,t.DL)(this.agentIdentifier),runtime:(0,t.OP)(this.agentIdentifier)}}start(){const t="features";try{const r=n(this.agentIdentifier),i=[...this.desiredFeatures];i.sort(((t,r)=>e.p[t.featureName]-e.p[r.featureName])),i.forEach((t=>{if(r[t.featureName]||t.featureName===e.D.pageViewEvent){const n=function(t){switch(t){case e.D.ajax:return[e.D.jserrors];case e.D.sessionTrace:return[e.D.ajax,e.D.pageViewEvent];case e.D.sessionReplay:return[e.D.sessionTrace];case e.D.pageViewTiming:return[e.D.pageViewEvent];default:return[]}}(t.featureName);n.every((e=>r[e]))||(0,l.Z)("".concat(t.featureName," is enabled but one or more dependent features has been disabled (").concat((0,D.P)(n),"). This may cause unintended consequences or missing data...")),this.features[t.featureName]=new t(this.agentIdentifier,this.sharedAggregator)}})),(0,T.Qy)(this.agentIdentifier,this.features,t)}catch(e){(0,l.Z)("Failed to initialize all enabled instrument classes (agent aborted) -",e);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,T.fP)();return delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.[t],delete this.sharedAggregator,r.ee?.abort(),delete r.ee?.get(this.agentIdentifier),!1}}}({features:[J,m,S,class extends h{static featureName=oe;constructor(t,r){if(super(t,r,oe,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;const n=this.ee;let i;(0,k.QU)(n),this.eventsEE=(0,k.em)(n),this.eventsEE.on(se,(function(e,t){this.bstStart=(0,p.z)()})),this.eventsEE.on(ae,(function(t,r){(0,s.p)("bst",[t[0],r,this.bstStart,(0,p.z)()],void 0,e.D.sessionTrace,n)})),n.on(ce+ne,(function(e){this.time=(0,p.z)(),this.startPath=location.pathname+location.hash})),n.on(ce+ie,(function(t){(0,s.p)("bstHist",[location.pathname+location.hash,this.startPath,this.time],void 0,e.D.sessionTrace,n)}));try{i=new PerformanceObserver((t=>{const r=t.getEntries();(0,s.p)(te,[r],void 0,e.D.sessionTrace,n)})),i.observe({type:re,buffered:!0})}catch(e){}this.importAggregator({resourceObserver:i})}},C,xe,B,class extends h{static featureName=de;constructor(e,r){if(super(e,r,de,!(arguments.length>2&&void 0!==arguments[2])||arguments[2]),!c.il)return;if(!(0,t.OP)(e).xhrWrappable)return;try{this.removeOnAbort=new AbortController}catch(e){}let n,i=0;const o=this.ee.get("tracer"),a=(0,k._L)(this.ee),s=(0,k.Lg)(this.ee),u=(0,k.BV)(this.ee),d=(0,k.Kf)(this.ee),f=this.ee.get("events"),l=(0,k.u5)(this.ee),h=(0,k.QU)(this.ee),g=(0,k.Gm)(this.ee);function m(e,t){h.emit("newURL",[""+window.location,t])}function v(){i++,n=window.location.hash,this[ve]=(0,p.z)()}function b(){i--,window.location.hash!==n&&m(0,!0);var e=(0,p.z)();this[pe]=~~this[pe]+e-this[ve],this[ye]=e}function y(e,t){e.on(t,(function(){this[t]=(0,p.z)()}))}this.ee.on(ve,v),s.on(be,v),a.on(be,v),this.ee.on(ye,b),s.on(ge,b),a.on(ge,b),this.ee.buffer([ve,ye,"xhr-resolved"],this.featureName),f.buffer([ve],this.featureName),u.buffer(["setTimeout"+le,"clearTimeout"+fe,ve],this.featureName),d.buffer([ve,"new-xhr","send-xhr"+fe],this.featureName),l.buffer([me+fe,me+"-done",me+he+fe,me+he+le],this.featureName),h.buffer(["newURL"],this.featureName),g.buffer([ve],this.featureName),s.buffer(["propagate",be,ge,"executor-err","resolve"+fe],this.featureName),o.buffer([ve,"no-"+ve],this.featureName),a.buffer(["new-jsonp","cb-start","jsonp-error","jsonp-end"],this.featureName),y(l,me+fe),y(l,me+"-done"),y(a,"new-jsonp"),y(a,"jsonp-end"),y(a,"cb-start"),h.on("pushState-end",m),h.on("replaceState-end",m),window.addEventListener("hashchange",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("load",m,(0,O.m$)(!0,this.removeOnAbort?.signal)),window.addEventListener("popstate",(function(){m(0,i>1)}),(0,O.m$)(!0,this.removeOnAbort?.signal)),this.abortHandler=this.#e,this.importAggregator()}#e(){this.removeOnAbort?.abort(),this.abortHandler=void 0}}],loaderType:"spa"})})(),window.NRBA=o})();</script><meta charset="UTF-8"/><meta name="robots" content="index, follow"/><meta name="DC.Creator" content="Shuheng Qin"/><meta name="DC.Creator" content="Yue Xu"/><meta name="DC.Creator" content="Hua Li"/><meta name="DC.Creator" content="Haiyan Chen"/><meta name="DC.Creator" content="Zhenwei Yuan"/><meta name="DC.title" content="Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy "/><meta name="DC.publisher" content="Royal Society of Chemistry"/><meta name="DC.Date" content="2021/12/21"/><meta name="DC.Identifier" scheme="doi" content="10.1039/D1BM00317H"/><meta name="DC.Language" content="en"/><meta name="citation_title" content="Recent advances in in situ oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy "/><meta name="citation_author" content="Shuheng Qin"/><meta name="citation_author" content="Yue Xu"/><meta name="citation_author" content="Hua Li"/><meta name="citation_author" content="Haiyan Chen"/><meta name="citation_author" content="Zhenwei Yuan"/><meta name="citation_online_date" content="2021/04/03"/><meta name="citation_date" content="2022"/><meta name="citation_journal_title" content="Biomaterials Science"/><meta name="citation_volume" content="10"/><meta name="citation_issue" content="1"/><meta name="citation_firstpage" content="51"/><meta name="citation_lastpage" content="84"/><meta name="citation_doi" content="10.1039/D1BM00317H"/><meta name="citation_pdf_url" content="https://pubs.rsc.org/en/content/articlepdf/2022/bm/d1bm00317h"/><meta name="citation_abstract_html_url" content="https://pubs.rsc.org/en/content/articlelanding/2022/bm/d1bm00317h"/><meta name="citation_fulltext_html_url" content="https://pubs.rsc.org/en/content/articlehtml/2022/bm/d1bm00317h"/><link rel="shortcut icon" href=""/><link type="text/css" rel="stylesheet" href="/content/stylesheets/rschtml2.css?ver=6_2_1"/><link href="https://www.rsc-cdn.org/oxygen/assets/webfonts/fonts.min.css" rel="stylesheet" type="text/css"/><link type="text/css" rel="stylesheet" href="/content/stylesheets/pubs-ui.min.css"/><meta name="viewport" content="width=device-width, initial-scale=1"/><script type="text/javascript" src="/content/scripts/JQueryPlugins.min.js"> </script><script type="text/javascript" src="/content/scripts/GetAnchorText.js"> </script><script type="text/javascript">
    
      $(function() {
      $("table.tgroup tfoot th").attr("colspan", "100");
      $("table.tgroup.rtable").each( function (idx, el) {
      var tw = $(this).width();
      $(this).parent().css("min-width", tw+"px");
      });

      });
      
    </script><!--6_2_1--></head><body class="oxy-ui pubs-ui ahtml-page"><!--Google Tag Manager (noscript)--><noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-56FZ7G" height="0" width="0" style="display:none;visibility:hidden"> </iframe></noscript><!--End Google Tag Manager (noscript)--><div class="viewport autopad"><div class="pnl pnl--drop autopad"><span id="top"/><div id="wrapper"><div class="left_head"><a class="simple" href="/"><img class="rsc-logo" border="0" src="/content/NewImages/royal-society-of-chemistry-logo.png" alt="Royal Society of Chemistry"/></a><br/><span class="btnContainer"><a class="btn btn--tiny btn--primary" target="_blank" title="Link to PDF version" href="/en/content/articlepdf/2022/bm/d1bm00317h">View PDF Version</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to previous article (id:d1bm01351c)" href="/en/content/articlehtml/2022/bm/d1bm01351c" target="_BLANK">Previous Article</a></span><span class="btnContainer"><a class="btn btn--tiny btn--nobg" title="Link to next article (id:d1bm01591e)" href="/en/content/articlehtml/2022/bm/d1bm01591e" target="_BLANK">Next Article</a></span></div><div class="right_head"><div id="crossmark_container"><div id="crossmark-content"><a id="open-crossmark" href="#" data-target="crossmark"><img style="max-width:100px" id="crossmark-logo" src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_square.svg" alt="Check for updates"/></a><script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"> </script></div></div> </div><div class="article_info"> DOI: <a target="_blank" title="Link to landing page via DOI" href="https://doi.org/10.1039/D1BM00317H">10.1039/D1BM00317H</a>
(Review Article)
<span class="italic"><a title="Link to journal home page" href="https://doi.org/10.1039/2047-4849/2013">Biomater. Sci.</a></span>, 2022, <strong>10</strong>, 51-84</div><h1 id="sect247"><span class="title_heading">Recent advances in <span class="italic">in situ</span> oxygen-generating and oxygen-replenishing strategies for hypoxic-enhanced photodynamic therapy</span></h1><p class="header_text">
      <span class="bold">
        
          
            Shuheng 
            Qin
          
        
      </span>, 
      <span class="bold">
        
          
            Yue 
            Xu
          
        
      </span>, 
      <span class="bold">
        
          
            Hua 
            Li
          
        
      </span>, 
      <span class="bold">
        
          
            Haiyan 
            Chen
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Haiyan Chen (orcid.org/0000-0002-1652-2730) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-1652-2730"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*<span class="bold"> and </span>
      <span class="bold">
        
          
            Zhenwei 
            Yuan
          
        
      </span><span class="orcid"><a target="_blank" title="Select to open ORCID record for Zhenwei Yuan (orcid.org/0000-0002-2339-7552) in a new window" id="connect-orcid-link" href="http://orcid.org/0000-0002-2339-7552"><img id="orcid-id-logo" src="/content/NewImages/orcid_16x16.png" alt="ORCID logo"/></a></span>*
      <br/><span class="italic">Department of Biomedical Engineering, School of Engineering, China Pharmaceutical University, 639 Longmian Road, Jiangning District, Nanjing 210009, China. E-mail: <a href="mailto:yuanzhenwei@cpu.edu.cn">yuanzhenwei@cpu.edu.cn</a>; <a href="mailto:chenhaiyan@cpu.edu.cn">chenhaiyan@cpu.edu.cn</a>;  Fax: +86-25-83271046;   Tel: +86-25-83271080</span>
    </p><div id="art-admin"><span class="italic bold">Received 
      24th February 2021
    </span><span class="bold italic">, Accepted 26th March 2021</span></div><p class="bold italic">First published on 3rd April 2021</p><hr/><div class="abstract"><h2>Abstract</h2><p>Cancer is a leading cause of death worldwide, accounting for an estimated 10 million deaths by 2020. Over the decades, various strategies for tumor therapy have been developed and evaluated. Photodynamic therapy (PDT) has attracted increasing attention due to its unique characteristics, including low systemic toxicity and minimally invasive nature. Despite the excellent clinical promise of PDT, hypoxia is still the Achilles’ heel associated with its oxygen-dependent nature related to increased tumor proliferation, angiogenesis, and distant metastases. Moreover, PDT-mediated oxygen consumption further exacerbates the hypoxia condition, which will eventually lead to the poor effect of drug treatment and resistance and irreversible tumor metastasis, even limiting its effective application in the treatment of hypoxic tumors. Hypoxia, with increased oxygen consumption, may occur in acute and chronic hypoxia conditions in developing tumors. Tumor cells farther away from the capillaries have much lower oxygen levels than cells in adjacent areas. However, it is difficult to change the tumor's deep hypoxia state through different ways to reduce the tumor tissue's oxygen consumption. Therefore, it will become more difficult to cure malignant tumors completely. In recent years, numerous investigations have focused on improving PDT therapy's efficacy by providing molecular oxygen directly or indirectly to tumor tissues. In this review, different molecular oxygen supplementation methods are summarized to alleviate tumor hypoxia from the innovative perspective of using supplemental oxygen. Besides, the existing problems, future prospects and potential challenges of this strategy are also discussed.</p></div><hr/>
    
      
      <h2 id="sect296"><span class="a_heading">1. Introduction</span></h2>
      <span>PDT is a promising modality for cancer treatment.<a title="Select to navigate to references" href="#cit1"><sup><span class="sup_ref">1</span></sup></a> It uses a photosensitizer in the presence of oxygen to ablate cancer cells by generating reactive oxygen (ROS) at a specific wavelength of irradiation.<a title="Select to navigate to references" href="#cit2"><sup><span class="sup_ref">2</span></sup></a> ROS species include singlet oxygen <small><sup>1</sup></small>O<small><sub>2</sub></small> (Type II PDT) and superoxide anion radical (O<small><sub>2</sub></small>˙<small><sup>−</sup></small>), hydroxyl radical (HO˙), and hydrogen peroxide (H<small><sub>2</sub></small>O<small><sub>2</sub></small>) (Type I PDT).<a title="Select to navigate to reference" href="#cit3"><sup><span class="sup_ref">3,4</span></sup></a> The two photochemical pathways for the photo-inducement of photosensitizers are classified as type I and type II. In most cases, the effect is achieved through a type II mechanism involving the conversion of triplet ground molecular oxygen (<small><sup>3</sup></small>O<small><sub>2</sub></small>) to its highly reactive singlet oxygen (<small><sup>1</sup></small>O<small><sub>2</sub></small>) analog.<a title="Select to navigate to reference" href="#cit3"><sup><span class="sup_ref">3,5</span></sup></a> However, the treatment method of type I PDT has also been reported in recent years.<a title="Select to navigate to reference" href="#cit6"><sup><span class="sup_ref">6–9</span></sup></a> This is the direct transfer of electrons or hydrogen atoms between photosensitizer (PS) and substrate molecules, usually resulting in the production of free radicals.<a title="Select to navigate to reference" href="#cit10"><sup><span class="sup_ref">10,11</span></sup></a> This process does not involve a large amount of O<small><sub>2</sub></small> consumption, and the fluorophore is a phenothiazine derivative.<a title="Select to navigate to references" href="#cit12"><sup><span class="sup_ref">12</span></sup></a> Peng's research group has conducted a study on photodynamic therapy to improve hypoxia by using this mechanism.<a title="Select to navigate to reference" href="#cit11"><sup><span class="sup_ref">11,12</span></sup></a> The difference between the two different types of photodynamic therapy lies in whether the therapy process is oxygen-dependent, and the mechanism of the two treatment modes is shown in <a title="Select to navigate to figure" href="#imgfig1">Fig. 1a</a>. Most of the existing PDT systems (Type II) are highly dependent on O<small><sub>2</sub></small> and consume a large amount of O<small><sub>2</sub></small> during treatment.<a title="Select to navigate to references" href="#cit13"><sup><span class="sup_ref">13</span></sup></a> The critical problem affecting the result of PDT is that the tumor's hypoxia and oxygen consumption during treatment will aggravate the degree of hypoxia,<a title="Select to navigate to references" href="#cit14"><sup><span class="sup_ref">14</span></sup></a> thus making the treatment effect worse.<a title="Select to navigate to reference" href="#cit15"><sup><span class="sup_ref">15,16</span></sup></a> In solid tumors, O<small><sub>2</sub></small> concentration varies with location, and oxygen levels in some internal regions are very low (partial pressure of O<small><sub>2</sub></small> &lt; 2.5 mmHg, severe tumor hypoxia),<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17,18</span></sup></a> contributing to the limited effectiveness of drug (doxorubicin) treatment,<a title="Select to navigate to references" href="#cit19"><sup><span class="sup_ref">19</span></sup></a> simultaneously due to the disruption of vascular growth factor balance, tumor invasiveness and resistance. To make matters worse, hypoxia in tumor tissue increases genetic instability, tumor progression, and metastasis-related problems.<a title="Select to navigate to reference" href="#cit20"><sup><span class="sup_ref">20,21</span></sup></a> while inhibiting the tumor response to cytotoxicity and targeted therapy; hypoxia is present in most cancer types,<a title="Select to navigate to reference" href="#cit22"><sup><span class="sup_ref">22,23</span></sup></a> common ones include pancreatic, breast, lung and prostate cancer. In recent years, many efforts have been made to defeat the photodynamic disturbance caused by hypoxia; among them, the method of increasing the O<small><sub>2</sub></small> supply of cancer tissues to treat cancer has also been proposed.<a title="Select to navigate to reference" href="#cit17"><sup><span class="sup_ref">17,24,25</span></sup></a> The core factor why anticancer drugs can hardly reach the tumor site is the separation of hypoxic tumor cells from blood.<a title="Select to navigate to references" href="#cit26"><sup><span class="sup_ref">26</span></sup></a> In this case, only a few given drugs can finally get to hypoxic tumors due to the hypoxia of the microenvironment, the decrease in drug reactivity and the decrease in affinity with DNA molecules, which are the Achilles’ heel of the treatment process.<a title="Select to navigate to reference" href="#cit27"><sup><span class="sup_ref">27,28</span></sup></a> The hyperbaric oxygen (HBO) treatment method has been proposed and related studies have been carried out.<a title="Select to navigate to references" href="#cit29"><sup><span class="sup_ref">29</span></sup></a> Pure oxygen is provided to patients in a pressurized chamber, breathing hyperbaric oxygen increases the pressure of oxygen, and when breathing, the oxygen content increases from 20% (50 Torr) to 100% (150–350 Torr) at 1 atm, which can advantageously reduce the hypoxia in tumor tissue and increase the sensitivity of tumor cells to drugs, increasing the curative effect in the treatment of tumor. The direct transport of oxygen molecules has been achieved using perfluorocarbon (PFC) materials approved by the FDA, such as C<small><sub>5</sub></small>F<small><sub>12</sub></small>. However, the problems of oxygen leakage and a frequent dose of tumor oxygenation strategy based on PFC have not been solved until now, which worsens the results of photodynamic therapy. Great achievements have been made in the study of anti-hypoxia-mediated tumor PDT; commonly used strategies of O<small><sub>2</sub></small> supplementation include using organic or inorganic catalysts to catalyze endogenous H<small><sub>2</sub></small>O<small><sub>2</sub></small>,<a title="Select to navigate to reference" href="#cit30"><sup><span class="sup_ref">30–32</span></sup></a> water splitting,<a title="Select to navigate to reference" href="#cit33"><sup><span class="sup_ref">33,34</span></sup></a> oxygen transportation,<a title="Select to navigate to references" href="#cit35"><sup><span class="sup_ref">35</span></sup></a> PFC, and respiratory inhibitors,<a title="Select to navigate to reference" href="#cit36"><sup><span class="sup_ref">36,37</span></sup></a> and the primary purpose is to improve the therapeutic effect of PDT by relieving hypoxia.<a title="Select to navigate to reference" href="#cit38"><sup><span class="sup_ref">38–41</span></sup></a> So far, the primary methods are divided into two categories, namely: (1) improve the tumor microenvironment and relieve hypoxia; and (2) improve tumor hypoxia through various oxygen delivery carriers, for example, nanoparticles designed according to different mechanisms for tumor oxygenation and enhanced cancer therapy, including fluorocarbons, hemoglobin, and oxygen-carrying nano-platforms.</span>
      <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig1"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f1.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f1.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 1 </b> <span id="fig1"><span class="graphic_title">Scheme illustration of the photochemical reactions for type I and type II PDT. (b) Schematic diagrams of the novel strategies to significantly promote the efficiency of PDT by relieving tumor hypoxia in different ways.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
    
    
      
      <h2 id="sect348"><span class="a_heading">2. Improve the tumor microenvironment and relieve hypoxia</span></h2>
      
        
        <h3 id="sect351"><span class="b_heading">2.1 Photosynthesis produces O<small><sub>2</sub></small></span></h3>
        <span>In the emergence and evolution of life on Earth, the primitive photosynthesis of microorganisms such as cyanobacteria and Archaea has been essential for the generation of molecular oxygen.<a title="Select to navigate to references" href="#cit42"><sup><span class="sup_ref">42</span></sup></a> Photosynthetic cyanobacteria are a kind of prokaryote that can grow with solar energy and CO<small><sub>2</sub></small> as the only energy and carbon source.<a title="Select to navigate to references" href="#cit43"><sup><span class="sup_ref">43</span></sup></a> Microalgae are naturally occurring single-celled microorganisms capable of photosynthesis that are used for biofuel and nutrition applications and animal feed, and as myocardial oxygenation factors for tissue-healing myocardial repair.<a title="Select to navigate to references" href="#cit44"><sup><span class="sup_ref">44</span></sup></a> It has been reported that engineered living microalgae are transported to anoxic tumor areas to increase local oxygen levels and re-sensitize drug-resistant cancer cells to radiation and light, and heat. Through the study, we found that the oxygen produced <span class="italic">in situ</span> through photosynthesis mediated by microalgae significantly improves the anoxic environment in the tumor, resulting in a significant effect of radiotherapy, and many literature studies have reported that <span class="italic">Chlorella</span> contains a variety of immunostimulatory substances, which can be used for the immunotherapy of tumors at the same time.<a title="Select to navigate to reference" href="#cit45"><sup><span class="sup_ref">45–47</span></sup></a> Oxygen production mainly depends on the active oxygen produced by the chlorophyll of microalgae during laser irradiation, which further enhances photosensitivity and tumor cell apoptosis. It is an innovative treatment strategy for photosynthesis to produce oxygen to alleviate tumor hypoxia.</span>
        <p class="otherpara">The tumor's hypoxic environment limits the cytotoxicity of many chemotherapeutic agents by blocking the ROS that are produced within the cell and leads to the inevitable recurrence and metastasis of cancer. Therefore, hypoxic tumors are rarely cured, but hypoxia in tumor tissues has been explored. Microbiology has provided some important reference value for researchers in agriculture, industry and public health research fields. As early as the late 19<small><sup>th</sup></small> century, W. Busch and W. Coley began trying to treat tumors with microorganisms.<a title="Select to navigate to references" href="#cit48"><sup><span class="sup_ref">48</span></sup></a> They treated sarcoma patients independently with <span class="italic">Streptococcus pyogenes</span> and <span class="italic">Serratia marcescens</span> and observed significant improvements in malignant tumors after treatment. This application is more promising because bacteria have excellent tumor targeting ability and are easy to obtain.<a title="Select to navigate to references" href="#cit49"><sup><span class="sup_ref">49</span></sup></a> In recent years, masses of studies have used these characteristics of bacteria to target tumor tissue, activate the nano-system in different ways <span class="italic">in situ</span>, and finally achieve drug release or combination therapy and accurate cancer treatment<a title="Select to navigate to reference" href="#cit44"><sup><span class="sup_ref">44,50</span></sup></a></p>
        <p class="otherpara">Against this background, Shi and collaborators have reported a chlorin e6 (Ce6)-integrated photosensitive cell.<a title="Select to navigate to references" href="#cit51"><sup><span class="sup_ref">51</span></sup></a> This was established by the modification of cyanobacteria (producing O<small><sub>2</sub></small> by photosynthesis) with the photosensitizer Ce6. With the irradiation of a 660 nm laser, photosynthesis produces O<small><sub>2</sub></small>, which is directly used by the PDT process and increases the PDT effect (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2a</a>). In addition to the application of Ce6 photosensitizer, the study was also extended to another negatively charged chlorin-based photosensitizer, protoporphyrin (Ppix), to construct Ppix hybrid cyanobacteria cells (Ppix-Cyan). With free Ce6, with different laser power densities (10, 20, and 30 mW cm<small><sup>−2</sup></small>), the change of dissolved oxygen (DO) in solution fluctuates over the range of 10 mmol<small><sup>−1</sup></small>, indicating the dynamic equilibrium of oxygen dissolution–evaporation. Hybrid bacteria ceCyan can increase the DO to 24.7 μmol L<small><sup>−1</sup></small> after 10 minutes of 20 mW cm<small><sup>−2</sup></small> excitation power, and on increasing this to 30 mW cm<small><sup>−2</sup></small>, DO significantly increased by 2.34 times (compared with the lower power of 20 mW cm<small><sup>−2</sup></small>). This indicated that cyanobacteria had high photosynthetic and oxygenation performance (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2b</a>). When using the free radical trapping agent 2,2,6,6-tetramethylpiperidine (TEMP) to verify the free radicals’ production, cyanobacteria were added, and the free radicals increased gradually with the increase of concentration, which further indicated that O<small><sub>2</sub></small> supplementation would increase the production of ROS in the process of PDT. The promoting effect of oxygen mitigation on ROS was also explored, and a Singlet Oxygen Sensor Green (SOSG) probe was used to observe the production of <small><sup>1</sup></small>O<small><sub>2</sub></small> in cells. After cyanobacteria, free Ce6 photosensitizer and ceCyan cells were co-incubated with the same intensity and time of light exposure and were observed by confocal fluorescence microscope; bright fluorescence of SOSG could only be observed in ceCyan-PDT treated cells, which indicated that significant <small><sup>1</sup></small>O<small><sub>2</sub></small> was produced by cascade photosynthesis and photodynamics. The hypoxia indicator [Ru(dpp)<small><sub>3</sub></small>]Cl<small><sub>2</sub></small> was also used to further verify that the hybrid bacteria irradiated by laser changed the state of hypoxia (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2c</a>). The oxygenation effect on tumor <span class="italic">in vivo</span> was studied by photoacoustic (PA) imaging accompanied by B-mode ultrasound (US) imaging using oxygen saturation mode (<small><sub>S</sub></small>O<small><sub>2</sub></small>), showing the continuous effect of oxygen production <span class="italic">in vivo</span> (<a title="Select to navigate to figure" href="#imgfig2">Fig. 2d</a>).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig2"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f2_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f2.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f2.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 2 </b> <span id="fig2"><span class="graphic_title">(a) Schematic diagram of the photodynamic process of photosynthesis enhancement. (b) After 660 nm laser irradiation for 10 minutes, the DO level changes (with or without cyanobacteria). (c) A hypoxia-sensitive probe and ROS indicator probe indicate the degree of hypoxia and ROS production of 4T1 cells after different treatments. (d) US and PA imaging and their combined images were performed on the tumor sections after intracranial injection of cyanobacteria and subsequent laser irradiation for tumor oxidation <span class="italic">in vivo</span>. Reproduced from ref. <a title="Select to navigate to references" href="#cit51">51</a> with permission from Wiley, copyright 2019.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Gold nanorods (AuNRs) showed excellent performance in expanding the tumor vasculature; after continuously irradiating with an NIR laser, the local temperature would increase to 42 °C,<a title="Select to navigate to references" href="#cit52"><sup><span class="sup_ref">52</span></sup></a> and thus the results of this can be utilized for promoting the release of oxygen-dependent drugs in hypoxic tumors.<a title="Select to navigate to references" href="#cit53"><sup><span class="sup_ref">53</span></sup></a> Similarly, a <span class="italic">Chlorella</span> AuNRs BSA-Gel was developed by Yu Seok Youn's research group;<a title="Select to navigate to references" href="#cit54"><sup><span class="sup_ref">54</span></sup></a> this is a BSA-PEG-based hydrogel library system containing <span class="italic">Chlorella</span> and gold nanorods. AuNRs are an attractive material, as high temperature can cause irreversible damage to tumor cells.<a title="Select to navigate to reference" href="#cit55"><sup><span class="sup_ref">55,56</span></sup></a> Chlorella can produce oxygen in local tumor tissue through photosynthesis under 808 nm excitation, without increasing whole-body oxygen content. The tumor will be ablated, together with using the drug doxorubicin after relieving tumor hypoxia. CT imaging of the tumor tissue with <span class="italic">Chlorella</span> AuNRsBSA-Gel was undertaken.</p>
        <p class="otherpara">In contrast to the PBS control group, the imaging ability of this system was good. The photosynthetic oxygen-production capacity of AuNRs BSA-Gel and the control group with or without 660 nm laser irradiation was evaluated. The data show its superior performance in oxygen production. The intracellular ROS production level of each group of 4T1 cells was observed by CLSM under normoxic and anoxic conditions. It was also proved that drug treatment with Dox was needed to produce ROS under the condition of oxygen to realize the ablation of tumor cells. The study on the anti-tumor effect of <span class="italic">Chlorella AuNRs</span> BSA-Gel on mice transplanted with 4T1 cells showed that the production of oxygen in the presence of <span class="italic">Chlorella</span> could promote tumor ablation.</p>
        <p class="otherpara">Through <span class="italic">Chlorella</span> photosynthesis, the oxygen generation strategy can be combined into different nano-systems, effectively providing oxygen to hypoxic tumor cells.<a title="Select to navigate to reference" href="#cit57"><sup><span class="sup_ref">57,58</span></sup></a> Both chemotherapy drugs and photodynamic therapy have high application expectations in treating hypoxic tumors.<a title="Select to navigate to references" href="#cit59"><sup><span class="sup_ref">59</span></sup></a> Jiang's research group designed an autotrophic light-triggered green oxygen supply machine (ALGAE),<a title="Select to navigate to references" href="#cit60"><sup><span class="sup_ref">60</span></sup></a> which was constituted of <span class="italic">Chlorella pyrenoidosa</span> and alginate by calcium cross-linking. The photodynamic oxygen generation ability induced by the algal system is different. After verification, they found that the oxygen production and repetitive oxygen production of <span class="italic">Chlorella</span> under irradiation conditions were better than in the dark. When Ce6 is irradiated by a 635 nm laser, the energy is transferred from Ce6 to the supplementary oxygen produced by the algae system, creating more singlet oxygen. Oxygen produced by photosynthesis can alleviate hypoxia during PDT therapy, down-regulate HIF-1α and VEGF expression, and up-regulate the expression of E-cadherin. This is consistent with the previously reported hypoxia-inducible HIF-1α inducing up-regulation of VEGF expression and E-cadherin loss, even with tumor progression and metastasis.<a title="Select to navigate to reference" href="#cit61"><sup><span class="sup_ref">61,62</span></sup></a> The wound healing experiment showed the comparison group's cell fusion rate, and those of the routine PDT treatment group, and algae PDT treatment group after 24 hours, and indicated that PDT with algae treatment can better inhibit cell metastasis. Through H&amp;E staining and TUNEL, and <span class="italic">in vivo</span> anticancer therapy, we can conclude that oxygen production by photosynthesis, which relied on algae implanted near the tumor tissue, can increase the proportion of apoptosis induced by PDT. The anti-cancer treatment <span class="italic">in vivo</span> was studied by using the model of the 4T1 tumor-bearing mouse, and the therapeutic potential of algae was proved again. The active photosynthetic bacteria Syne was also used for PDT.<a title="Select to navigate to references" href="#cit50"><sup><span class="sup_ref">50</span></sup></a> The photosensitized encapsulated nanoparticles (HSA/ICG) were assembled by intermolecular disulfide cross-linking and linked to the surface of the Syne. Then takes shape a biomimetic system (S/HSA/ICG) with photosynthesis and PDT effects (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3a</a>). Syne is used as the targeted photosensitizer promoting the delivery of ICG to the tumor (FL images of the mice up to 72 h) and photocatalytic oxygen production <span class="italic">in situ</span>. It is verified by PA imaging that Syne can achieve an anti-tumor immune response with 660 nm laser irradiation through mediation of O<small><sub>2</sub></small> self-sufficient PDT and immunogenic cell death (ICD). And, the temperature of S/HSA/ICG irradiated by 808 nm laser is as high as 77.8 °C. The synergistic effect of PDT/PTT can induce 84% cell death, achieve good bactericidal ability, and affect the viability and growth of bacteria to a great extent. After intravenous injection of S/HSA/ICG into mice, it accumulates effectively under laser irradiation through photosynthesis, continuously produces oxygen, significantly relieves tumor hypoxia, and enhances active oxygen production. Thus it achieved complete ablation of triple-negative breast cancer without primary tumor metastasis, and there was no tumor recurrence after 24 days of continuous treatment.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig3"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f3_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f3.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f3.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 3 </b> <span id="fig3"><span class="graphic_title">(a) Schematic diagram of the photosensitizer (HSA/ICG) conjugated with Syne as an <span class="italic">in situ</span> photocatalytic oxygen generation system for PDT. Syne and HAS have strong tumor-targeting ability. Syne accumulates in the tumor tissue and produces oxygen under laser irradiation, enhancing the efficacy of PDT therapy and reversing the tumor immunosuppressive microenvironment. In the 4T1 MTNBC mouse model, Syne (S/HSA/ICG NP coated) can synergistically inhibit local and metastatic tumors. Reproduced from ref. <a title="Select to navigate to references" href="#cit50">50</a> with permission from Wiley, copyright 2020. (b) During tumor hypoxia, laser irradiation produces oxygen through photosynthesis, and oxygen collection is used for sustainable PDT. Reproduced from ref. <a title="Select to navigate to references" href="#cit63">63</a> with permission from Elsevier, copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Similarly, one of the advantages of PDT therapy is that it promotes an anti-tumor immune response and sustained oxygen release. A self-enriched oxygen photodynamic therapy (Oxy-PDT) was established through loading a photosensitizer into PFC nanodroplets (<a title="Select to navigate to figure" href="#imgfig3">Fig. 3b</a>).<a title="Select to navigate to references" href="#cit63"><sup><span class="sup_ref">63</span></sup></a> This is a novel, long-lasting PDT that is controlled by light and enables photosynthesis to produce oxygen. With the high oxygen-carrying capacity of PFC, a high oxygen content can be sustained. Therefore, although the tumor oxygen content is still limited in the PDT process, sufficient O<small><sub>2</sub></small> could be enriched in perfluorinated carbon nanodroplets for consumption by loaded photosensitizers. Thus, by improving the photodynamic efficiency, persistent PDT also promoted the activation of DCs and enhanced the anti-tumor immunity. After stopping the light, <span class="italic">Chlorella</span> further served as an adjuvant to promote (DC) activation in dendritic cells and promoted the anti-tumor immune response. Moreover, <small><sup>1</sup></small>O<small><sub>2</sub></small> exists much longer in PFC than in the cellular environment or water. Therefore, Oxy-PDT can help photosensitizers reach their full therapeutic potential. <span class="italic">In vivo</span> studies have revealed that tumor growth in Oxy-PDT-treated mice was inhibited after Oxy-PDT was injected into the tumor. Besides, when Oxy-PDT was injected intravenously into tumor-bearing mice, the treatment results showed that it could significantly inhibit tumor growth. At the same time, normal PDT didn't get such impressive results.</p>
        <p class="otherpara">Due to the use of chlorella, the tumor tissues of mice need to be dissected before the chlorella can be implanted into the tumor tissues, and after the implantation, the chlorella needs to be sutured. Therefore, Zhang's team developed a new strategy, which relies on an injectable hydrogel (ALG-MI-S2973) to achieve the same photosynthetic function to produce oxygen, and the oxygen pump based on S.2973 is compounded with silica nanoparticles loaded with ICG.<a title="Select to navigate to references" href="#cit64"><sup><span class="sup_ref">64</span></sup></a> After evaluating the effect of PDT, they found that PDT is feasible. This novel strategy of photo-oxygen-dynamic therapy (PODT) combined a light-driven biological oxygen pump and PDT for the rapid growth of <span class="italic">Synechococcus elongatus</span> UTEX 2973. This method reduces the damage to the body. Still, the biggest advantage is that the treatment process becomes fast and convenient and is expected to be used in clinic by its hypoxia relieving properties. Besides, most of the previous studies used the same excitation wavelength for photosynthesis and the PDT trigger. Zhang's team creatively separated the growth of S.2973 and the stimulus of PDT through disparate wavelengths of laser, avoiding the damaging effect of ROS on S.2973 induced by PDT in the early stages of treatment. Hence, a result of maximum oxygen production can be ensured. The excellent oxygen production of ALG-MI-S2973 can significantly reduce HIF-1α under the action of an oxygen pump, and the inhibition rate of 4T1 tumor cells is almost 100%.</p>
        <p class="otherpara">Cyanobacteria are prokaryotes with a highly differentiated membrane system capable of photosynthesis. They have thylakoid membranes that perform fully functional photosynthetic and respiratory electron transport chain functions. The existence of different membrane systems gives a unique complexity to the cells of these bacteria. The efficient O<small><sub>2</sub></small> production of chloroplasts is attributed to their delicate Z-type structure, which is composed of two different light systems (PS-I and PS-II) that located on the chloroplast thylakoid membrane (TM).<a title="Select to navigate to references" href="#cit65"><sup><span class="sup_ref">65</span></sup></a> Yan <span class="italic">et al.</span> constructed UCTM NPs by combining thylakoid membrane with upconversion nanoparticles, which was formed by modifying chloroplast thylakoid membrane with upconversion nanoparticles to release oxygen to promote the production of ROS.<a title="Select to navigate to references" href="#cit66"><sup><span class="sup_ref">66</span></sup></a> Under the irradiation by a 980 nm laser, UCNPs can emit red light to activate PS-I and PS-II of the TM to promote the production of oxygen in water. <span class="italic">In vivo</span> experiments have proved that UCTM NPs have excellent biocompatibility, and 980 nm laser irradiation in PDT can effectively remove anoxic tumors in mice. Also, the publications about photosynthesis to produce oxygen were summaried in <a title="Select to navigate to table" href="#tab1">Table 1</a>.</p>
        
<div class="table_caption"><b>Table 1</b> <span id="tab1">Summary of publications about photosynthesis to produce oxygen</span>
		</div>

            <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="49.29pt"/><col align="left" width="62.00pt"/><col align="left" width="177.41pt"/><col align="left" width="43.64pt"/><col align="left" width="36.01pt"/><col align="left" width="75.40pt"/><col align="left" width="44.28pt"/><col align="left" width="83.29pt"/><col align="left" width="81.36pt"/><col align="left" width="25.62pt"/></colgroup>
              
              
              
              
              
              
              
              
              
              
              <thead align="left">
                <tr align="left" valign="bottom">
                  <th align="left" valign="bottom" class="border_black">Application</th>
                  <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                  <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                  <th align="left" valign="bottom" class="border_black">ROS species</th>
                  <th align="left" valign="bottom" class="border_black">PSs</th>
                  <th align="left" valign="bottom" class="border_black">Cyanobacterial cells</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vitro</span> (cells)</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                  <th align="left" valign="bottom" class="border_black">DO</th>
                  <th align="left" valign="bottom" class="border_black">Ref.</th>
                </tr>
              </thead>
              <tfoot align="left">
                <tr align="left">
                  <th colspan="10">Abbreviations: chlorin e6 (Ce6); <span class="italic">Synechococcus elongatus</span> PCC 7942 strain (<span class="italic">S. elongatus</span> PCC 7942); <span class="italic">Synechococcus elongatus</span> UTEX 2973 (<span class="italic">S. elongatus</span> UTEX 2973); hypoxia alleviation assessment (HAA), photosystem-I (PS-I) and photosystem-II (PS-II), thylakoid membranes (TM).</th>
                </tr>
              </tfoot>
              <tbody align="left">
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Photosynthesis</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 660 nm, 20 mW cm<small><sup>−2</sup></small>, 15 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">Ce6</td>
                  <td rowspan="2" valign="top">
                    <span class="italic">S. elongatus</span> PCC 7942</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">57.9 μmol L<small><sup>−1</sup></small> (30 mW cm<small><sup>−2</sup></small>)</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit51">51</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 660 nm, 50 mW cm<small><sup>−2</sup></small></td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">Photosynthesis</td>
                  <td valign="top">635 nm, 50 mW cm<small><sup>−2</sup></small></td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">Ce6</td>
                  <td valign="top">
                    <span class="italic">Chlorella</span>
                  </td>
                  <td valign="top">4T1</td>
                  <td valign="top">4T1</td>
                  <td valign="top">∼10.0 mg L<small><sup>−1</sup></small> (50 mW cm<small><sup>−2</sup></small>)</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit60">60</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="3" valign="top">PDT</td>
                  <td rowspan="3" valign="top">Photosynthesis</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 660 nm, 0.1 W cm<small><sup>−2</sup></small>, 5 min</td>
                  <td rowspan="3" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="3" valign="top">ICG</td>
                  <td rowspan="3" valign="top">
                    <span class="italic">S. elongatus</span> PCC 7942</td>
                  <td rowspan="3" valign="top">4T1</td>
                  <td rowspan="3" valign="top">4T1 mTNBC</td>
                  <td rowspan="3" valign="top">∼6.0 mg L<small><sup>−1</sup></small></td>
                  <td rowspan="3" valign="top">
                    <a title="Select to navigate to references" href="#cit50">50</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">808 nm, 0.8 W cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 660/808 (5 min), sequential radiation</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Photosynthesis</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 660 nm, 1 W cm<small><sup>−2</sup></small></td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">Ce6</td>
                  <td rowspan="2" valign="top">
                    <span class="italic">Chlorella</span>
                  </td>
                  <td rowspan="2" valign="top">CT26</td>
                  <td rowspan="2" valign="top">CT26</td>
                  <td rowspan="2" valign="top">∼90 μM (170 mW cm<small><sup>−2</sup></small>)</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit63">63</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 660 nm, 170 mW cm<small><sup>−2</sup></small>, 5 min (HAA); 660 nm, 1 W cm<small><sup>−2</sup></small>, 30 s (PDT)</td>
                </tr>
                <tr align="left">
                  <td rowspan="3" valign="top">PDT</td>
                  <td rowspan="3" valign="top">Photosynthesis</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 808 nm, 2 W cm<small><sup>−2</sup></small></td>
                  <td rowspan="3" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="3" valign="top">ICG</td>
                  <td rowspan="3" valign="top">Cyanobacteria</td>
                  <td rowspan="3" valign="top">4T1</td>
                  <td rowspan="3" valign="top">4T1</td>
                  <td rowspan="3" valign="top">8 mg L<small><sup>−1</sup></small> (0.25 W cm<small><sup>−2</sup></small>)</td>
                  <td rowspan="3" valign="top">
                    <a title="Select to navigate to references" href="#cit64">64</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 640 nm, 0.25 W cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td valign="top">808 nm, 0.25 W cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Photosynthesis</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 980 nm, 0.5 W cm<small><sup>−2</sup></small>, 10 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">PS-I, PS-II</td>
                  <td rowspan="2" valign="top">TM</td>
                  <td rowspan="2" valign="top">3T3, 4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">200 µg mL<small><sup>−1</sup></small></td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit65">65</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 980 nm, 0.5 W cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
              </tbody>
            </table></div></div>
          <hr class="hrule"/><br/>
      
      
        
        <h3 id="sect619"><span class="b_heading">2.2 Improving tumor hypoxia by generating O<small><sub>2</sub></small><span class="italic">in situ</span></span></h3>
        <div>
          
          <span id="sect624"/><span class="c_heading_indent">2.2.1 Catalase catalysis. </span>
          <span>Hydrogen peroxide (H<small><sub>2</sub></small>O<small><sub>2</sub></small>) can be produced in mitochondria and has as a vital role in physiological metabolism. In both normal and tumor tissues, catalase, as an important biological enzyme, lets cells escape from the oxidative damage with its highly efficient catalytic decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small>. H<small><sub>2</sub></small>O<small><sub>2</sub></small> can be produced in large amounts in tumor tissue (50–100 μM), which is significantly higher than normal tissue and is closely related to the tumor's occurrence and development. A large amount of H<small><sub>2</sub></small>O<small><sub>2</sub></small> will promote cell carcinogenesis and abnormal cell proliferation, angiogenesis, and DNA damage, and promote tumor cell infiltration and metastasis. Therefore, in the photodynamic therapy, the decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small> into oxygen in the tumor tissue can improve the local oxygen level and improve the therapeutic effect. This strategy is also used continuously by wrapping catalase and photosensitizer into the nano-system and applying it to the treatment of the tumor.<a title="Select to navigate to references" href="#cit67"><sup><span class="sup_ref">67</span></sup></a></span>
          <p class="otherpara">For example, the polymer vesicle named HC@P1-Vesicle was designed,<a title="Select to navigate to references" href="#cit68"><sup><span class="sup_ref">68</span></sup></a> and H<small><sub>2</sub></small>O<small><sub>2</sub></small> and polyamide dendrimer (CC-PAMAM) was assembled with ROS responsive triblock copolymers. When different excitation light was used as a trigger for oxygen production and the release of CC-PAMAM, it showed different therapeutic effects. Under irradiation (805 nm), the photothermal treatment effect was triggered, resulting in the thermal decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small>. Under excitation light irradiation of 660 nm, photoactive CC-PAMAM is allowed to be released from the vesicles to achieve complete ablation of hypoxic, low-osmotic pancreatic tumors, and the therapeutic effect of this method is the best (<a title="Select to navigate to figure" href="#imgfig4">Fig. 4a</a>). Aiming at tumor therapy, Lei's group used nanoparticles for PDT and PTT. They designed BQ-MIL@cat-MIL nanoparticles based on the metal–organic skeleton (MOF).<a title="Select to navigate to references" href="#cit69"><sup><span class="sup_ref">69</span></sup></a> By accurately wrapping black phosphorus quantum dots (BQ) and catalase in the inner and outer layers of the MOF, H<small><sub>2</sub></small>O<small><sub>2</sub></small> was converted into O<small><sub>2</sub></small> in the stable outer layer of catalase in the MOF. Then O<small><sub>2</sub></small> was directly injected into MOF-sensitized BQ (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5a</a>). A high singlet oxygen quantum yield was obtained, and photodynamic-thermal synergistic therapy was achieved <span class="italic">in vitro</span> and <span class="italic">in vivo</span>.</p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig4"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f4_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f4.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f4.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 4 </b> <span id="fig4"><span class="graphic_title">(a) The treatment results of BxPC-3 tumor-bearing BALB/c nude mice with different therapies. Reproduced from ref. <a title="Select to navigate to references" href="#cit68">68</a> with permission from Wiley, copyright 2017. (b) The therapeutic process and mechanism demonstration of multifunctional CMGCC nanoclusters. Reproduced from ref. <a title="Select to navigate to references" href="#cit72">72</a> with permission from the American Chemical Society, copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig5"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f5_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f5.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f5.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 5 </b> <span id="fig5"><span class="graphic_title">(a) A schematic diagram of the stepwise assembly process of BQ and catalase in homologous MOF aims to enhance therapy against hypoxic tumor cells. Reproduced from ref. <a title="Select to navigate to references" href="#cit69">69</a> with permission from Wiley, copyright 2018. (b) Schematic illustration for the preparation of O<small><sub>2</sub></small>@UiO-66@ICG@RBC and the NIR-triggered O<small><sub>2</sub></small> releasing and enhanced PDT mechanism. Reproduced from ref. <a title="Select to navigate to references" href="#cit70">70</a> with permission from Elsevier B.V., copyright 2018. (c) The nanoparticles of PLGA-FA/IR780-H<small><sub>2</sub></small>O<small><sub>2</sub></small>, and illustrations of their application for PTT/PDT. Reproduced from ref. <a title="Select to navigate to references" href="#cit71">71</a> with permission from the Royal Society of Chemistry, copyright 2018. (d) A schematic diagram of a nano-catalase system (Cat@PDS) that enhances chemotherapy–photodynamic therapy by decomposing and releasing oxygen through the phospholipid membrane coating. Reproduced from ref. <a title="Select to navigate to references" href="#cit74">74</a> with permission from Elsevier B.V., copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">Progress has been made in photodynamic-thermal synergistic therapy both <span class="italic">in vivo</span> and <span class="italic">in vitro</span>, and it further promotes apoptosis and activates caspase-3. Combining all the merits, it is considered a promising therapeutic platform for the anti-hypoxic tumor microenvironment. With the metal–organic skeleton (MOF), it makes use of its gas adsorption ability to prepare a bionic oxygen evolution PDT nano-platform with long cycle characteristics.<a title="Select to navigate to references" href="#cit70"><sup><span class="sup_ref">70</span></sup></a> Simultaneously, the photothermal effect of a near-infrared thermo-sensitizer was used to catalyze oxygen production from hydrogen peroxide. UiO-66@ICG@RBC nanoparticles were designed using zirconium-based MOF (UIO-66) as an oxygen storage carrier (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5b</a>). Afterwards this was coupled with ICG (coordination reaction) and this then continued by coating with the erythrocyte membrane. The photothermal properties of ICG can promote the sudden release of O<small><sub>2</sub></small> in UIO-66. Afterward, the production of O<small><sub>2</sub></small> was able to improve the therapeutic effect of PDT on hypoxic tumors. The same strategy used triggered photo-thermotherapy to thermally decompose H<small><sub>2</sub></small>O<small><sub>2</sub></small>.<a title="Select to navigate to references" href="#cit71"><sup><span class="sup_ref">71</span></sup></a> The nanoparticles (PLGA–FA/IR780–H<small><sub>2</sub></small>O<small><sub>2</sub></small>NPs) were constructed from core–shell poly(lactic-<span class="italic">co</span>-glycolic acid) nanoparticles (PLGA) and a H<small><sub>2</sub></small>O<small><sub>2</sub></small>/poly(vinylpyrrolidone) complex (O<small><sub>2</sub></small> source) covalently bound to the targeted unit of folic acid and embedded in a shell IR780 diode (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5c</a>). In <span class="italic">in vitro</span> experiments, the cell survival rate was analyzed by irradiation for one minute (808 nm, 0.5 mW cm<small><sup>−2</sup></small>), and the cell viability was reduced by about 80%, indicating the photothermal effect and ROS production ability of this nano-system. The <span class="italic">in vivo</span> experiment confirmed that the photothermal effect promoted the thermal decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small> and increased the local O<small><sub>2</sub></small> concentration of the tumor during photothermal therapy. Simultaneously, a therapeutic experiment in HepG2 tumor-bearing mice further demonstrated the good tumor-therapeutic effect of this nano-system.</p>
          <p class="otherpara">The core–shell nano-system has some special advantages; the nanoparticle RC@RFC was constructed that can combat tumor resistance to PDT, change the hypoxia state of the tumor and inhibit the expression of HIF-1α at the same time.<a title="Select to navigate to references" href="#cit73"><sup><span class="sup_ref">73</span></sup></a> This nano-system, through self-assembly of hydrophobic rapamycin (RAP) and photosensitizer Ce6, forms the carrier-free double drug and then coats the surface with a layer of the metal–organic skeleton (MOF) to support catalase. The total drug loading reaches 60%, and this nano-system can be passively accumulated in the tumor tissue. For evaluation of the RC@RFC nanoparticles’ effect on tumor growth by activating the nanoparticles’ activity with the help of light irradiation, the therapeutic effect is reflected directly according to the change of tumor volume. Hyper-hypoxic tumors showed a strong effect of PDT. The <span class="italic">in situ</span> O<small><sub>2</sub></small> production of RC@TFC nanoparticles and the dissolved oxygen level under laser irradiation were analyzed, which showed that RC@TFC showed a concentration dependence and adequate continuous oxygen production capacity. Besides, the nanoparticles of Cat@PDS could target tumor tissue by wrapping catalase nanoparticles in a polyethylene glycol phospholipid membrane (<a title="Select to navigate to figure" href="#imgfig5">Fig. 5d</a>).<a title="Select to navigate to references" href="#cit74"><sup><span class="sup_ref">74</span></sup></a> After the process of PDT, the tumor O<small><sub>2</sub></small> content was increased, and the expression of HIF-1α decreased, which finally had a remarkable inhibitory effect on tumor growth and led to 97.2% inhibition of lung metastasis. Using the catalase-catalyzed hydrogen peroxide oxygen production strategy, a tumor-targeted bioreactor LIP-IR-CAT was designed by co-loading liposomes with IR780 and catalase.<a title="Select to navigate to references" href="#cit75"><sup><span class="sup_ref">75</span></sup></a> Based on the high fluorescence quantum yield (up to 0.127) of the IR780 photosensitizer and the specific targeting of mitochondria, the physical and chemical problems of IR780 as a single photosensitizer were solved by using this method of a NIR fluorescence probe loaded on liposomes. Intra-tumor oxygen saturation was monitored by PA imaging. The results show that the oxygen produced by LIP-IR-CAT in the tumor can supplement the O<small><sub>2</sub></small> consumption during PDT and provide additional O<small><sub>2</sub></small> to relieve tumor hypoxia. At the same time, after the application of this nano-reactor, the PDT effect in tumor-bearing mice was noteworthily stronger than that in the other control groups, and the level of ATP was significantly lower (about 68.8%). The content of glutathione (GSH) in tumor cells is at least 4 times higher than that in normal cells.<a title="Select to navigate to reference" href="#cit76"><sup><span class="sup_ref">76,77</span></sup></a> It is worth noting that the GSH in intracellular fluid is also 10–1000 times higher than in extracellular fluid.<a title="Select to navigate to references" href="#cit78"><sup><span class="sup_ref">78</span></sup></a> Therefore, the efficiency of PDT can be improved by adding MnO<small><sub>2</sub></small> to nano-systems capable of targeting tumor tissue by reacting with glutathione. Based on this strategy of consuming intracellular GSH to enhance the therapeutic effect of PDT, a multi-functional nano-platform CMGCC was developed,<a title="Select to navigate to references" href="#cit72"><sup><span class="sup_ref">72</span></sup></a> which consists of catalase (CAT) and MnO<small><sub>2</sub></small> nanoparticles integrated with Ce6-modified ethylene glycol chitosan polymer micelles, in which CAT catalyzes the decomposition of hydrogen peroxide and MnO<small><sub>2</sub></small> can consume intracellular GSH, and produce Mn<small><sup>2+</sup></small> for <span class="italic">T</span><small><sub>1</sub></small>-weighted magnetic resonance imaging (as a contrast agent). In addition, the pH-sensitive surface charge can be switched from neutral to positively charged GC polymer, and this shift can improve the accumulation of PS in the tumor area. The process of collaborative treatment is shown in <a title="Select to navigate to figure" href="#imgfig4">Fig. 4b</a>. After proving the good PDT performance <span class="italic">in vitro</span>, they continued to study the potential of the CMGCC nanoclusters as a <span class="italic">T</span><small><sub>1</sub></small>-weighted MR imaging contrast agent, and the final <span class="italic">in vivo</span> PDT shows that this multi-functional nano-therapy is effective at the level of the therapeutic effect on the tumor. Also, the publications about the decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small> by catalase or heat were summaried in <a title="Select to navigate to table" href="#tab2">Table 2</a>.</p>
          
<div class="table_caption"><b>Table 2</b> <span id="tab2">Summary of publications about the decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small> by catalase or heat</span>
		</div>

              <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="49.60pt"/><col align="left" width="38.63pt"/><col align="left" width="33.56pt"/><col align="left" width="42.87pt"/><col align="left" width="163.23pt"/><col align="left" width="34.56pt"/><col align="left" width="76.43pt"/><col align="left" width="57.74pt"/><col align="left" width="25.62pt"/></colgroup>
                
                
                
                
                
                
                
                
                
                <thead align="left">
                  <tr align="left" valign="bottom">
                    <th align="left" valign="bottom" class="border_black">Application</th>
                    <th align="left" valign="bottom" class="border_black">Catalyst</th>
                    <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                    <th align="left" valign="bottom" class="border_black">PSs</th>
                    <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                    <th align="left" valign="bottom" class="border_black">TROS species</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vitro</span> (cell line)</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                    <th align="left" valign="bottom" class="border_black">Ref.</th>
                  </tr>
                </thead>
                <tfoot align="left">
                  <tr align="left">
                    <th colspan="9">Abbreviations: chlorin e6 (Ce6); cyanine 3 (Cy3); NIR dye (IR780 iodide); phospholipid membrane coated nanocatalase system (Cat@PDS).</th>
                  </tr>
                </tfoot>
                <tbody align="left">
                  <tr align="left">
                    <td valign="top">PDT</td>
                    <td valign="top">Heat</td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">Ce6</td>
                    <td valign="top">805/660 nm, 3/5 min, 1 W cm<small><sup>−2</sup></small>/0.1 W cm<small><sup>−2</sup></small></td>
                    <td valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td valign="top">BxPC-3</td>
                    <td valign="top">BxPC-3</td>
                    <td valign="top">
                      <a title="Select to navigate to references" href="#cit68">68</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT/PTT</td>
                    <td rowspan="2" valign="top">Catalase</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">Cy3</td>
                    <td valign="top">PTT: 808 nm, 1 W cm<small><sup>−2</sup></small>, 10 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">HeLa</td>
                    <td rowspan="2" valign="top">HeLa</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit69">69</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">PDT: 660 nm, 150 mW cm<small><sup>−2</sup></small>, 3 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT/PTT</td>
                    <td rowspan="2" valign="top">None</td>
                    <td rowspan="2" valign="top">UiO-66</td>
                    <td rowspan="2" valign="top">ICG</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 808 nm, 0.06 W cm<small><sup>−2</sup></small>, 5 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">RAW264.7 and MCF-7</td>
                    <td rowspan="2" valign="top">MCF-7</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit70">70</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 808 nm, 0.06 W cm<small><sup>−2</sup></small>, 1 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT/PTT</td>
                    <td rowspan="2" valign="top">Heat</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">IR780</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 808 nm, 0.5 W cm<small><sup>−2</sup></small>, 30 s</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">HepG2 and EC</td>
                    <td rowspan="2" valign="top">HepG2</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit71">71</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 808 nm, 0.5 W cm<small><sup>−2</sup></small>, 3 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Catalase</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">Ce6</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 635 nm, 0.75 W cm<small><sup>−2</sup></small>, 2 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">MDA-MB-231</td>
                    <td rowspan="2" valign="top">MDA-MB-231</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit73">73</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 635 nm, 0.75 W cm<small><sup>−2</sup></small>, 5 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Catalase</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">Cat@PDS</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 655 nm, 1 W cm<small><sup>−2</sup></small>, 2 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit74">74</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 655 nm, 1 W cm<small><sup>−2</sup></small>, 5 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Catalase</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">IR780</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 808 nm, 1 W cm<small><sup>−2</sup></small>, 20 s</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">MDA-MB-231</td>
                    <td rowspan="2" valign="top">MDA-MB-231</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit75">75</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 808 nm, 1.5 W cm<small><sup>−2</sup></small>, 20 s</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Catalase</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">Ce6</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 660 nm, 100 mW cm<small><sup>−2</sup></small>, 5 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">HEK 293 and HeLa</td>
                    <td rowspan="2" valign="top">HeLa</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit72">72</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 660 nm, 100 mW cm<small><sup>−2</sup></small>, 10 min</td>
                  </tr>
                </tbody>
              </table></div></div>
            <hr class="hrule"/><br/>
        </div>
        <div>
          
          <span id="sect911"/><span class="c_heading_indent">2.2.2 MnO<small><sub>2</sub></small> catalysis. </span>
          <span>As we all know, catalase can decompose H<small><sub>2</sub></small>O<small><sub>2</sub></small> into H<small><sub>2</sub></small>O and O<small><sub>2</sub></small>. Other nanomaterials also have a similar effect, such as MnO<small><sub>2</sub></small> nanoparticles, platinum and gold nanocluster nanoparticles. They are already used in photodynamic systems.<a title="Select to navigate to reference" href="#cit79"><sup><span class="sup_ref">79,80</span></sup></a> Tumor cells use mechanisms that scavenge reactive oxygen species to resist “oxidative therapy”, such as PDT or chemotherapy. Tumor cells showed higher oxidative stress than normal cells.</span>
          <p class="otherpara">To improve the abnormal oxidative state of tumor cells and reduce oxidative damage, tumor cells take measures by activating several pathways to clear ROS, including GSH, catalase (CAT), superoxide dismutase (SOD), and vitamins.<a title="Select to navigate to reference" href="#cit81"><sup><span class="sup_ref">81–83</span></sup></a> Among them, GSH is the highest antioxidant in cells,<a title="Select to navigate to references" href="#cit84"><sup><span class="sup_ref">84</span></sup></a> which seriously hinders the efficacy of PDT. However, GSH-mediated drug resistance produces extensive challenges for various treatments,<a title="Select to navigate to reference" href="#cit85"><sup><span class="sup_ref">85,86</span></sup></a> so the consumption of GSH content helps improve the therapeutic effect.<a title="Select to navigate to reference" href="#cit87"><sup><span class="sup_ref">87–89</span></sup></a> In the tumor microenvironment, when the H<small><sub>2</sub></small>O<small><sub>2</sub></small> met the MnO<small><sub>2</sub></small> nanosheets, the MnO<small><sub>2</sub></small> was reduced to Mn<small><sup>2+</sup></small> together with the generation of O<small><sub>2</sub></small>. The process is shown in the following equations:<a title="Select to navigate to references" href="#cit90"><sup><span class="sup_ref">90</span></sup></a></p>
          <p class="otherpara">pH = 5.5<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn1"/><span id="eqn1">MnO<small><sub>2</sub></small> + 2H<small><sup>+</sup></small> → Mn<small><sup>2+</sup></small> + H<small><sub>2</sub></small>O + 1/2O<small><sub>2</sub></small></span></td><td class="rightEqn">(1)</td></tr></table><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn2"/><span id="eqn2">MnO<small><sub>2</sub></small> + H<small><sub>2</sub></small>O<small><sub>2</sub></small> + 2H<small><sup>+</sup></small> → Mn<small><sup>2+</sup></small> + H<small><sub>2</sub></small>O + O<small><sub>2</sub></small></span></td><td class="rightEqn">(2)</td></tr></table></p>
          <p class="otherpara">pH = 7.4<table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn3"/><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-t1_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-t1.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-t1.gif"/></a></td><td class="rightEqn">(3)</td></tr></table></p>
          <p class="otherpara">Combined with the combination of MnO<small><sub>2</sub></small> and glucose depletion reaction, a tumor-targeting MnO<small><sub>2</sub></small> motor nano-system (MG/HA) was designed,<a title="Select to navigate to references" href="#cit91"><sup><span class="sup_ref">91</span></sup></a> which can effectively consume glucose to inhibit tumor progression and relieve hypoxia, inhibit metabolism by reducing the expression of Glut1, and further inhibit tumor invasion metastasis. In the nanocomposite, after the cancer cells with overexpression of CD44 specifically ingest MG/HA, GOD catalyzes the oxidation of glucose to gluconic acid and H<small><sub>2</sub></small>O<small><sub>2</sub></small>. When consuming O<small><sub>2</sub></small>, it generates at the same time, by the reaction, H<small><sub>2</sub></small>O<small><sub>2</sub></small> and acid, which seems to be a circular process (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6a</a>). The abnormal expression of Glut1 is related to tumor proliferation, metastasis, and poor prognosis.<a title="Select to navigate to references" href="#cit92"><sup><span class="sup_ref">92</span></sup></a><span class="italic">In vitro</span> experiments showed that the expression of Glut1 in normal COS-7 cells was lower than that in CT-26 and HeLa cells. There was a highly positive correlation between the expression level of GLT1 and the concentration of glucose. The decrease of sugar content caused by effective glucose consumption in the MG/HA group could significantly inhibit the high expression of Glut1, and the starvation toxicity of MG/HA was considerably higher than that of G/HA. <span class="italic">In vivo</span> observation showed that the MG/HA group showed a potent anti-tumor effect during the two-week treatment, showing an apparent O<small><sub>2</sub></small> cycle starvation effect. The slight weight gain in all groups indicated that each sample had good biocompatibility. In general, compared with the traditional nano-system, the overexpression of Glut1 in tumor cells can be directly suppressed by combining the MnO<small><sub>2</sub></small> motor with the designed MG/HA nano-system, thereby reducing tumor invasion and metastasis, thus further promoting treatment and being used to overcome the obstacle of starvation treatment. Lin's team also developed a nano-system containing MnO<small><sub>2</sub></small> to couple photosensitizers (Au25 nanoclusters) with platinum(<span class="small_caps">IV</span>) (Pt(<span class="small_caps">IV</span>)) prodrugs using MnO<small><sub>2</sub></small> nanotablets as carriers to achieve synergistic PDT and chemotherapy.<a title="Select to navigate to references" href="#cit93"><sup><span class="sup_ref">93</span></sup></a> GSH can bring the content of MnO<small><sub>2</sub></small> nano-tablets down. Pt(<span class="small_caps">IV</span>) prodrugs in tumor tissues cooperate with MnO<small><sub>2</sub></small> to catalyze H<small><sub>2</sub></small>O<small><sub>2</sub></small> to produce oxygen, increasing the therapeutic effect of PDT. Mn<small><sup>2+</sup></small> can be used as a contrast agent in MRI to realize the integration of diagnosis and treatment.</p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig6"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f6_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f6.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f6.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 6 </b> <span id="fig6"><span class="graphic_title">(a) The MG/HA nano-system interferes with the up-regulation of Glut1 and explains the process of ablation of tumor cells. Reproduced with permission. Reproduced from ref. <a title="Select to navigate to references" href="#cit91">91</a> with permission from the American Chemical Society, copyright 2018. (b) A schematic diagram of the process of tumor treated with GO/CisPt/Ce6@MH nanoparticle CDT/PDT. (c) The kinetics of O<small><sub>2</sub></small> generation catalyzed by GO/CisPt/Ce6 and GO/CisPt/Ce6@MH in presence or absence of 1 mmol/L H<small><sub>2</sub></small>O<small><sub>2</sub></small>. Inset: photographs of each reaction tube after reaction. (d) The kinetics of <small><sup>1</sup></small>O<small><sub>2</sub></small> generation for GO/CisPt/Ce6 or GO/CisPt/Ce6@MH in the presence or absence of 1 mmol/L H<small><sub>2</sub></small>O<small><sub>2</sub></small> under laser irradiation. Reproduced from ref. <a title="Select to navigate to references" href="#cit97">97</a> with permission from Elsevier B.V., copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">In recent years, two-dimensional graphene oxide (GO) has been extensively used as a drug carrier for nano-drugs because of its large surface, effective adsorption of aromatic drugs, and wealth of functional groups for drug coupling.<a title="Select to navigate to reference" href="#cit94"><sup><span class="sup_ref">94–96</span></sup></a> Therefore, Zhou's team made use of the better carrier function of GO,<a title="Select to navigate to references" href="#cit97"><sup><span class="sup_ref">97</span></sup></a> and also used the strategy of MnO<small><sub>2</sub></small> catalysis to alleviate tumor hypoxia and reduce intracellular glutathione levels (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6b</a>), to improve the sensitivity of chemo-photodynamic therapy.<a title="Select to navigate to reference" href="#cit94"><sup><span class="sup_ref">94,98,99</span></sup></a> A nanometer platform GO/CisPt/Ce6@MH was developed, CisPt was covalently bonded to the edge of the GO by ester bonds, and MnO<small><sub>2</sub></small> nanoparticles were further modified on a 2D surface. In <span class="italic">in vitro</span> experiments, dissolved oxygen was measured. This nano-platform significantly produces O<small><sub>2</sub></small> in the presence of hydrogen peroxide (<a title="Select to navigate to figure" href="#imgfig6">Fig. 6c and d</a>). The ability of this self-oxygen supply system to enhance PDT is explored. With the SOSG probe for monitoring the <small><sup>1</sup></small>O<small><sub>2</sub></small>, together with H<small><sub>2</sub></small>O<small><sub>2</sub></small>, GO/CisPt/Ce6@MH shows a swift rate of <small><sup>1</sup></small>O<small><sub>2</sub></small> formation, which confirms the advantage of MnO<small><sub>2</sub></small> in enhancing PDT therapy. In <span class="italic">in vivo</span> tests, BALB/c mice were treated with Ce6 and CisPt (0.5 mg kg<small><sup>−1</sup></small>, 1.25 mg kg<small><sup>−1</sup></small>), respectively. The results showed that synergistic treatment with GO/CisPt/Ce6@MH was very useful.</p>
          <p class="otherpara">A new Intelligent Nano platform that was composed of mesoporous organosilicon dioxide nanoparticles (MONS) coated with glucose oxidase (Gox) and MnO<small><sub>2</sub></small> nanoparticles-Ce6 was designed and named MONsGOx@MnO<small><sub>2</sub></small>-Ce6.<a title="Select to navigate to references" href="#cit100"><sup><span class="sup_ref">100</span></sup></a> Gox oxidizes glucose to gluconic acid and produces H<small><sub>2</sub></small>O<small><sub>2</sub></small> at the same time. The released MnO<small><sub>2</sub></small> nanowires can regenerate O<small><sub>2</sub></small> in the presence of H<small><sub>2</sub></small>O<small><sub>2</sub></small> and react with GSH (as an oxidant) to improve the photodynamic treatment effect. MONS-Gox@MnO<small><sub>2</sub></small>-Ce6 can realize the imaging of cancer cells and reduce intracellular glucose uptake and Glut1 expression and inhibit the metabolism of cancer cells. The new Nano platform continued to be designed for relieving tumor hypoxia; through assembling a Mn ferromanganese (Mn) nanoparticle, a hollow ferromanganese (Mn) nanoparticle was designed.<a title="Select to navigate to references" href="#cit101"><sup><span class="sup_ref">101</span></sup></a> When exposed to a tumor hypoxic microenvironment, the vesicles disintegrate and release drugs and ferromanganese oxide nanoparticles quickly. The ferromanganese oxide can catalyze the excess H<small><sub>2</sub></small>O<small><sub>2</sub></small> to produce oxygen. Combined with immunotherapy, the nanovesicles showed good efficacy in combination with chemotherapy and immunotherapy. Also, the publications about the decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small> by MnO<small><sub>2</sub></small> were summaried in <a title="Select to navigate to table" href="#tab3">Table 3</a>.</p>
          
<div class="table_caption"><b>Table 3</b> <span id="tab3">Summary of publication about the decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small> by MnO<small><sub>2</sub></small></span>
		</div>

              <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="49.29pt"/><col align="left" width="36.33pt"/><col align="left" width="39.49pt"/><col align="left" width="24.63pt"/><col align="left" width="148.57pt"/><col align="left" width="42.73pt"/><col align="left" width="73.51pt"/><col align="left" width="82.06pt"/><col align="left" width="25.62pt"/></colgroup>
                
                
                
                
                
                
                
                
                
                <thead align="left">
                  <tr align="left" valign="bottom">
                    <th align="left" valign="bottom" class="border_black">Application</th>
                    <th align="left" valign="bottom" class="border_black">Catalyst</th>
                    <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                    <th align="left" valign="bottom" class="border_black">PS</th>
                    <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                    <th align="left" valign="bottom" class="border_black">ROS species</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vitro</span> (cell line)</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                    <th align="left" valign="bottom" class="border_black">Ref.</th>
                  </tr>
                </thead>
                <tfoot align="left">
                  <tr align="left">
                    <th colspan="9">Abbreviations: starving therapy (ST); glucose (GLU); chemotherapy (CT).</th>
                  </tr>
                </tfoot>
                <tbody align="left">
                  <tr align="left">
                    <td valign="top">ST</td>
                    <td valign="top">MnO<small><sub>2</sub></small></td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small>, GLU</td>
                    <td valign="top">NO</td>
                    <td valign="top">NO</td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">CT-26, COS-7 and HeLa</td>
                    <td valign="top">CT-26</td>
                    <td valign="top">
                      <a title="Select to navigate to references" href="#cit91">91</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT/CT</td>
                    <td rowspan="2" valign="top">MnO<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">Au<small><sub>25</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 650 nm, 5 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">HeLa</td>
                    <td rowspan="2" valign="top">U14</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit93">93</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 650 nm, 15 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">MnO<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">Ce6</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 635 nm, 0.1 W cm<small><sup>−2</sup></small>, 1 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">MDA-MB-231</td>
                    <td rowspan="2" valign="top">MDA-MB-231</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit97">97</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 635 nm, 0.1 W cm<small><sup>−2</sup></small>, 5 min</td>
                  </tr>
                  <tr align="left">
                    <td valign="top">PDT</td>
                    <td valign="top">MnO<small><sub>2</sub></small></td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">Ce6</td>
                    <td valign="top">660 nm, 7.2 mW cm<small><sup>−2</sup></small>, 30 min</td>
                    <td valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td valign="top">HeLa</td>
                    <td valign="top">NO</td>
                    <td valign="top">
                      <a title="Select to navigate to references" href="#cit100">100</a>
                    </td>
                  </tr>
                </tbody>
              </table></div></div>
            <hr class="hrule"/><br/>
        </div>
        <div>
          
          <span id="sect1142"/><span class="c_heading_indent">2.2.3 Platinum (Pt) NPs. </span>
          <span>Pt NPs are the most advanced catalyst. In the current research, as a good catalyst, they can efficiently break the O–O bond of H<small><sub>2</sub></small>O<small><sub>2</sub></small> and eventually contribute to the production of oxygen.<a title="Select to navigate to reference" href="#cit102"><sup><span class="sup_ref">102,103</span></sup></a></span>
          <p class="otherpara">There are fatal shortcomings in the application of metal–organic framework (MOF) integrated photosensitizers in the process of PDT, but Pt-modified MOFs can be used in other treatments (chemotherapy, radiotherapy, sonodynamic therapy), although the poor efficiency of the treatment is also limited by hypoxia.<a title="Select to navigate to reference" href="#cit104"><sup><span class="sup_ref">104,105</span></sup></a> The PDT efficiency of MOFs is seriously limited by tumor hypoxia. The PCN-224-Pt nanoparticles were designed, therefore, to solve the above problems by decorating platinum nano-enzymes on the photosensitizer-integrated MOF as a new strategy.<a title="Select to navigate to references" href="#cit106"><sup><span class="sup_ref">106</span></sup></a> In an <span class="italic">in vivo</span> experiment, in a subcutaneous tumor model, PCN-224-PT was given by intratumor injection for photodynamic therapy. Under 638 nm excitation light irradiation (1 W cm<small><sup>−2</sup></small>) for 10 min, the PCN-224-PT + light group's tumor ablation ability was the most significant compared with the control group after intravenous injection.</p>
          <p class="otherpara">A new strategy of <span class="italic">in situ</span> growth was applied that decorated black phosphorus (BP) nanosheets with Pt nanoparticles (NPs), forming Pt@BP nanoparticles.<a title="Select to navigate to references" href="#cit107"><sup><span class="sup_ref">107</span></sup></a> As an artificial catalase, Pt@NPs can effectively decompose the accumulated H<small><sub>2</sub></small>O<small><sub>2</sub></small> and relieve tumor hypoxia in the tumor, and then improve the PDT effect of BP nanoparticles. When exposed to tumor hypoxia, BP nanosheets will not cause the decomposition of H<small><sub>2</sub></small>O<small><sub>2</sub></small>, while the Pt@BP nano-hydride will cause the deterioration of H<small><sub>2</sub></small>O<small><sub>2</sub></small>. The hypoxia environment was simulated in a cell experiment. As a hypoxia indicator probe,<a title="Select to navigate to reference" href="#cit108"><sup><span class="sup_ref">108,109</span></sup></a> the fluorescence intensity was decreased significantly when using Pt@BP nanocomposites, which indicated that Pt@BP nanohybrids had high efficiency in regulating intracellular hypoxia. In addition, after Pt@BP nanohybrid treatment, immunohistochemical staining confirmed that HIF-1α was significantly down-regulated, indicating that Pt@BP nanohybrids can also effectively reverse the hypoxia state of the tumor, and inhibit the hypoxia-related signal pathway. Zhang's research group designed and synthesized Pda-Pt@PCN-FA,<a title="Select to navigate to references" href="#cit110"><sup><span class="sup_ref">110</span></sup></a> which is composed of a polydopamine (Pda) nucleus, PTNP mesosphere, Zr-TCPP(PCN) porphyrin shell, and Zr6 coordination with a folic acid carboxyl group (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7a</a>). The platinum nanoparticle intermediate layer can catalyze endogenous H<small><sub>2</sub></small>O<small><sub>2</sub></small> to O<small><sub>2</sub></small>, which plays a dual role in inhibiting the tumor cells’ growth and promoting death. Under irradiation, oxygen is converted through the PCN shell to lethal ROS. In an <span class="italic">in vitro</span> experiment, O<small><sub>2</sub></small> was measured by a dissolved oxygen meter, the liquid surface was sealed with liquid paraffin, and the O<small><sub>2</sub></small> production reached the maximum (about 50 mg L<small><sup>−1</sup></small>) within 25 minutes after adding H<small><sub>2</sub></small>O<small><sub>2</sub></small>. The disodium salt of 9,10-anthracene-dipropionic acid (ADPA) was used as the probe for detecting <small><sup>1</sup></small>O<small><sub>2</sub></small>,<a title="Select to navigate to references" href="#cit111"><sup><span class="sup_ref">111</span></sup></a> and the hypoxia microenvironment in the tumor was simulated by blowing nitrogen for half an hour. The fluorescence intensity of ADPA decreased rapidly after treatment with Pda-Pt@PCN. Cell experiments were carried out again to check the oxygen-production capacity and ROS-production capacity of Pda-Pt@PCN-FA.</p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig7"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f7_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f7.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f7.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 7 </b> <span id="fig7"><span class="graphic_title">(a) The simple preparation process of PCN-224-Pt and the schematic diagram of reactive oxygen species produced by PCN-224-Pt to kill tumor cells. Reproduced from ref. <a title="Select to navigate to references" href="#cit110">110</a> with permission from John Wiley &amp; Sons, copyright 2018. (b) Preparation of Pt@BP nano-hybrids and the scheme of tumor cell death caused by a series of reactions under NIR illumination. Reproduced from ref. <a title="Select to navigate to references" href="#cit112">112</a> with permission from the American Chemical Society, copyright 2019.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">They confirmed that metastasis's driving force could be caused by an anoxic microenvironment, detected cell movement by a wound healing test, and found that Pda-Pt@PCN-FA could inhibit tumor metastasis by reducing the degree of hypoxia. In <span class="italic">in vivo</span> experiments, the imaging and distribution of Pda-Pt@PCN-FA were studied by the small animal imaging system. Fluorescence imaging was executed accompanied by intravenous injection of the nanomaterial, and the fluorescence intensity was most substantial at 28 hours after injection, indicating a good imaging ability. Simultaneously, measurements in animals showed no significant metastatic sites in the lungs of mice injected with Pda-Pt@PCN-FA, regardless of whether radiation was or was not used. In the end, they confirmed that the inhibition of tumor metastasis is caused by the improvement of hypoxia in tumor tissue and explained the correlation between them. For overcoming the poor results of PDT, caused by premature leakage of photosensitizer and hypoxia, FA/PtBSA@MB-MSNS nanocomposites were designed and synthesized.<a title="Select to navigate to references" href="#cit112"><sup><span class="sup_ref">112</span></sup></a> Platinum nanoclusters (Pt-BSA) were coated with bovine serum albumin (BSA) with oxygen and combined with mesoporous silica nanospheres to develop intelligent nano-aggregates to achieve a better therapeutic effect on anoxic tumors. Disulfide bond bridged mesoporous silica nanospheres (MSNS) contain methylene blue (MB), with BSA-encapsulated Pt nanoparticles (Pt-BSA) as a biological coating (<a title="Select to navigate to figure" href="#imgfig7">Fig. 7b</a>). In <span class="italic">in vitro</span> experiments, they evaluated the photodynamic conversion efficiency of biological tissue after nano-drug release under light irradiation. Chicken skin has a similar biological barrier effect to human tissue, so they used chicken skin with a thickness of 1 mm to stimulate the production of <small><sup>1</sup></small>O<small><sub>2</sub></small>, which decreased to 72.15% after being irradiated by 635 nm laser (6 mW cm<small><sup>−2</sup></small>), with DPBF in FA/PtBSA@MB-MSNS aqueous solution for 120 s. This result confirmed that FA/PtBSA@MB-MSNS could produce <small><sup>1</sup></small>O<small><sub>2</sub></small> under the skin, highlighting its potential to kill cancer cells in tumor therapy. In an <span class="italic">in vivo</span> experiment, the ablation ability of PDT towards tumor cells <span class="italic">in vivo</span> was studied by using the cancer cell (HeLa) tumor model. Different treatments were used to track tumor volume change, and the therapeutic effect was by PDT treatment. Both the MB and MB-MSNS treatment groups slightly hindered tumor growth, while the PtBSA@MB-MSNS treatment group had the most significant ablation ability.</p>
          <p class="otherpara">For making up for the instability of most photosensitizers at present, a new nano-platform HCS@Pt-Ce6 NPs was designed,<a title="Select to navigate to references" href="#cit113"><sup><span class="sup_ref">113</span></sup></a> which has been developed to load and deliver photosensitizers. There are reported two different Pt/carbon (Pt/C) nano-enzymes that were loaded as Ce6 nano-carriers. Pt NPs as a nano-enzyme had excellent peroxidase-like and oxidase-like activity. It was verified that Pt showed higher enzyme imitation and anti-tumor activity when loaded outside the carbon shell. In an <span class="italic">in vivo</span> experiment, 4 hours after injection of 7.5 mg kg<small><sup>−1</sup></small> nano-particles into the tail vein, with 660 nm laser for 10 minutes, a comparison of treatment results between the experimental group and the control group showed that the tumor volumes of the HCS@Pt nanoparticle group and HCS@PtCe6 nanoparticle group were inhibited, indicating that catalytic therapy based on HCS@Pt nanoparticles has a specific effect <span class="italic">in vivo</span>. It also shows that HCS@Pt-Ce6 nanoparticles as photodynamic and catalytic synergistic therapy are feasible. In particular, a nano-sheet, which was constructed from a two-dimensional (2D) metal–organic skeleton Sm-tetrakis(4-carboxyphenyl) porphyrin (TCPP),<a title="Select to navigate to references" href="#cit114"><sup><span class="sup_ref">114</span></sup></a> was assembled with transition metal ions (Sm<small><sup>3+</sup></small>) and PSs (TCPP) and grew platinum enzymes mimicking catalase (CAT) on them <span class="italic">in situ</span>. As a new type of 2D porous nanomaterial, the 2D metal–organic framework has excellent properties for gas adsorption,<a title="Select to navigate to reference" href="#cit115"><sup><span class="sup_ref">115–117</span></sup></a> photocatalysis,<a title="Select to navigate to reference" href="#cit118"><sup><span class="sup_ref">118,119</span></sup></a> drug delivery,<a title="Select to navigate to reference" href="#cit120"><sup><span class="sup_ref">120,121</span></sup></a><span class="italic">etc</span>. In this nanomaterial system, the 2D MOF has a simplified one-dimensionality, which can remove the diffusion restriction on the generation of ROS, thus showing higher PDT efficiency than three-dimensional (3D) MOF. Due to the improvement of the physical and chemical properties of bulky Sm nodes and the enhancement of intersystem crossing, <small><sup>1</sup></small>O<small><sub>2</sub></small> generation capacity was enhanced. More importantly, the CAT-mimicking Pt nanoenzyme on Sm-TCPP nanoparticles can alleviate the hypoxia of the tumor microenvironment, mainly by using the decomposition of overexpressed H<small><sub>2</sub></small>O<small><sub>2</sub></small> to O<small><sub>2</sub></small>. The most important organelles that produce H<small><sub>2</sub></small>O<small><sub>2</sub></small> and are very sensitive to ROS are the mitochondria. The triphenylphosphine (TPP) molecule that was introduced to Sm-TCPP-Pt achieved the function of good mitochondrion-targeting, and became an O<small><sub>2</sub></small> self-supply PDT system. The prodrug nanoparticles of CPT-TK-HPPH/Pt NP that were created were loaded with platinum nanoparticles (Pt NP) in order to solve the problems of targeting defects and poor efficacy of PDT in hypoxia-related solid tumors.<a title="Select to navigate to references" href="#cit122"><sup><span class="sup_ref">122</span></sup></a> The excellent therapeutic effects of camptothecin (CPT) and the photosensitizer – 2-(1-hexoxy ethyl)-2-decadienyl pyropheophorbide pheophorbide (HPPH) were used, respectively.<a title="Select to navigate to reference" href="#cit123"><sup><span class="sup_ref">123–125</span></sup></a> The prodrug consists of a thioketal bond connecting the CPT and HPPH, and the loaded Pt NPs are used to catalyze the release of O<small><sub>2</sub></small> from H<small><sub>2</sub></small>O<small><sub>2</sub></small> (<a title="Select to navigate to figure" href="#imgfig8">Fig. 8</a>). In current studies, many photosensitizers can produce ROS and effectively decompose ROS-responsive covalent bonds by using this positive feedback regulation, such as thioketal, aryl boron ester, thioether, diselenide ether, and peroxyacetate.<a title="Select to navigate to reference" href="#cit126"><sup><span class="sup_ref">126–128</span></sup></a> By introducing drugs and photosensitizers linked with a thioketal bond as prodrugs, the ROS produced by excitation light breaks down the covalent bonds and releases the drugs. The <span class="italic">in vitro</span> ROS-production ability of the nano-system was verified. In order to explore the ability for intracellular ROS production, a commercial probe for detecting ROS was used. Different groups were irradiated with or without excitation, and the results showed that the CPT-TK-HPPH NP and CPT-TK-HPPH/Pt NP groups produced ROS, and the ROS contents under excitation light were 1.5 and 2.3 times higher than those without the laser, respectively. In <span class="italic">in vivo</span> imaging experiments, they studied whether the drug would accumulate in the tumor, directly affecting the anti-tumor effect <span class="italic">in vivo</span>. They evaluated the biological distribution and tumor-targeting ability of CPT-TK-HPPH/Pt NPs by NIR imaging and PA imaging. Its accumulation ability in tumor tissue was strong, and the fluorescence intensity was enhanced within 24 hours. The ablation ability of the tumor <span class="italic">in vivo</span> was also verified. The inhibition ability in the CPT-TK-HPPH/Pt NP + laser group was the strongest, which was due to Pt NPs in CPT-TK-HPPH/PtNP catalyzing the decomposition of hydrogen peroxide in tumor tissue to produce oxygen and improving tumor hypoxia.</p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig8"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f8_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f8.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f8.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 8 </b> <span id="fig8"><span class="graphic_title">Schematic diagram of combined treatment of tumor cells with CPT-TK-HPPH/Pt NP under 660 nm laser irradiation. Reproduced from ref. <a title="Select to navigate to references" href="#cit122">122</a> with permission from Wiley, copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          <p class="otherpara">In a recent investigation, for enhancing oxygen delivery, nanoparticle-stabilized oxygen microcapsules were prepared by interfacial polymerization.<a title="Select to navigate to references" href="#cit129"><sup><span class="sup_ref">129</span></sup></a> The novel vehicle of polydopamine–nanoparticle-stabilized oxygen microcapsules applied for oxygen delivery is effective. In aqueous solution, it shows good biocompatibility; moreover, oxygen placed in the microcapsule can diffuse well from the core to the outside of the capsule, and thus can increase the oxygen content in the microenvironment. The feasibility of this strategy has been well proved by <span class="italic">in vivo</span> and <span class="italic">in vitro</span> experiments. In <span class="italic">in vivo</span> experiments, when it was injected subcutaneously, the hypoxia could be improved, and in the end suppressed the growth of the tumor. This oxygen supplementation strategy can be used in a wider range of applications, such as photodynamic therapy or other treatments with more aerobic therapy. Also, the publications about H<small><sub>2</sub></small>O<small><sub>2</sub></small> decomposition by Pt NPs were summaried in <a title="Select to navigate to table" href="#tab4">Table 4</a></p>
          
<div class="table_caption"><b>Table 4</b> <span id="tab4">Summary of publications about H<small><sub>2</sub></small>O<small><sub>2</sub></small> decomposition by Pt NPs</span>
		</div>

              <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="49.29pt"/><col align="left" width="36.33pt"/><col align="left" width="38.59pt"/><col align="left" width="168.84pt"/><col align="left" width="59.59pt"/><col align="left" width="34.25pt"/><col align="left" width="59.87pt"/><col align="left" width="49.86pt"/><col align="left" width="25.62pt"/></colgroup>
                
                
                
                
                
                
                
                
                
                <thead align="left">
                  <tr align="left" valign="bottom">
                    <th align="left" valign="bottom" class="border_black">Application</th>
                    <th align="left" valign="bottom" class="border_black">Catalyst</th>
                    <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                    <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                    <th align="left" valign="bottom" class="border_black">PSs</th>
                    <th align="left" valign="bottom" class="border_black">ROS species</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vitro</span> (cell line)</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                    <th align="left" valign="bottom" class="border_black">Ref.</th>
                  </tr>
                </thead>
                <tfoot align="left">
                  <tr align="left">
                    <th colspan="9">Abbreviations: tetrakis (4-carboxyphenyl) porphyrin (TCPP); black phosphorus nanosheets (BP); chlorin e6 (Ce6); Pt/carbon (Pt/C) nanozymes; catalase (CAT)-mimicking platinum nanozymes.</th>
                  </tr>
                </tfoot>
                <tbody align="left">
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Pt NP</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 638 nm, 1 W cm<small><sup>−2</sup></small>, 10 min</td>
                    <td rowspan="2" valign="top">TCPP</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">RAW264.7, 4T1 and HeLa</td>
                    <td rowspan="2" valign="top">H22</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit106">106</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 638 nm, 1 W cm<small><sup>−2</sup></small>, 8 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Pt NP</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 660 nm, 1 W cm<small><sup>−2</sup></small>, 5 min</td>
                    <td rowspan="2" valign="top">BP</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit107">107</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 660 nm, 1 W cm<small><sup>−2</sup></small>, 10 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Pt NP</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 660 nm, 30 mW cm<small><sup>−2</sup></small>, 2 min</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>TCPP</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">CT26 and COS7</td>
                    <td rowspan="2" valign="top">CT26</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit110">110</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 660 nm, 220 mW cm<small><sup>−2</sup></small>, 5 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Pt BSA</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 635 nm, 45 mW cm<small><sup>−2</sup></small>, 30 min</td>
                    <td rowspan="2" valign="top">MB</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">HeLa and A549</td>
                    <td rowspan="2" valign="top">HeLa</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit112">112</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 635 nm, 100 mW cm<small><sup>−2</sup></small>, 15 min</td>
                  </tr>
                  <tr align="left">
                    <td valign="top">PDT</td>
                    <td valign="top">Pt/C</td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 660 nm, 0.346 W cm<small><sup>−2</sup></small>, 10 min</td>
                    <td valign="top">Ce6</td>
                    <td valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td valign="top">4T1 and A549</td>
                    <td valign="top">CT26</td>
                    <td valign="top">
                      <a title="Select to navigate to references" href="#cit113">113</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">PDT</td>
                    <td valign="top">Pt NP</td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 660 nm, 100 mW cm<small><sup>−2</sup></small>, 15 min</td>
                    <td valign="top">TCPP</td>
                    <td valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td valign="top">MCF-7</td>
                    <td valign="top">MCF-7</td>
                    <td valign="top">
                      <a title="Select to navigate to references" href="#cit114">114</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">PDT</td>
                    <td valign="top">Pt NP</td>
                    <td valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 660 nm, 200 mW cm<small><sup>−2</sup></small>, 5 min</td>
                    <td valign="top">CPT-TK-HPPH</td>
                    <td valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td valign="top">CT26</td>
                    <td valign="top">CT26</td>
                    <td valign="top">
                      <a title="Select to navigate to references" href="#cit122">122</a>
                    </td>
                  </tr>
                </tbody>
              </table></div></div>
            <hr class="hrule"/><br/>
        </div>
      
      
        
        <h3 id="sect1408"><span class="b_heading">2.3 CaO<small><sub>2</sub></small> decomposition</span></h3>
        <span>The ability of calcium peroxide to produce O<small><sub>2</sub></small> is widely used in tissue engineering, agriculture, aquaculture and relieving hypoxia in tumor tissue.<a title="Select to navigate to reference" href="#cit130"><sup><span class="sup_ref">130–132</span></sup></a> As a supplementary source of oxygen, it can release oxygen for a long time to improve the viability of organisms when they are in constant contact with water.<a title="Select to navigate to references" href="#cit133"><sup><span class="sup_ref">133</span></sup></a> Calcium peroxide (CaO<small><sub>2</sub></small>) is a promising material for regulating tumor hypoxia and improving PDT efficiency because of its good biocompatibility and high efficiency and long-lasting O<small><sub>2</sub></small> production. PDT uses light-activated photosensitizers to convert O<small><sub>2</sub></small> to ROS, while CDT uses <span class="italic">in situ</span> Fenton or Fenton-like reactions between H<small><sub>2</sub></small>O<small><sub>2</sub></small> and the catalyst to produce ˙OH. However, a large amount of GSH in the tumor microenvironment can deplete ROS. CaO<small><sub>2</sub></small> is a safe solid inorganic peroxide that decomposes when it meets with water and releases O<small><sub>2</sub></small> and H<small><sub>2</sub></small>O<small><sub>2</sub></small> at the same time. Therefore, the strategy of introducing CaO<small><sub>2</sub></small> into therapies involving ROS to enhance ROS production is widely used. The CaO<small><sub>2</sub></small> component in the nano-system is reactive to water, causing O<small><sub>2</sub></small> to be released in the water for a long time (<a title="" href="#eqn4">eqn (4) and (5)</a>)<a title="Select to navigate to reference" href="#cit134"><sup><span class="sup_ref">134–136</span></sup></a><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn4"/><span id="eqn4">2CaO<small><sub>2</sub></small> + 2H<small><sub>2</sub></small>O → 2Ca(OH)<small><sub>2</sub></small> + O<small><sub>2</sub></small></span></td><td class="rightEqn">(4)</td></tr></table><table><td class="leftEqn"> </td><tr><td class="eqn"><span id="eqn5"/><span id="eqn5">2CaO<small><sub>2</sub></small> + 4H<small><sub>2</sub></small>O → 2Ca(OH)<small><sub>2</sub></small> + 2H<small><sub>2</sub></small>O<small><sub>2</sub></small> → 2Ca(OH)<small><sub>2</sub></small> + 2H<small><sub>2</sub></small>O + O<small><sub>2</sub></small></span></td><td class="rightEqn">(5)</td></tr></table></span>
        <p class="otherpara">A NIR rechargeable “optical battery” for avoiding irradiating PDT was designed, which was formed by embedding three different components into biocompatible polydimethylsiloxane (namely, upconversion materials, persistent luminescence materials, photosensitizer) (<a title="Select to navigate to figure" href="#imgfig9">Fig. 9a</a>).<a title="Select to navigate to references" href="#cit137"><sup><span class="sup_ref">137</span></sup></a> They used NIR irradiation (980 nm, 2 W cm<small><sup>−2</sup></small>) for a short charging process of 5 s, and the luminescence could be sustained for a long time (about 30 min). According to previous studies, the battery was tested using different thicknesses of pork tissue to simulate human tissue (the penetration depth is up to 1 cm). After using this way to test it, they found that when the NIR irradiation was shone at pork tissue, <small><sup>1</sup></small>O<small><sub>2</sub></small> could be produced at a depth of 4 mm. What is interesting is that the NIR rechargeable irradiation-free PDT implants can easily be made in any size and shape. In addition, the cell has good biocompatibility in the human colon adenocarcinoma cell line HT29 without light and will produce strong cytotoxicity with laser irradiation. When they encapsulated the CaO<small><sub>2</sub></small> in the battery, they found a higher molecular oxygen concentration. Hence, they further used oxygen production to alleviate tumor hypoxia; they implanted this device into an HT29 solid tumor, used NIR radiation for treatment (660 nm, 30 mW cm<small><sup>−2</sup></small>), and finally successfully solved the hypoxia condition of the tumor tissue, and a good tumor ablation effect was achieved (<a title="Select to navigate to figure" href="#imgfig9">Fig. 9c</a>), so it also promoted the therapeutic effect of PDT.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig9"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f9_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f9.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f9.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 9 </b> <span id="fig9"><span class="graphic_title">(a) Fast charging with NIR light can achieve a long-lasting luminescence activation of a PDT “optical battery” implanted into the tumor to produce reactive oxygen species. Reproduced with permission from ref. <a title="Select to navigate to references" href="#cit137">137</a>. Copyright 2020, Royal Society of Chemistry (b) CaO<small><sub>2</sub></small>/B1/NH<small><sub>4</sub></small>HCO<small><sub>3</sub></small> liposome can generate O<small><sub>2</sub></small> for PDT under the NIR light irradiation; the bottom of the picture shows the mechanism for killing cancer cells. Reproduced from ref. <a title="Select to navigate to references" href="#cit139">139</a> with permission from the American Chemical Society, copyright 2014. (c) and (d) Curve of tumor volume changes in mice during different treatments. Reproduced from ref. <a title="Select to navigate to references" href="#cit137">137</a> with permission from the Royal Society of Chemistry, copyright 2020 (c). Reproduced from ref. <a title="Select to navigate to references" href="#cit139">139</a> with permission from the Royal Society of Chemistry, copyright 2019 (d).</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Encouraged by previous research methods, Song's research group developed a nanomaterial.<a title="Select to navigate to references" href="#cit138"><sup><span class="sup_ref">138</span></sup></a> Through the implanted oxygen production bank, the local oxygen therapy enhanced the ablation of malignant tumors by Dox in a highly specific manner without increasing oxygen levels in tissues and organs in the whole body. The O<small><sub>2</sub></small> production pool's design method puts CaO<small><sub>2</sub></small> (contained in alginate solution) and catalase into a calcium chloride (CaCl<small><sub>2</sub></small>) bath to form calcium cross-linked microcapsule particles. When the oxygen-producing reservoir is implanted subcutaneously near the tumor, the exposed interstitial medium will react with it, and then the O<small><sub>2</sub></small> is produced <span class="italic">in situ</span>, thus effectively reducing the anoxic area in the tumor tissue. <span class="italic">In vitro</span> experiments showed that the ROS level and apoptosis rate of Hep3B cells treated with Dox increased under normoxic conditions, but the ability of Dox to induce ROS was significantly decreased under hypoxic pressure, which enhanced the resistance of anoxic cells to Dox. Simultaneously, it is suggested that the oxygen-producing nanoparticles significantly enhance the cytotoxicity of Dox on ROS-induced cells. <span class="italic">In vivo</span>, the improvement of cytotoxicity of Dox on the tumor induced by the oxygen transport pool was further evaluated by positron emission tomography (PET). The maximum uptake of <small><sup>18</sup></small>F-fludeoxyglucose (<small><sup>18</sup></small>F-FDG) in pellets + Dox (1.68 ± 0.06 %ID g<small><sup>−1</sup></small>) was significantly lower than that in other groups, indicating the therapeutic effect of this nano-system and slowing down the metabolism and proliferation of tumor cells.</p>
        <p class="otherpara">Similarly, an O<small><sub>2</sub></small>-self-sufficient nano-platform (LipoMB/CaO<small><sub>2</sub></small>) for PDT of anoxic tumors was designed.<a title="Select to navigate to references" href="#cit140"><sup><span class="sup_ref">140</span></sup></a> In this system, a photosensitizer (MB) and CaO<small><sub>2</sub></small> nanoparticles are wrapped within a hydrophilic cavity. The nano-platform can amplify the production of O<small><sub>2</sub></small> under dual-stage light-driven PDT, regulate intracellular hypoxia and enhance the production of <small><sup>1</sup></small>O<small><sub>2</sub></small> in the process of PDT. After the first-stage laser irradiation, the release of O<small><sub>2</sub></small> originating from the reaction of CaO<small><sub>2</sub></small> and H<small><sub>2</sub></small>O alleviated tumor hypoxia. <span class="italic">In vivo</span> experiments also proved that LipoMB/CaO<small><sub>2</sub></small> has good biocompatibility and can reduce tumor hypoxia and have an anti-tumor metastasis effect. In addition, a liposome was produced that achieved the function of being oxygen self-sufficient, named CaO<small><sub>2</sub></small>/B1/NH<small><sub>4</sub></small>HCO<small><sub>3</sub></small> liposome.<a title="Select to navigate to references" href="#cit139"><sup><span class="sup_ref">139</span></sup></a> The liposome consists of hydrophobic aza-BODIPY dye (B1), oxygen-producing nanoparticles and hydrophilic thermally active ammonium bicarbonate (NH<small><sub>4</sub></small>HCO<small><sub>3</sub></small>) (<a title="Select to navigate to figure" href="#imgfig9">Fig. 9b</a>). The results of <span class="italic">in vitro</span> experiments showed that CaO<small><sub>2</sub></small>/B1/NH<small><sub>4</sub></small>HCO<small><sub>3</sub></small> had an excellent ability to produce ROS after the tumor tissue was irradiated by 730 nm and 100 mW cm<small><sup>−2</sup></small> for 5 minutes. At the same time, the <span class="italic">in vivo</span> experiments showed that this nano-platform had an excellent tumor therapeutic effects (<a title="Select to navigate to figure" href="#imgfig9">Fig. 9d</a>). The heat generated promotes the thermal decomposition of NH<small><sub>4</sub></small>HCO<small><sub>3</sub></small> to produce oxygen, which increases the therapeutic effect of PDT and confirming the feasibility of this strategy.</p>
        <p class="otherpara">In tumor therapy, the lack of substrates needed in treatment, such as hypoxia in PDT and deficiency of hydrogen peroxide in CDT, will limit the therapeutic effect of ROS. Professor Dong's team jointly designed an H<small><sub>2</sub></small>O<small><sub>2</sub></small>/O<small><sub>2</sub></small> self-sufficient nano agent (MSNs@CaO<small><sub>2</sub></small>-ICG)@LA.<a title="Select to navigate to references" href="#cit141"><sup><span class="sup_ref">141</span></sup></a> This nano-system consists of manganese silicate (MSN) loaded calcium peroxide (CaO<small><sub>2</sub></small>) and the photosensitizer indocyanine green (ICG), with further shaping of the surface, that was modified with phase-change material (LA), as an open-source and cost-saving ROS generation strategy for CDT/PDT synergistic therapy. In this nano-system, the strategy of laser irradiation to generate heat is also adopted to expose the CaO<small><sub>2</sub></small> in the nano-system. CaO<small><sub>2</sub></small> is protected by outer LA to avoid direct contact with water. Under NIR irradiation, which induces the photothermal action of photosensitizer ICG, the outer LA can melt, and the exposed CaO<small><sub>2</sub></small> reacts with water, resulting in the rapid formation of H<small><sub>2</sub></small>O<small><sub>2</sub></small> and O<small><sub>2</sub></small>, and further exposure of the internal MSN. The oxygen released can alleviate the hypoxia in the cells, thereby enhancing ICG-mediated PDT. The interaction between MSNs and GSH leads to the release of the Fenton-like agent Mn<small><sup>2+</sup></small>, which is used in H<small><sub>2</sub></small>O<small><sub>2</sub></small>-supplemented CDT and magnetic resonance imaging (MRI)-guided therapy; the consumption of GSH deeply destroys the intracellular redox environment, thus further improving the production efficiency of ROS. An <span class="italic">in vitro</span> experiment explored the synergistic therapeutic effect of MSNsCaO<small><sub>2</sub></small>-ICG@LA-mediated CDT/PDT. The concentration of Mn<small><sup>2+</sup></small> was measured at different time points, and showed the blood circulation curve of MSNs@CaO<small><sub>2</sub></small>-ICG@LA in mice. Because the EPR effect is conducive to the accumulation of MSNs@CaO<small><sub>2</sub></small>-ICG@LA in the tumor tissue, the brightness of the tumor site of the MSN-treated mice was higher than that of the control group, indicating that MSNs could be degraded into Mn<small><sup>2+</sup></small> by GSH <span class="italic">in vivo</span>. It also illustrates the excellent thermal response characteristics of the nano-system, and the combined therapy of this nano-system enhances the ablation ability of the tumor. Compared with the nanometer platform designed by Zhang's research group in 2017, this topic also combined with MRI, which can realize the integration of diagnosis and treatment in the process of therapy, and provides excellent value for tumor treatment and further clinical application.</p>
        <p class="otherpara">From the point of view of re-injecting oxygen into the infarcted myocardium to protect cardiomyocytes and reconstruct cardiac function in acute myocardial infarction treatment, Hao's team developed a nano-system named CMHP.<a title="Select to navigate to references" href="#cit142"><sup><span class="sup_ref">142</span></sup></a> This nano-system is formed by forming CaO<small><sub>2</sub></small> in a mesoporous silica nano-platform and then assembling the thermosensitive materials eicosane and polyethylene glycol. In an <span class="italic">in vivo</span> experiment, pathomorphological analysis showed that there was significant left ventricular wall thinning in the myocardial infarction group, while less in the CMHPv + US group. Therefore, the survival rate of cardiomyocytes under hypoxia was significantly increased, and infarcted myocardial tissue injury was reduced to a minimum.</p>
      
      
        
        <h3 id="sect1536"><span class="b_heading">2.4 Water splitting</span></h3>
        <span>For tumor tissue, hypoxia hinders the effect of PDT treatment. PDT methods to alleviate hypoxia have been constantly explored, with the use of oxygen produced by photosynthesis to alleviate tumor microenvironment hypoxia,<a title="Select to navigate to reference" href="#cit50"><sup><span class="sup_ref">50,143,144</span></sup></a> but the process of this method is tedious. The preparation of molecular hydrogen and oxygen can be accomplished by decomposing water under the action of solar energy. This method is a promising way of obtaining renewable energy storage,<a title="Select to navigate to reference" href="#cit145"><sup><span class="sup_ref">145,146</span></sup></a> so, using water in the human body as a direct resource, catalytic cracking of water to produce oxygen will be more convenient and direct. It may also be used as a lasting method of providing O<small><sub>2</sub></small>. Inspired by this, the photolysis strategy of water in organisms has been used to generate O<small><sub>2</sub></small> in the body and promote ROS production or other ways to improve PDT efficiency. Among many water separation materials, carbon nitride (C<small><sub>3</sub></small>N<small><sub>4</sub></small>) has attracted much attention because of its adjustable band gap and position, and low-permeability to light such as ultraviolet absorption has a great effect on the body,<a title="Select to navigate to references" href="#cit147"><sup><span class="sup_ref">147</span></sup></a> so C<small><sub>3</sub></small>N<small><sub>4</sub></small> can be modified to drive the decomposition of water under highly permeating red light (&gt;600 nm). This makes C<small><sub>3</sub></small>N<small><sub>4</sub></small> suitable for <span class="italic">in vivo</span> treatment.<a title="Select to navigate to reference" href="#cit148"><sup><span class="sup_ref">148,149</span></sup></a> In 2015, Kang's research team designed a metal-free carbon nanodot–carbon nitride (C<small><sub>3</sub></small>N<small><sub>4</sub></small>) nanocomposite, and verified this nanocomposite had an impressive performance. After ensuring the amount of composite catalyst in water, the optimum CDots/C<small><sub>3</sub></small>N<small><sub>4</sub></small> ratio is 4.8 × 10<small><sup>−3</sup></small> g<small><sub>CDots</sub></small>/g<small><sub>catalyst</sub></small>, with CDots–C<small><sub>3</sub></small>N<small><sub>4</sub></small> composites at <span class="italic">λ</span> = 420 ± 20 nm and <span class="italic">λ</span> = 580 ± 15 nm. The QEs that can decompose water into H<small><sub>2</sub></small> and O<small><sub>2</sub></small> are 16% and 6.3%, respectively. For the photocatalyst g-C<small><sub>3</sub></small>N<small><sub>4</sub></small>, it has the characteristics of rich resources and low cost,<a title="Select to navigate to reference" href="#cit150"><sup><span class="sup_ref">150,151</span></sup></a> and the most important thing is that the preparation is relatively simple,<a title="Select to navigate to reference" href="#cit152"><sup><span class="sup_ref">152,153</span></sup></a> so it is convenient for the application of this new catalyst. Some studies have proved that g-C<small><sub>3</sub></small>N<small><sub>4</sub></small> has great potential as a photosensitizer to alleviate tumor hypoxia.<a title="Select to navigate to reference" href="#cit154"><sup><span class="sup_ref">154,155</span></sup></a> Under weak light (20 mW cm<small><sup>−2</sup></small>), it can produce ROS and kill tumor cells. In addition, carbon points (CdS) have the advantages of unique photoelectron transfer and luminescence properties. This study also made Yang's team think of using the combination of g-C<small><sub>3</sub></small>N<small><sub>4</sub></small> and CdS to form an excellent performance PDT photosensitizer: (i) 2H<small><sub>2</sub></small>O → H<small><sub>2</sub></small>O<small><sub>2</sub></small> + H<small><sub>2</sub></small>; (ii) 2H<small><sub>2</sub></small>O<small><sub>2</sub></small> → 2H<small><sub>2</sub></small>O + O<small><sub>2</sub></small>.<a title="Select to navigate to reference" href="#cit153"><sup><span class="sup_ref">153,156</span></sup></a> They integrated dual-mode photodynamic therapy (Dual-PDT) into one system for multiple functions.<a title="Select to navigate to references" href="#cit157"><sup><span class="sup_ref">157</span></sup></a> First, the core–shell structured upconversion nanoparticles were attached on graphitic-phase g-C<small><sub>3</sub></small>N<small><sub>4</sub></small> nanosheets (one photosensitizer), and then by way of <span class="italic">in situ</span> growth, as-prepared nanocomposite and carbon dots were assembled in ZIF-8 metal–organic frameworks, and in the end, a dual photosensitizer mixing system for PDT was realized by stepwise water splitting. In <span class="italic">in vivo</span> experiments, the tumor growth rate of a UCNPS-g-C<small><sub>3</sub></small>N<small><sub>4</sub></small>@ZIF-8 complex culture was significantly different with or without light, indicating that the production of oxygen under light conditions alleviated tumor hypoxia and increased the therapeutic effect. This research group also reported a new multi-functional nano-platform named UCNPs@BiOCl, which is based on the integration of NaGdF<small><sub>4</sub></small>:Yb,Tm@NaGdF<small><sub>4</sub></small> UCNPs and bismuth oxyhalide (BiOCl) sheets, for 980 nm near-infrared light-triggered PDT.<a title="Select to navigate to references" href="#cit158"><sup><span class="sup_ref">158</span></sup></a> With the same hydrolysis strategy, the loaded UCNPs can convert near infrared light into UV/Vis region emissions, which drives the pure water pyrolysis of BiOCl sheets, and the resulting reactive oxygen species are used to kill the tumor cells.</span>
        <p class="otherpara">A kind of multifunctional nanocomposite (PCCN) based on C<small><sub>3</sub></small>N<small><sub>4</sub></small> was adopted to solve the problem of hypoxia restricting the efficacy of PDT.<a title="Select to navigate to references" href="#cit159"><sup><span class="sup_ref">159</span></sup></a> The nanomaterial PCCN was designed and synthesized, which contains protoporphyrin photosensitizer IX (PpIX), a polyethylene glycol chain connector and an RGD sequence Arg–Gly–Asp motif, and was prepared by the accumulation of π–π bond between C<small><sub>3</sub></small>N<small><sub>4</sub></small> and PpIX. PCCN uses RGD targeting and the EPR effect to reach tumor tissue, where it accumulates. PCCN produces O<small><sub>2</sub></small> by cracking water, which is irradiated by 630 nm laser. Photosensitizers can also redistribute the energy and transfer it to the resulting O<small><sub>2</sub></small> and produce cytotoxic <small><sup>1</sup></small>O<small><sub>2</sub></small>. In addition, PCCN can also down-regulate the expression of hypoxia-related proteins, thus inhibiting tumor metastasis and treating tumors in two modes: ablation and inhibition of tumor metastasis. Similarly, Zhang's team (the same team as the last report) continued to develop their hydrolyzed oxygen project.<a title="Select to navigate to references" href="#cit160"><sup><span class="sup_ref">160</span></sup></a> Taking advantage of the advantage of Ru(<span class="small_caps">II</span>) complex as a photosensitizer for two-photon photodynamic excitation,<a title="Select to navigate to reference" href="#cit161"><sup><span class="sup_ref">161,162</span></sup></a> a composite nanoparticle (FCRH) was designed, which was composed of iron-doped carbon nitride (Fe–C<small><sub>3</sub></small>N<small><sub>4</sub></small>), Ru(Bpy)<small><sub>3</sub></small><small><sup>2+</sup></small> and hyperbranched conjugated copolymer (HOP) with a polyethylene glycol arm. By π–π bond stacking on Ru(Bpy)<small><sub>3</sub></small><small><sup>2+</sup></small>, photogenerated electrons are injected into Fe–C<small><sub>3</sub></small>N<small><sub>4</sub></small> from Ru(Bpy)<small><sub>3</sub></small><small><sup>2+</sup></small> to promote charge localization, which can more effectively separate the charge and prevent electron–hole pair recombination, thus improving the photocatalytic activity and O<small><sub>2</sub></small> production.<a title="Select to navigate to reference" href="#cit7"><sup><span class="sup_ref">7,163</span></sup></a> In <span class="italic">in vitro</span> experiments, after accumulating nanocomposites by enhancing EPR, FCRH has been proved to alleviate tumor hypoxia, thus strengthening the anti-tumor effect of PDT.<a title="Select to navigate to reference" href="#cit159"><sup><span class="sup_ref">159,164,165</span></sup></a> Under 800 nm excitation light irradiation, there was apparent oxygen production, and the EPR spectrum confirmed the production of <small><sup>1</sup></small>O<small><sub>2</sub></small>. After 24 hours of intravenous injection of IR780-labeled nanocomposite material, the apparent tumor contrast IR780 fluorescence gradually increased and then decreased after 36 hours, confirming its excellent tumor-specific accumulation ability <span class="italic">in vivo</span>. In the treatment experiment, the tumor volume of the FCRH combined with irradiation group was suppressed entirely within 14 days, while the inhibitory effect of FCRH on 4T1 tumors was negligible under the condition of no light; this shows the same excellent therapeutic effect. In the same way as in the previous work, photocatalytic materials were developed from TiO<small><sub>2</sub></small>, C<small><sub>3</sub></small>N<small><sub>4</sub></small> and bismuth halide flakes. NIR radiation is also adopted, and the near-infrared light has the characteristics of low toxicity and vigorous penetration. The energy produced after excitation promotes the catalytic decomposition of H<small><sub>2</sub></small>O to O<small><sub>2</sub></small> and improves the PDT efficiency.<a title="Select to navigate to reference" href="#cit157"><sup><span class="sup_ref">157,166</span></sup></a> The above studies have played a leading role in using the hydrolysis of water in the body to prepare O<small><sub>2</sub></small> to alleviate the hypoxia of tumor tissues, especially in the further improvement of the strategy in the later stages, with the use of high-penetration red light for water cleavage, which is suitable for <span class="italic">in vivo</span> treatment. Also, the publications about water splitting were summaried in <a title="Select to navigate to table" href="#tab5">Table 5</a>.</p>
        
<div class="table_caption"><b>Table 5</b> <span id="tab5">Summary of publications about water splitting</span>
		</div>

            <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="46.65pt"/><col align="left" width="34.45pt"/><col align="left" width="57.53pt"/><col align="left" width="47.56pt"/><col align="left" width="164.90pt"/><col align="left" width="47.56pt"/><col align="left" width="44.16pt"/><col align="left" width="53.79pt"/><col align="left" width="25.62pt"/></colgroup>
              
              
              
              
              
              
              
              
              
              <thead align="left">
                <tr align="left" valign="bottom">
                  <th align="left" valign="bottom" class="border_black">Application</th>
                  <th align="left" valign="bottom" class="border_black">Catalyst</th>
                  <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                  <th align="left" valign="bottom" class="border_black">PSs</th>
                  <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                  <th align="left" valign="bottom" class="border_black">ROS species</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vitro</span> (cell line)</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                  <th align="left" valign="bottom" class="border_black">Ref.</th>
                </tr>
              </thead>
              <tfoot align="left">
                <tr align="left">
                  <th colspan="9">Abbreviations: water splitting (Ws); mediating the photosensitizer (BiOCl); protoporphyrin IX (PpIX); ruthenium(<span class="small_caps">II</span>) complex (Ru(bpy)<small><sub>3</sub></small><small><sup>2+</sup></small>); hypoxemia after acute myocardial infarction (AMI); the phase change of heneicosane (PCH).</th>
                </tr>
              </tfoot>
              <tbody align="left">
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">CaO<small><sub>2</sub></small></td>
                  <td valign="top">Water splitting</td>
                  <td valign="top">RB</td>
                  <td valign="top">980 nm, 2 W cm<small><sup>−2</sup></small>, 5 s</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">HT29</td>
                  <td valign="top">HT29</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit137">137</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">CaO<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">Water splitting</td>
                  <td rowspan="2" valign="top">MB</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 660 nm, 30 mW cm<small><sup>−2</sup></small>, 6 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit140">140</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 658 nm, 280 mW cm<small><sup>−2</sup></small>, 10 min</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT/PTT</td>
                  <td rowspan="2" valign="top">CaO<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">CaO<small><sub>2</sub></small>/B1/NH<small><sub>4</sub></small>HCO<small><sub>3</sub></small></td>
                  <td rowspan="2" valign="top">aza-BODIPY</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 730 nm, 500 mW cm<small><sup>−2</sup></small>, 5 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">HeLa</td>
                  <td rowspan="2" valign="top">HeLa</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit139">139</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 730 nm, 100 mW cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td valign="top">CDT/PDT</td>
                  <td valign="top">CaO<small><sub>2</sub></small></td>
                  <td valign="top">Water splitting</td>
                  <td valign="top">ICG</td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 808 nm, 0.64 W cm<small><sup>−2</sup></small>, 10 min</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small>, ˙OH</td>
                  <td valign="top">MCF-7 and A549</td>
                  <td valign="top">MCF-7</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit141">141</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">US + CMHP</td>
                  <td valign="top">US</td>
                  <td valign="top">Water splitting</td>
                  <td valign="top">NO</td>
                  <td valign="top">1.0 MHz, 0.6 W cm<small><sup>−2</sup></small>, 30 s</td>
                  <td valign="top">NO</td>
                  <td valign="top">H9c2</td>
                  <td valign="top">NO</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit142">142</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">C<small><sub>3</sub></small>N<small><sub>4</sub></small></td>
                  <td rowspan="2" valign="top">Ws</td>
                  <td rowspan="2" valign="top">UCNPs</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 980 nm, 0.5 W cm<small><sup>−2</sup></small>, 5 min</td>
                  <td rowspan="2" valign="top">˙O<small><sub>2</sub></small><small><sup>−</sup></small>, <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">L929</td>
                  <td rowspan="2" valign="top">U14</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit157">157</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 980 nm, 0.5 W cm<small><sup>−2</sup></small>, 10 min</td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">C<small><sub>3</sub></small>N<small><sub>4</sub></small></td>
                  <td valign="top">Water splitting</td>
                  <td valign="top">BiOCl</td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 980 nm, 0.5 W cm<small><sup>−2</sup></small>, 10 min</td>
                  <td valign="top">OH˙, ˙O<small><sub>2</sub></small><small><sup>−</sup></small></td>
                  <td valign="top">HeLa</td>
                  <td valign="top">U14</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit158">158</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">C<small><sub>3</sub></small>N<small><sub>4</sub></small></td>
                  <td rowspan="2" valign="top">PCCN</td>
                  <td rowspan="2" valign="top">PpIX</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 630 nm He–Ne, 80 mW cm<small><sup>−2</sup></small>, 10 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">4T1 and MCF-7</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit159">159</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 630 nm He–Ne, 40 mW cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Fe–C<small><sub>3</sub></small>N<small><sub>4</sub></small></td>
                  <td rowspan="2" valign="top">Water splitting</td>
                  <td rowspan="2" valign="top">Ru(bpy)<small><sub>3</sub></small><small><sup>2+</sup></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 800 nm, 2.7 W, 3 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit160">160</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 800 nm, 2.7 W, 5 min</td>
                </tr>
              </tbody>
            </table></div></div>
          <hr class="hrule"/><br/>
      
    
    
      
      <h2 id="sect1838"><span class="a_heading">3. Improve tumor hypoxia through various oxygen delivery carriers</span></h2>
      <span>The culprit in hypoxia is the formation of abnormal blood vessels, often forming malformed blood vessels and poor blood flow.<a title="Select to navigate to reference" href="#cit38"><sup><span class="sup_ref">38,167–173</span></sup></a> In tumor tissue this will lead to a decrease in the average level of tissue partial pressure of oxygen, which often occurs during vascular disease,<a title="Select to navigate to reference" href="#cit174"><sup><span class="sup_ref">174,175</span></sup></a> lung disease, and cancer. Normal cell metabolism or treatment (PDT, drug therapy, <span class="italic">etc</span>.) needs oxygen, and hypoxia will seriously affect its therapeutic effect. Therefore, increasing the concentration of O<small><sub>2</sub></small> by accelerating the blood flow pathway will be a new way to improve therapeutic efficacy.</span>
      
        
        <h3 id="sect1846"><span class="b_heading">3.1 Accelerate the blood flow</span></h3>
        <span>The former study found that changing the blood temperature (40–42 °C) can increase the blood flow speed,<a title="Select to navigate to reference" href="#cit176"><sup><span class="sup_ref">176,177</span></sup></a> and the blood will continue to carry oxygen, so the acceleration of blood flow speed will also alleviate hypoxia.<a title="Select to navigate to reference" href="#cit178"><sup><span class="sup_ref">178–183</span></sup></a> The common method of increasing blood temperature is the hyperthermia produced by PTT;<a title="Select to navigate to reference" href="#cit184"><sup><span class="sup_ref">184–187</span></sup></a> PTT absorbing light through the NIR region can accelerate the blood flow velocity of patients with a solid tumor, and thus improve the oxygenation level of the cancer and reduce the treatment resistance related to hypoxia. It converts light energy into heat energy by exciting light to irradiate photosensitizers. There are many kinds of photosensitizer, including small molecule fluorescent probes,<a title="Select to navigate to reference" href="#cit188"><sup><span class="sup_ref">188–193</span></sup></a> nanomaterials,<a title="Select to navigate to reference" href="#cit194"><sup><span class="sup_ref">194,195</span></sup></a> and so on. Therefore, the use of a mild heating method for tumor treatment is an effective way to alleviate hypoxia and promote PDT outcomes.</span>
        <div>
          
          <span id="sect1855"/><span class="c_heading_indent">3.1.1 Increase the temperature through the process of PTT. </span>
          <span>Aiming to increase the temperature, the quite synergistic liquid metal nanoparticles–enzyme (LM@GOX) for combined starvation/photothermal therapy of tumors was prepared.<a title="Select to navigate to references" href="#cit196"><sup><span class="sup_ref">196</span></sup></a> In this system, when irradiated with a laser (808 nm) for 15 minutes, the photothermal effect increases along with the increase of LM or light intensity. They also studied the effect of temperature on enzyme activity, and the enzyme activity was measured by monitoring the production of H<small><sub>2</sub></small>O<small><sub>2</sub></small>. When the temperature reached a maximum of 60 °C, the enzyme activity decreased, so the PTT process would not affect the enzyme activity. In addition, 4T1 cells were used to verify the enhanced enzyme activity of LM@GOX under <span class="italic">in vitro</span> irradiation. The production of H<small><sub>2</sub></small>O<small><sub>2</sub></small> was confirmed by using the ROS probe 2′,7-dichlorofluorescein diacetate (DCFH-DA). The fluorescence intensity in LM@GOX-treated cells was significantly enhanced. This shows that the photothermal conversion of LM produces the heat, and under light it can improve the enzyme activity of GOX in cells. In an <span class="italic">in vivo</span> experiment, NIR dye Cy5 was anchored to an LM@GOX nano-system (LM@GOX-CY5) for <span class="italic">in vivo</span> fluorescence imaging to evaluate tumor accumulation <span class="italic">in vivo</span>. The results showed that LM@GOX-Cy5 could accumulate in the tumor after injection, and showed long-term retention, which was conducive to continuous light irradiation and therapy. Using the 4T1 tumor model injected subcutaneously, the anti-tumor experiment was carried out with NIR irradiation of the light group, and LM without NIR exposure could not effectively inhibit the growth of the tumor. Compared with chemotherapy or PTT alone, the synergistic effect of LM@GOX has been shown under 808 nm light, and the synergistic therapy can effectively eradicate tumor cells.</span>
          <p class="otherpara">The staining experiment of HIF-1α confirmed that the tumor's hypoxia state was obviously improved.<a title="Select to navigate to reference" href="#cit167"><sup><span class="sup_ref">167,197</span></sup></a> Immunofluorescence in the LM + NIR treatment group was weak, indicating that HIF-1α was expressed at a low level in tumor tissues, and the hypoxia tolerance catalyzed by GOX may be alleviated. It was further proved that blood flow accelerated, and hypoxia was relieved during PTT treatment. Feng <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit198"><sup><span class="sup_ref">198</span></sup></a> prepared a liposome system containing photosensitizer Ce6 and a photothermal agent (DIR). An NIR light-activated liposome Ce6 preparation was constructed, and HCe6 and DIR molecules were co-encapsulated in PEG shell liposome bilayers. Under NIR laser irradiation at 785 nm, the fluorescence of hCe6 in dir-hCe6-liposomes will be awakened. Irradiated with 660 nm LED light at 2 mW cm<small><sup>−2</sup></small>, the function of PDT can be triggered by stimulating PS and Ce6 to produce a mild photothermal heating, which can accelerate the circulation of blood flow, lighten tumor hypoxia and promote the therapeutic effect of PDT. At the same time, it has shown great potential in skin protection and is an excellent class of activable photosensitizer.<a title="Select to navigate to reference" href="#cit199"><sup><span class="sup_ref">199,200</span></sup></a><span class="italic">In vivo</span> experiments show that this liposome system can significantly improve tumor blood flow and alleviate tumor hypoxia.</p>
        </div>
        <div>
          
          <span id="sect1875"/><span class="c_heading_indent">3.1.2 Chemotherapy drugs. </span>
          <span>In addition to accelerating the rate of blood flow in the tumor by generating heat through PTT, some chemotherapy drugs also have a similar function. By regulating the chaotic structure of tumor blood vessels, the accelerated blood flow drives more oxygen into the tumor microenvironment and improves the hypoxia. Common chemotherapy drugs include taxane, gemcitabine, cyclophosphamide, and cisplatin.</span>
          <p class="otherpara">Nanoparticles containing Pt(<span class="small_caps">IV</span>) and dihydro porphyrin e6 and loaded with UCNPs were designed and developed, and can convert near-infrared light of 980 nm into emission light of 365 nm and 660 nm (<a title="Select to navigate to figure" href="#imgfig10">Fig. 10a</a>).<a title="Select to navigate to references" href="#cit201"><sup><span class="sup_ref">201</span></sup></a> When UCPP decomposition is triggered by 980 nm laser irradiation, O<small><sub>2</sub></small> can be produced to compensate for consumption in the process of PDT, releasing active Pt(<span class="small_caps">II</span>) for synergistic photochemotherapy. The nano-system does not need to be accompanied by catalytic substances, such as MnO<small><sub>2</sub></small> or catalase,<a title="Select to navigate to reference" href="#cit57"><sup><span class="sup_ref">57,202–204</span></sup></a> and could solve the limitation of hypoxia PDT treatment. In an <span class="italic">in vitro</span> experiment, L929 cells were carefully studied by CLSM to reverse PDT-induced hypoxia. An ROS probe was used to detect ROS under hypoxia and normoxic conditions. Whether under normoxic or anoxic conditions, UCPP-treated L929 cells presented bright green fluorescence, indicating that UCPP could indeed produce O<small><sub>2</sub></small> inside the cells and provide enough O<small><sub>2</sub></small> for PDT to conquer PDT-induced hypoxia (<a title="Select to navigate to figure" href="#imgfig10">Fig. 10b</a>). In an <span class="italic">in vivo</span> experiment, two kinds of orthotopic superficial carcinoma, B16 and MDA-MB-231 tumor models, and two subcutaneous tumor models, HeLa and HCT116, were used to evaluate the anticancer activity. When B16, HCT116 and MDA-MB-231 tumor-bearing mice were treated with UCPP nanoparticles and then given 980 nm laser irradiation, all xenografts disappeared only after laser irradiation (<a title="Select to navigate to figure" href="#imgfig10">Fig. 10c</a>). The remarkable anti-tumor result <span class="italic">in vivo</span> was achieved by reasonably designed UCPP. The UCPP can generate O<small><sub>2</sub></small> and Pt(<span class="small_caps">II</span>) under NIR irradiation, thereby alleviating the state of hypoxia and achieving synergistic PDT-chemotherapy.</p>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig10"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f10_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f10.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f10.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 10 </b> <span id="fig10"><span class="graphic_title">(a) Schematic illustration of UCPP nanoparticles. (b) CLSM imaging of different nano-systems under normoxic and anoxic conditions. (c) The change of various cancer cells (HCT116, MDA-MB-231, and B16) in tumor-bearing mice with different treatments. Reproduced from ref. <a title="Select to navigate to references" href="#cit201">201</a> with permission from Springer Nature Limited, copyright 2018.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        </div>
        <div>
          
          <span id="sect1899"/><span class="c_heading_indent">3.1.3 Z-Scheme heterostructures for hypoxic tumor therapy. </span>
          <span>High-Z element nanomaterials are a kind of functional nanomaterial which can simultaneously reduce tumor hypoxia and enhance tumor ionizing radiation energy deposition on a single nanometer platform,<a title="Select to navigate to reference" href="#cit205"><sup><span class="sup_ref">205,206</span></sup></a> thus improving the effectiveness of radiotherapy without the need for additional and complex O<small><sub>2</sub></small> delivery or O<small><sub>2</sub></small> generation systems; as a novel strategy, it has made great changes in improving the effect of radiotherapy for hypoxic tumors. PVP-Bi<small><sub>2</sub></small>Se<small><sub>3</sub></small>@Sec nanoparticles are outstanding.<a title="Select to navigate to references" href="#cit207"><sup><span class="sup_ref">207</span></sup></a> The X-ray attenuation and high NIR absorption performances were quite good, so these nanoparticles are equipped for use in CT/PA imaging contrast agents for imaging-guided photothermal radiation therapy.<a title="Select to navigate to references" href="#cit208"><sup><span class="sup_ref">208</span></sup></a> They show a noticeable enhancement of free radical production under X-ray radiation and NIR laser irradiation. The photothermal effect can increase the oxygenation within tumors by accelerating the blood flow, thus reducing the radio-resistance of cancer. PVP-Bi<small><sub>2</sub></small>Se<small><sub>3</sub></small>@Sec-mediated PTT/RT synergistic therapy inhibited the growth of the tumor after 5 days, and no recurrence occurred within three weeks. The final anti-tumor rate of the synergistic group was more than 98%, which further indicated that PVP-Bi<small><sub>2</sub></small>Se<small><sub>3</sub></small>@Sec NPs could enhance the synergistic therapeutic effect of PTT and RT on tumors. The authors speculate that the improvement in the effectiveness of synergistic therapy may be due to the hyperthermia condition that can effectively kill those cells that a not sensitive to radiotherapy. In addition, appropriate hyperthermia can increase tumor oxygenation by improving the blood flow within the tumor, which can reverse radiation resistance in tumor tissues. Cheng <span class="italic">et al.</span> designed novel bismuth sulfide (Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>)@bismuth (Bi) Z-scheme nanorods (NRs), as narrow bandgap Bi<small><sub>2</sub></small>S<small><sub>3</sub></small> and Bi components can generate abundant electrons and holes in NIR light (<a title="Select to navigate to figure" href="#imgfig11">Fig. 11a</a>).<a title="Select to navigate to references" href="#cit209"><sup><span class="sup_ref">209</span></sup></a> In addition, the Z-scheme heterostructure endows Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>@Bi NRS with effective electron–hole separation ability and strong redox potential. The holes in the Bi<small><sub>2</sub></small>S<small><sub>3</sub></small> valence band can react with water, providing O<small><sub>2</sub></small> for the electrons in the Bi conduction band, thus producing reactive oxygen species. The results show that when the oxidation potential of the valence band hole of the nanomaterial is greater than that of the water oxidation potential (1.23 V, relative to the standard hydrogen electrode), the hole will react with water to produce O<small><sub>2</sub></small>, while when the reduction potential of the electrons in the conduction band of the nanomaterials is less than the formation potential of O<small><sub>2</sub></small>˙<small><sup>−</sup></small> (−0.13 V), the electrons can react with O<small><sub>2</sub></small> to form O<small><sub>2</sub></small>˙<small><sup>−</sup></small> and further form OH˙.<a title="Select to navigate to references" href="#cit210"><sup><span class="sup_ref">210</span></sup></a><span class="italic">In vitro</span>, after laser irradiation, the cell injury induced by Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>@Bi NRs was stronger than that induced by Bi<small><sub>2</sub></small>S<small><sub>3</sub></small> + Bi, showing the prominent phototherapeutic effect (<a title="Select to navigate to figure" href="#imgfig11">Fig. 11b</a>). In an <span class="italic">in vivo</span> experiment, after the tumor-targeting ability of nano-particles was confirmed by CT imaging, they used 4T1 tumor-bearing mice to study the phototherapy effect of Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>@Bi NRs. Under NIR laser irradiation, Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>@BiNRs significantly down-regulated HIF-1α, indicating that tumor hypoxia had been relieved successfully. When the biocompatible modified Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>@Bi NRs were injected into the tumor tissue by way of the tail vein, they showed a major inhibitory effect on tumor growth (<a title="Select to navigate to figure" href="#imgfig11">Fig. 11b</a>). Near-infrared irradiation could weaken the hypoxia condition of the tumor microenvironment and produce strong oxidative damage to tumor tissue, showing a good therapeutic effect of PDT on hypoxic tumors. Also, the publications about accelerating blood flow to introduce O<small><sub>2</sub></small> were summaried in <a title="Select to navigate to table" href="#tab6">Table 6</a>.</span>
          <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig11"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f11_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f11.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f11.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 11 </b> <span id="fig11"><span class="graphic_title">(a) Schematic diagram of the therapeutic process of oxygen produced by Bi<small><sub>2</sub></small>S<small><sub>3</sub></small>@BiNRs nanoparticles irradiated by near-infrared laser to promote ROS production. (b) After different treatments, the tumor growth curve of mice with or without laser irradiation. Reproduced from ref. <a title="Select to navigate to references" href="#cit209">209</a> with permission from Wiley, copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
          
<div class="table_caption"><b>Table 6</b> <span id="tab6">Summary of publications about accelerating blood flow to introduce O<small><sub>2</sub></small></span>
		</div>

              <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="45.29pt"/><col align="left" width="41.33pt"/><col align="left" width="47.67pt"/><col align="left" width="58.66pt"/><col align="left" width="152.36pt"/><col align="left" width="47.81pt"/><col align="left" width="51.60pt"/><col align="left" width="51.88pt"/><col align="left" width="25.62pt"/></colgroup>
                
                
                
                
                
                
                
                
                
                <thead align="left">
                  <tr align="left" valign="bottom">
                    <th align="left" valign="bottom" class="border_black">Application</th>
                    <th align="left" valign="bottom" class="border_black">PS</th>
                    <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                    <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> level detection</th>
                    <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                    <th align="left" valign="bottom" class="border_black">ROS species</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vitro</span> (cell lines)</th>
                    <th align="left" valign="bottom" class="border_black">
                      <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                    <th align="left" valign="bottom" class="border_black">Ref.</th>
                  </tr>
                </thead>
                <tfoot align="left">
                  <tr align="left">
                    <th colspan="9">Abbreviations: indicator ([Ru(dpp)<small><sub>3</sub></small>]Cl<small><sub>2</sub></small>); chlorin e6 (Ce6); oxygen dissolving meter (ODM); increase blood flow (IBF); pimonidazole hydrochloride (Hypoxyprobe™).</th>
                  </tr>
                </tfoot>
                <tbody align="left">
                  <tr align="left">
                    <td rowspan="2" valign="top">PTT</td>
                    <td rowspan="2" valign="top">NO</td>
                    <td rowspan="2" valign="top">IBF</td>
                    <td rowspan="2" valign="top">NO</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 808 nm, 1.0 W cm<small><sup>−2</sup></small>, 15 min</td>
                    <td rowspan="2" valign="top">H<small><sub>2</sub></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit196">196</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 808 nm, 1.0 W cm<small><sup>−2</sup></small>, 5 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT/PTT</td>
                    <td rowspan="2" valign="top">Chlorin e6</td>
                    <td rowspan="2" valign="top">IBF</td>
                    <td rowspan="2" valign="top">Hypoxyprobe™</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 785 nm, 1.0 W cm<small><sup>−2</sup></small>, 10 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit198">198</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 785 (660) nm, 2 W cm<small><sup>−2</sup></small>, 20 min (1 h)</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Chlorin e6</td>
                    <td rowspan="2" valign="top">UCPP</td>
                    <td rowspan="2" valign="top">ODM</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 909 nm, 0.85 W cm<small><sup>−2</sup></small>, 5 min</td>
                    <td rowspan="2" valign="top">
                      <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                    <td rowspan="2" valign="top">L929</td>
                    <td rowspan="2" valign="top">HeLa and HCT116</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit201">201</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 909 nm, 0.85 W cm<small><sup>−2</sup></small>, 10 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PTT</td>
                    <td rowspan="2" valign="top">NO</td>
                    <td rowspan="2" valign="top">IBF</td>
                    <td rowspan="2" valign="top">NO</td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 808 nm, 1.0 W cm<small><sup>−2</sup></small>, 10 min</td>
                    <td rowspan="2" valign="top">Free radicals</td>
                    <td rowspan="2" valign="top">HUVEC and MDA-MB-231</td>
                    <td rowspan="2" valign="top">BEL-7402</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit207">207</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 808 nm, 0.3 W cm<small><sup>−2</sup></small>, 10 min</td>
                  </tr>
                  <tr align="left">
                    <td rowspan="2" valign="top">PDT</td>
                    <td rowspan="2" valign="top">Bi<small><sub>2</sub></small>S<small><sub>3</sub></small></td>
                    <td rowspan="2" valign="top">Bi<small><sub>2</sub></small>S<small><sub>3</sub></small> + water</td>
                    <td rowspan="2" valign="top">[Ru(dpp)<small><sub>3</sub></small>]Cl<small><sub>2</sub></small></td>
                    <td valign="top">
                      <span class="italic">In vitro</span>: 808 nm, 0.5 W cm<small><sup>−2</sup></small>, 10 min</td>
                    <td rowspan="2" valign="top">O<small><sub>2</sub></small>˙<small><sup>−</sup></small>, OH˙</td>
                    <td rowspan="2" valign="top">4T1 and 3T3</td>
                    <td rowspan="2" valign="top">4T1</td>
                    <td rowspan="2" valign="top">
                      <a title="Select to navigate to references" href="#cit209">209</a>
                    </td>
                  </tr>
                  <tr align="left">
                    <td valign="top">
                      <span class="italic">In vivo</span>: 808 nm, 0.5 W cm<small><sup>−2</sup></small>, 5 min</td>
                  </tr>
                </tbody>
              </table></div></div>
            <hr class="hrule"/><br/>
        </div>
      
      
        
        <h3 id="sect2088"><span class="b_heading">3.2 Perfluorocarbons</span></h3>
        <span>PFCs are a kind of organic fluorine compound. The reason why PFCs can dissolve relatively large volumes of gas is due to the weak interactions (van der Waals force) and they are clinically used as an artificial blood substitute.<a title="Select to navigate to reference" href="#cit211"><sup><span class="sup_ref">211,212</span></sup></a> When the oxygen pressure in PFCs is lower than 760 Torr (1 atm) at room temperature (25 °C),<a title="Select to navigate to references" href="#cit213"><sup><span class="sup_ref">213</span></sup></a> the amount of dissolved oxygen per 100 mL liquid (40–50 mL) is twice as much as that in normal human blood.<a title="Select to navigate to references" href="#cit214"><sup><span class="sup_ref">214</span></sup></a> Because of its high O<small><sub>2</sub></small>-generating capacity,<a title="Select to navigate to reference" href="#cit215"><sup><span class="sup_ref">215–217</span></sup></a> at a determined partial pressure of oxygen, it can have a higher amount of oxygen relative to the tumor matrix at a given partial oxygen pressure. From 1988, Henderson and his co-workers began using PFCs to enhance PDT by injecting porphyrin photosensitizers containing PFC nanoemulsions.<a title="Select to navigate to references" href="#cit218"><sup><span class="sup_ref">218</span></sup></a> In addition, nano-carriers containing PFC can be used as a US imaging agent and high intensity focused ultrasound (HIFU) agent.<a title="Select to navigate to reference" href="#cit219"><sup><span class="sup_ref">219,220</span></sup></a> Gasification is a new PFC application technology that can significantly improve oxygenation and lung function in oleic acid-induced lung injury.<a title="Select to navigate to references" href="#cit221"><sup><span class="sup_ref">221</span></sup></a></span>
        <p class="otherpara">After applying this nanomaterials to mice, the tumor's oxygenation was enhanced, which could significantly improve the efficacy of PDT and radiotherapy. The introduction of a fluorinated chain segment increased the solubility of PS, increased the local O<small><sub>2</sub></small> concentration of polystyrene in the ground state (<small><sup>3</sup></small>O<small><sub>2</sub></small>) and excited state (<small><sup>1</sup></small>O<small><sub>2</sub></small>), and improved the O<small><sub>2</sub></small> diffusivity. Additionally, PFC emulsions have been approved by the FDA.<a title="Select to navigate to references" href="#cit222"><sup><span class="sup_ref">222</span></sup></a> Inspired by this, PFCs bring oxygen molecules into auxiliary PDT in different ways, which is a possible new method to alleviate hypoxia.</p>
        <p class="otherpara">The designed nanoparticles get the most out of the O<small><sub>2</sub></small> and longer <small><sup>1</sup></small>O<small><sub>2</sub></small> lifetime of PFCs to significantly utilize the loaded functional photosensitizer to perfect the outcome of PDT.<a title="Select to navigate to reference" href="#cit212"><sup><span class="sup_ref">212,223</span></sup></a> In <span class="italic">in vitro</span> experiments, PDT was performed on LIP (IR780) and LIP (IR780 + PFH) under different hypoxia conditions (including 0.1, 1, 7, and 21 kPa O<small><sub>2</sub></small>). The LIP (IR780 + PFH) group could significantly increase O<small><sub>2</sub></small> production under both hypoxia and normoxic conditions, and the PFC could successfully promote the production of <small><sup>1</sup></small>O<small><sub>2</sub></small> under hypoxic conditions. In an <span class="italic">in vivo</span> PDT experiment, they first measured the <small><sup>1</sup></small>O<small><sub>2</sub></small> production of LIP (IR780) and LIP (IR780 + PFH). In order to prevent the extra effect caused by the photothermal effect, which affects the reliability of the experimental results, they separated the irradiation times, and enough time was provided to restore the original temperature, so the method of a one-minute interval was adopted for two consecutive laser irradiations. In an <span class="italic">in vivo</span> experiment, the therapeutic effect of intratumoral injection was studied first, and the tumor volume was also tracked with or without laser irradiation. Through the study of tumor accumulation imaging and ultrasound imaging of IR780, the mice were irradiated by a 808 nm laser 24 hours after intravenous injection, and the tumor volume irradiated with light (808 nm, 10 s, 2 W cm<small><sup>−2</sup></small>) was about 4 times smaller than that of mice treated with IR780 alone. Tang <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit224"><sup><span class="sup_ref">224</span></sup></a> adopted the Oxy-PDT strategy, loading a hydrophobic NIR photosensitizer into PFC nano-droplets as an effective photodynamic nano-drug. PFH was selected as the core of the PFC. During laser irradiation, the generation of <small><sup>1</sup></small>O<small><sub>2</sub></small> in the PFC phase will be faster. In this way, when the tumor is in a state of hypoxia, the photodynamic effect is good. The model of a hypoxic CT26 subcutaneous tumor was established and confirmed <span class="italic">in vivo</span>. All in all, it shows that the photosensitizer loaded into perfluorinated carbon nanodroplets can successfully treat hypoxic tumors resistant to traditional PDT. Using the same method, a PCF nano-emulsion containing fluorinated porphyrin, using the PFC nanoemulsion to transport O<small><sub>2</sub></small> and PS simultaneously, was designed and synthesized.<a title="Select to navigate to references" href="#cit225"><sup><span class="sup_ref">225</span></sup></a> The efficacy of PDT was determined by emulsion containing photosensitizer in cellulose. The uptake of nano-emulsion by human malignant melanoma (A375) cells was first verified by a co-localization test. Under laser irradiation, cell death was indicated by NucGreen™ fluorescence and confirmed again by flow cytometry analysis.<a title="Select to navigate to references" href="#cit226"><sup><span class="sup_ref">226</span></sup></a> It was determined that the use of fluorine-containing soluble photosensitizer is the most promising method for PDT with a PFC nano-emulsion. Besides, a reversible addition-fragmentation chain transfer (RAFT) polymerization technique was used, so plenty of amphiphilic/fluorine random copolymers with different contents of perfluorocarbon (perfluorooctyl) were prepared.<a title="Select to navigate to references" href="#cit227"><sup><span class="sup_ref">227</span></sup></a> The higher PFC content in the copolymers can produce ROS more effectively, thus improving PDT efficiency <span class="italic">in vitro</span>. They found that an increase in the PFC amount can carry more oxygen and therefore produce more ROS. The determination of <small><sup>1</sup></small>O<small><sub>2</sub></small> by 630 nm laser illumination (F-polymer (P<small><sub>6</sub></small>-F59%)-HB, H-polymer (P<small><sub>2</sub></small>-H54%)-HB) proved that the addition of PFC effectively promoted the production of <small><sup>1</sup></small>O<small><sub>2</sub></small>.</p>
        <p class="otherpara">Plasma gold metal nanostructures were combined with the semiconductors of Cu<small><sub>2</sub></small>O, ASC was loaded into O<small><sub>2</sub></small> PFH droplets, and then LIP (ASC/PFH) nanocomposites were formed by coating liposomes (LIP).<a title="Select to navigate to references" href="#cit228"><sup><span class="sup_ref">228</span></sup></a> At the same time, due to the high O<small><sub>2</sub></small> capacity of PFH, under a certain oxygen partial pressure, its high oxygen content can be maintained for a certain period of time and is higher than that of the tumor matrix.<a title="Select to navigate to references" href="#cit229"><sup><span class="sup_ref">229</span></sup></a> A high quantum yield of <small><sup>1</sup></small>O<small><sub>2</sub></small> was evaluated that was nearly 0.71, which was produced by the mechanism of plasmon-induced resonance energy transfer (PIRET) that produced, from addition of Au to Cu<small><sub>2</sub></small>O, Au@SiO<small><sub>2</sub></small>@Cu<small><sub>2</sub></small>O under NIR irradiation for ten minutes. In an <span class="italic">in vitro</span> experiment, the <small><sup>1</sup></small>O<small><sub>2</sub></small> production capacity of ASC added to Cu<small><sub>2</sub></small>O, Au@SiO<small><sub>2</sub></small>, and Au@Cu<small><sub>2</sub></small>O was evaluated by a DPBF probe, and 670 nm (0.48 W cm<small><sup>−2</sup></small>) laser was used for irradiation for 10 minutes. In addition, the real-time oxygen-carrying capacity of PFH is as high as 168 mg L<small><sup>−1</sup></small>, so it can be proved that it has good oxygen-carrying capacity. The antitumor activity of LIP (ASC/PFH) <span class="italic">in vivo</span> was studied, and a significant therapeutic effect in the LIP (ASC/PFH) group was shown when the laser irradiation was applied for 10 minutes every time. An H&amp;E staining assay showed that LIP (ASC/PFH) had good biocompatibility.</p>
        <p class="otherpara">Recently, a well-targeted oxygen self-sufficiency and tumor-penetration nano-platform, including IR780-loaded pH-sensitive fluorocarbon functionalized nanoparticles (SFNs) and target peptide-iRGD, has been developed (<a title="Select to navigate to figure" href="#imgfig12">Fig. 12a</a>).<a title="Select to navigate to references" href="#cit230"><sup><span class="sup_ref">230</span></sup></a> Through the real-time monitoring of the dissolved oxygen, a special study was carried out on the loading and release behavior of oxygen. The potential application of SFNs as oxygen storage was also studied, and the excellent O<small><sub>2</sub></small> loading performance and the capacity of high release were verified. An <span class="italic">in vivo</span> PA system and HIF-1α staining analysis were used to evaluate the hypoxia state of the tumors after the use of IR780@O<small><sub>2</sub></small>-SFNs/iRGD, IR780@O<small><sub>2</sub></small>-SFNs and IR780-SHN systems. The most significant change in the FL intensity of HbO<small><sub>2</sub></small> was in the IR780@O<small><sub>2</sub></small>-SFNs/iRGD group (50.1%), indicating that IR780@O<small><sub>2</sub></small>-SFNs/iRGD can transport O<small><sub>2</sub></small> and PS from the hydrophobic core to the deep and anoxic areas of the solid tumor, obviously improving the oxygenation of the tumor. A biodegradable hollow MoSe<small><sub>2</sub></small>/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nano-heterostructure was used as a PDT enhancer for multimode imaging (CT/MR/IR) and synergistic anti-tumor therapy, and hence the nanoparticle O<small><sub>2</sub></small>@PFC@MF-2@PEG/Dox was designed (<a title="Select to navigate to figure" href="#imgfig12">Fig. 12b</a>).<a title="Select to navigate to references" href="#cit231"><sup><span class="sup_ref">231</span></sup></a> Due to effective photoinduced charge separation, MoSe<small><sub>2</sub></small>/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> can produce twice as much ROS as a single MoSe<small><sub>2</sub></small>. On this basis, the use of a new hollow structure provides enough space for the PFC and O<small><sub>2</sub></small> carrier, and O<small><sub>2</sub></small>@PFC@MF-2 can effectively overcome the anoxic microenvironment and further lead to more than 3 times the production of ROS. The anticancer drug doxorubicin (Dox) was assembled into an MF-2@PEG nanomaterial for chemotherapy so that the final O<small><sub>2</sub></small>@PFC@MF-2@PEG/Dox realized the function of multimodal imaging and treatment. With MoSe<small><sub>2</sub></small>/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> as the PDT agent, the production ability of ROS was detected by a DCFH-DA probe, and after 808 nm laser irradiation, MoSe<small><sub>2</sub></small>/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanocomposites showed enhanced emission and ROS production. In order to evaluate the antitumor effect of this nano-system, the mice were classified into five groups for different treatment; the tumor volume of the O<small><sub>2</sub></small>@PFC@MF-2@PEG + NIR and O<small><sub>2</sub></small>@PFC@MF-2@PEG/Dox + NIR groups was significantly reduced, and the O<small><sub>2</sub></small>@PFC@MF-2@PEG/Dox + NIR group showed the most significant tumor inhibitory effect due to the multimodal therapy (chemotherapy, PTT and PDT).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig12"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f12_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f12.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f12.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 12 </b> <span id="fig12"><span class="graphic_title">(a) Structure and O<small><sub>2</sub></small> self-sufficient mechanism of an IR780@O<small><sub>2</sub></small>-SFNs/iRGD nano platform. Reproduced from ref. <a title="Select to navigate to references" href="#cit230">230</a> with permission from the American Chemical Society, copyright 2019. (b) The routine process of ROS production by nanoparticles under laser irradiation. Reproduced from ref. <a title="Select to navigate to references" href="#cit231">231</a> with permission from the American Chemical Society, copyright 2019. (c) Schematic diagram of an O<small><sub>2</sub></small> delivery system for tumor imaging guidance with cooperative PDT/PTT. Reproduced from ref. <a title="Select to navigate to references" href="#cit234">234</a> with permission from Dove Press Ltd, copyright 2020.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">According to the advantages that IR780 can be preferentially accumulated in mitochondria and can be modified as a mitochondrial targeting agent,<a title="Select to navigate to reference" href="#cit232"><sup><span class="sup_ref">232,233</span></sup></a> Chen <span class="italic">et al.</span><a title="Select to navigate to references" href="#cit234"><sup><span class="sup_ref">234</span></sup></a> designed an O<small><sub>2</sub></small> delivery system based on a mitochondrial liquid PFC, which was created for imaging-guided synergistic PDT/PTT of tumors (<a title="Select to navigate to figure" href="#imgfig12">Fig. 12c</a>). The nanoparticles can target mitochondria. Mitochondrial organelles and ROS production,<a title="Select to navigate to references" href="#cit235"><sup><span class="sup_ref">235</span></sup></a> redox state regulation and apoptosis-mediated cell death regulation play an essential role. Mitochondria are sensitive to hyperthermia and ROS, and finally induce tumor cell apoptosis by destroying the balance of mitochondrial ROS in cancer treatment; the most essential factor of applied IR780 as a PS is that it can significantly excite the triplet state of the PS and produce <small><sup>1</sup></small>O<small><sub>2</sub></small>.<a title="Select to navigate to references" href="#cit236"><sup><span class="sup_ref">236</span></sup></a> So it is feasible to use a targeted mitochondrial strategy for tumor therapy. In the study of photothermal and photodynamic properties, PBS, IRP NPs and IR780 were irradiated by NIR irradiation for 5 minutes, and the temperature of the latter two groups increased to 60 °C. The temperature increased with the increase of concentration. SOSG was used to confirm the production of <small><sup>1</sup></small>O<small><sub>2</sub></small><span class="italic">in vitro</span> according to the fluorescence intensity. This method can verify the potential of IRP/O<small><sub>2</sub></small>NPs as a photosensitizer. The fluorescence intensity of 5 µM SOSG containing IRP/O<small><sub>2</sub></small>NPs (20 mg mL<small><sup>−1</sup></small>) increased sharply with the extension of irradiation time (2 W cm<small><sup>−2</sup></small>, 5 s), and increased by 4 times within 80 s. In an <span class="italic">in vivo</span> treatment experiment, synergistic therapy with IRP/O<small><sub>2</sub></small>NPs (PDT/PTT), through different ways, such as the generation of ROS, damage caused by mitochondrial hyperthermic and other methods, both achieved a significant anti-tumor effect, and had good biocompatibility and minimal systemic side effects. Nanoparticles (PFH@HSC) with a PFH core, hyaluronic acid (HA) and Ce6 shell were designed.<a title="Select to navigate to references" href="#cit237"><sup><span class="sup_ref">237</span></sup></a> The photoactivation property of PFH@HSC is through destroying the structure through a “redox response” and activating it from “OFF” to “ON”; after targeting anoxic tumor tissue, laser irradiation is carried out to release Ce6 and O<small><sub>2</sub></small>, and finally the production of more singlet oxygen boosts the efficacy of PDT. Due to the excellent imaging performance of Ce6, PFH@HSC can monitor tumor aggregation by fluorescence and PA imaging after intravenous administration into tumor-bearing mice. PFH@HSC nanoparticles showed a contrast ability for PA imaging related to the Ce6 concentration, which confirmed that PA imaging could be used to analyze the aggregation of PFH@HSC nanoparticles in tumors. They showed that PFH@HSC nanoparticles could improve the hypoxia inside the tumor by intravenous injection of PFH@HSC, using a hypoxia probe to examine both groups’ tumor sections for immunofluorescence staining. The anti-tumor effect of PFH@HSC nanoparticles on mice with MDA-MB-231 tumors was evaluated <span class="italic">in vivo</span>, and the redox activated and oxygen-enriched PFH@HSC nanoparticles showed the most effective tumor growth inhibition.</p>
        <p class="otherpara">Recently, PDT as an <span class="italic">in situ</span> vaccine can be used to increase the response rate of PD-1/PD-L1 antibodies.<a title="Select to navigate to references" href="#cit238"><sup><span class="sup_ref">238</span></sup></a> Hence, a bionic nanoemulsion expressing PD-1 membrane camouflage and applied to synergistic photodynamic immunotherapy for hypoxic breast tumors was developed. The perfluorocarbons in the nanoemulsion can provide oxygen and thus act as a PDT “energy source” against hypoxic tumors. The realization of the co-delivery function of photosensitizer and PD-1 protein by the nanoemulsion confirmed the synergistic therapeutic effect of PDT and immunotherapy, and the synergistic therapeutic completely inhibited the growth of primary and distal subcutaneous 4T1 tumors. Also, the publications about PFC as an O<small><sub>2</sub></small> source were summaried in <a title="Select to navigate to table" href="#tab7">Table 7</a>.</p>
        
<div class="table_caption"><b>Table 7</b> <span id="tab7">Summary of publications about PFC as an O<small><sub>2</sub></small> source</span>
		</div>

            <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="45.29pt"/><col align="left" width="63.36pt"/><col align="left" width="55.92pt"/><col align="left" width="155.42pt"/><col align="left" width="37.91pt"/><col align="left" width="85.70pt"/><col align="left" width="53.01pt"/><col align="left" width="25.62pt"/></colgroup>
              
              
              
              
              
              
              
              
              <thead align="left">
                <tr align="left" valign="bottom">
                  <th align="left" valign="bottom" class="border_black">Application</th>
                  <th align="left" valign="bottom" class="border_black">PSs</th>
                  <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                  <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                  <th align="left" valign="bottom" class="border_black">ROS species</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vitro</span> (cell lines)</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vivo</span> (tumour-bearing mice)</th>
                  <th align="left" valign="bottom" class="border_black">Ref.</th>
                </tr>
              </thead>
              <tfoot align="left">
                <tr align="left">
                  <th colspan="8">Abbreviations: perfluorohexane (PFH); perfluorocarbon (PFC); chlorin e6 (Ce6); adriamycin (Dox); sinoporphyrin sodium (DVDMS).</th>
                </tr>
              </tfoot>
              <tbody align="left">
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">IR780</td>
                  <td valign="top">PFH</td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 808 nm, 2 W cm<small><sup>−2</sup></small>, 20 s</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">MCF-7 and CT26</td>
                  <td valign="top">CT26</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit229">229</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">IR780</td>
                  <td valign="top">PFH</td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 808 nm, 2 W cm<small><sup>−2</sup></small>, 10 s</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">CT26</td>
                  <td valign="top">CT26</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit224">224</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">Fluorous porphyrin 1,2</td>
                  <td valign="top">PFH</td>
                  <td valign="top">420 nm, 8.5 mW cm<small><sup>−2</sup></small>, 30 min</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">A375, MCF7, and HEK293</td>
                  <td valign="top">NO</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit225">225</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">Hypocrollin B</td>
                  <td valign="top">PFC</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 630 nm, 20 mW cm<small><sup>−2</sup></small>, 300 s</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">H-1299</td>
                  <td valign="top">NO</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit227">227</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">Ce6</td>
                  <td valign="top">PFH</td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 670 nm, 0.48 W cm<small><sup>−2</sup></small>, 10 min</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">MCF-7</td>
                  <td valign="top">MCF-7</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit228">228</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">IR780</td>
                  <td rowspan="2" valign="top">Fluorinated nanoplatform</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 808 nm, 2 W cm<small><sup>−2</sup></small>, 200 s</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit230">230</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 808 nm, 2 W cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT/PTT</td>
                  <td valign="top">MoSe<small><sub>2</sub></small>/Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>, Dox</td>
                  <td valign="top">PFC</td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 808 nm, 0, 0.5, 1, 1.5 W cm<small><sup>−1</sup></small>, 10 min</td>
                  <td valign="top">˙OH</td>
                  <td valign="top">HepG2</td>
                  <td valign="top">H22</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit231">231</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT/PTT</td>
                  <td rowspan="2" valign="top">IR780, ICG</td>
                  <td rowspan="2" valign="top">PFC</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 808 nm, 2.0 W cm<small><sup>−2</sup></small>, 5 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit234">234</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 808 nm, 1.0 W cm<small><sup>−2</sup></small>, 5 min</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Ce6</td>
                  <td rowspan="2" valign="top">PFH</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 660 nm, 100 mW cm<small><sup>−2</sup></small>, 5 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small> + ROS</td>
                  <td rowspan="2" valign="top">MDA-MB-231</td>
                  <td rowspan="2" valign="top">MDA-MB-231</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit237">237</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 660 nm, 100 mW cm<small><sup>−2</sup></small>, 10 min</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">DVDMS</td>
                  <td rowspan="2" valign="top">Biomimetic nanoemulsion</td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 635 nm, 200 mW cm<small><sup>−2</sup></small>, 5 min</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit238">238</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 635 nm, 200 mW cm<small><sup>−2</sup></small>, 30 min</td>
                </tr>
              </tbody>
            </table></div></div>
          <hr class="hrule"/><br/>
      
      
        
        <h3 id="sect2417"><span class="b_heading">3.3 Red blood cells or hemoglobin</span></h3>
        <span>Red blood cells (RBC) are the staple oxygen carriers of all the vertebrates, providing enough O<small><sub>2</sub></small> to various tissues and organs through blood transport.<a title="Select to navigate to references" href="#cit239"><sup><span class="sup_ref">239</span></sup></a> Each red blood cell contains a lot of hemoglobin molecules (Hb),<a title="Select to navigate to references" href="#cit240"><sup><span class="sup_ref">240</span></sup></a> which is a metal protein that binds to oxygen and plays a role in carrying oxygen.<a title="Select to navigate to references" href="#cit241"><sup><span class="sup_ref">241</span></sup></a> Hb is a biosafe oxygen carrier and a single Hb can bind to four oxygen molecules, so it can make good use of the ability to carry oxygen for PDT.<a title="Select to navigate to reference" href="#cit242"><sup><span class="sup_ref">242,243</span></sup></a> On account of the short cycle half-life and poor stability of Hb, exposed Hb is not suitable for oxygen transport. Because of this disadvantage, people continued to explore how to make up for the shortcomings of the original poor physical properties, so there began to be the emergence of artificial red blood cell composites.<a title="Select to navigate to references" href="#cit244"><sup><span class="sup_ref">244</span></sup></a> It is reported that particles camouflaged with natural erythrocyte membranes can overcome biological obstacles and extend the time of blood circulation.<a title="Select to navigate to reference" href="#cit245"><sup><span class="sup_ref">245–247</span></sup></a></span>
        <p class="otherpara">In a recent study, Wang <span class="italic">et al.</span> prepared RBC microcarriers to selectively deliver O<small><sub>2</sub></small> into anoxic areas.<a title="Select to navigate to references" href="#cit248"><sup><span class="sup_ref">248</span></sup></a> This RBC microcarrier can surmount a series of complex biological obstacles, including transport through inflamed endothelial cells and escape from the mononuclear phagocytic system. In addition, RBC microcarriers have effective tumor accumulation capacity and can transport a mass of O<small><sub>2</sub></small> for PDT under NIR radiation, so achieve effective solid tumor eradication. Using this strategy, a novel site-specific hypoxia probe (HP) was combined with a PDT photosensitizer (Rose Bengal, RB) to form orthogonal excitation-emission UCNPs. The author also evaluated the formation of ROS in hypoxic U87MG cells with RBC microcarriers under alternating 980 nm and 808 nm NIR irradiation with the most significant apoptosis of RBC microcarriers, indicating a large amount of O<small><sub>2</sub></small> release. The ability of RBC microcarriers to overcome the biological barrier was also studied before the <span class="italic">in vivo</span> experiment, with mesoporous silicon microcarriers as the control group (cross-linked with HP, RB-modified UCNP, and FA), and the interaction between RBC microcarriers and a (HUVEC) fusion monolayer of human umbilical vein endothelial cells under inflammatory conditions was also studied. The results show that the use of erythrocyte microcarriers can effectively bypass tumor vessels and reduce immune clearance. Vascular oxygen saturation (sO<small><sub>2</sub></small>) in U87MG solid tumors was evaluated by PA imaging, and caudal vein injection of RBC microcarriers increased sO<small><sub>2</sub></small> by 23% in half an hour. The therapeutic ability of this nano-system was evaluated in U87MG solid tumor mice. The results showed that the tumor volume decreased significantly after alternating 980 nm and 808 nm laser irradiation for two weeks. For example, Guo <span class="italic">et al.</span> designed an oxygen transfer biocompatible photosensitive liposome (LIH), to enhance PDT against hypoxic tumors by loading the compound with oxygen-carrier Hb and photosensitizer (<a title="Select to navigate to figure" href="#imgfig13">Fig. 13a</a>).<a title="Select to navigate to references" href="#cit249"><sup><span class="sup_ref">249</span></sup></a> Liposomes loaded with ICG and Hb (LIH) showed effective tumor accumulation. The effects of laser irradiation (808 nm, 1 W cm<small><sup>−2</sup></small>, 1 min) and different O<small><sub>2</sub></small> levels on the production of <small><sup>1</sup></small>O<small><sub>2</sub></small> in the liposome solution were studied <span class="italic">in vitro</span>. LIH can produce a large amount of <small><sup>1</sup></small>O<small><sub>2</sub></small> under normoxic or anoxic conditions. Under the state of hypoxia, LIH can down-regulate the high expression level of HIF-1α, which proves the oxygen-carrying capacity of LIH. The PDT effect of LIH <span class="italic">in vivo</span> was evaluated. Mice bearing CT-26 xenografts were divided into four groups, which were treated with saline, LI + NIR irradiation, LIH or LIH + NIR irradiation, respectively. The results showed that the LIH + NIR irradiation treatment group showed the best therapeutic ability, indicating that LIH + NIR irradiation promoted cell apoptosis and inhibited proliferation.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig13"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f13_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f13.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f13.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 13 </b> <span id="fig13"><span class="graphic_title">(a) Schematic diagram of a nano-system for relieving tumor hypoxia and enhancing PDT. Reproduced from ref. <a title="Select to navigate to references" href="#cit249">249</a> with permission from Informa UK Limited, copyright 2018. (b) The P-Hb-B NPs by virtue of the carried O<small><sub>2</sub></small> achieves PDT on cancer cells. Reproduced from ref. <a title="Select to navigate to references" href="#cit253">253</a> with permission from Springer Nature Switzerland AG, copyright 2018.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Although the nanoparticle drug carriers are similar. The novel nano red blood cells contain oxyhemoglobin (oxy-Hb) and the gaseous generator ammonium bicarbonate (ABC).<a title="Select to navigate to references" href="#cit250"><sup><span class="sup_ref">250</span></sup></a> The co-loading and controlled release of ICG and Dox resulted in synergistic therapeutic effects. After NIR laser irradiation, ICG in DIRAS exerts a PTT/PDT effect towards various breast cancer cells, and its PDT efficiency will be improved due to the oxygen participation of oxy-Hb. Due to the temperature rise caused by the PTT effect, ABC can be decomposed into NH<small><sub>3</sub></small> and CO<small><sub>2</sub></small>, which further contributes to the release of Dox and plays a role in ablating tumors. <span class="italic">In vivo</span> experiments further evaluated the efficacy of DIRAS on PTT/PDT in 4T1 tumor-bearing mice. After irradiation, tumors treated by free ICG, ICG/RAS mixture and DIAS all showed strong green fluorescence, but the <small><sup>1</sup></small>O<small><sub>2</sub></small> produced by the DIAS group was the highest. Meanwhile, the fluorescence intensity of tumors treated with ICG/RAS mixture and DIRAS was significantly enhanced after laser irradiation, and the presence of oxy-Hb in RAS and DIRAS was conducive to the enhancement of PDT efficacy by ICG. In general, DIRAS had a strong efficacy of PTT/PDT <span class="italic">in vivo</span>. In 2018, Liu <span class="italic">et al.</span> prepared an artificial RBC nanomaterial (AmmRBC) for oxygen-self-supplied tumor PDT to overcome hypoxia-mediated tumor resistance.<a title="Select to navigate to references" href="#cit251"><sup><span class="sup_ref">251</span></sup></a> Biomembrane recombination technology has been used to produce biovesicles composed of erythrocyte membrane (RBCM), which encapsulates a complex formed between hemoglobin and biocompatible dopamine (PDA) (<a title="Select to navigate to figure" href="#imgfig14">Fig. 14</a>). AmmRBCs have demonstrated great ability for tumor accumulation and a high tolerance of PDT to extreme hypoxia in the tumor, resulting in complete ablation of the tumor. In general, as a highly biocompatible component in the human body, red blood cells have great application prospects in the adjuvant treatment of cancer with photodynamic therapy. Li's group designed a multifunctional nano-complex (BP@RB-HB) through the molecule assembly method.<a title="Select to navigate to references" href="#cit252"><sup><span class="sup_ref">252</span></sup></a> Because of the large overlap of emission spectra between Rose Bengal (RB) and BP, RB was chosen as the FRET receptor. Under two-photon laser irradiation, RB is indirectly excited by the intra-particle FRET mechanism, thus boosting the depth of treatment. In addition, Hb in nanocomposites can bring O<small><sub>2</sub></small> into the tumor through active and passive targeting mechanisms, and improve the efficiency of PDT. Liu <span class="italic">et al.</span> synthesized an NIR photosensitizer – brominated 4,4-difluoro-4-bora-3a,a-diaza-<span class="italic">s</span>-indacene (BODIPY-Br<small><sub>2</sub></small>) with high <small><sup>1</sup></small>O<small><sub>2</sub></small> production efficiency and high fluorescence emission (<a title="Select to navigate to figure" href="#imgfig13">Fig. 13b</a>).<a title="Select to navigate to references" href="#cit253"><sup><span class="sup_ref">253</span></sup></a> NIR photosensitizer Hb-conjugated biodegradable peptides as O<small><sub>2</sub></small> carriers were synthesized through a click reaction between polypeptides and Hb-BODIPY-Br<small><sub>2</sub></small>NPs, denoted as (p-Hb-B-NPs), and near-infrared imaging-guided PDT was achieved. The oxygen-carrying capacity and tumor tracking and treatment ability of the prepared polymer nanoparticles were verified by the study of HepG2 cancer cells. The phototoxic effect was best when the concentration of p-HB-B-NPs was 4 μM, and there was no phototoxic effect under a N<small><sub>2</sub></small> atmosphere. In addition, it was proved that p-Hb-B-NPs also had a strong cell killing force under hypoxia and weak light irradiation (25 mW cm<small><sup>−2</sup></small>, 10 min).</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig14"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f14_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f14.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f14.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 14 </b> <span id="fig14"><span class="graphic_title">Schematic illustration of AmmRBCs for tumor therapy. Reproduced from ref. <a title="Select to navigate to references" href="#cit251">251</a> with permission from Wiley, copyright 2018.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        <p class="otherpara">Gao <span class="italic">et al.</span> reported an acoustically driven and magnetically navigated analog red cell (RBCM) micromotor that serves as an O<small><sub>2</sub></small> and PS delivery platform that can actively transport O<small><sub>2</sub></small> and PS.<a title="Select to navigate to references" href="#cit254"><sup><span class="sup_ref">254</span></sup></a> They made use of the natural cell membrane camouflage that particles display in a long circulation of blood in living organisms and prepared a new type of RBCM micromotor by wrapping Fe<small><sub>3</sub></small>O<small><sub>4</sub></small> nanoparticles and ICG with hemoglobin. By co-incubating normal hepatocytes (L02 cells) with different concentrations of RBCM, it was proved that RBCM micromotors had no obvious toxic effect on hepatocytes, indicating that RBCM micromotors had good cytocompatibility. They also used a microfluidic chip to test the ability of the RBCM micromotor to target the predetermined tumor area. With propulsion from an ultrasonic field and navigation from an external magnetic field, the RBCM micromotor quickly entered the right-side reservoir along the microfluidic channel. The O<small><sub>2</sub></small>-carrying capacity of the RBCM micromotor was evaluated by p50. Tumor killing ability was evaluated by flow cytometry. After irradiation (808 nm, 0.35 W cm<small><sup>−2</sup></small>, 15 min), dual-oxygen-ICG-loaded RBCM nanoparticles could kill more than 75% of the cells, and an MTT assay was carried out again to confirm this result. In conclusion, the use of an RBCM micromotor as an active transmission platform can improve the anticancer effect of photodynamic therapy.</p>
        <p class="otherpara">In recent years, new fluorescent materials have developed rapidly, aiming at the many advantages of conjugated polymer nanoparticles (CPNs), such as enhanced light capture ability, low cytotoxicity and excellent photostability.<a title="Select to navigate to reference" href="#cit255"><sup><span class="sup_ref">255,256</span></sup></a> Inspired by these, Jiang <span class="italic">et al.</span> used conjugated polymer nanoparticles (CPNs) connected with hemoglobin (Hb) to prepare a PDT system that can luminesce and supply O<small><sub>2</sub></small>.<a title="Select to navigate to references" href="#cit257"><sup><span class="sup_ref">257</span></sup></a> Hb acts as a catalyst for the luminol–H<small><sub>2</sub></small>O<small><sub>2</sub></small> chemiluminescence system and provides O<small><sub>2</sub></small>. To change the state of Hb during blood circulation, Hb-NPs were coated to form Hb-NPs@liposomes. When H<small><sub>2</sub></small>O<small><sub>2</sub></small> and Hb exist at the same time, luminol emits blue light in the range of 375–550 nm, while NPs based on MEH-PPV have an absorption spectrum in the 400–550 nm range, so this situation meets the requirement of CRET as a donor–acceptor pair. After absorbing luminol radiation, Hb-NPs can sensitize oxygen molecules in Hb and produce ROS to kill cancer cells. The cell survival rate with S/deoxy-Hb-NPs@liposome at all concentrations was significantly higher than that with S/oxy-Hb-NPs@liposome, which confirmed the crucial role of oxygen in PDT. They studied the relationship between nanoparticle size and efficacy and found that smaller HB-NP groups produced more ROS.</p>
        <p class="otherpara">In another effort, a hybrid protein oxygen nano-carrier was uncovered, which hybridized with Hb and HSA by an intermolecular disulfide bond (C@HPOC) to enhance the resistance of PDT to tumor growth and metastasis.<a title="Select to navigate to references" href="#cit258"><sup><span class="sup_ref">258</span></sup></a> C@HPOC possesses targeted delivery of photosensitizer and O<small><sub>2</sub></small> to the tumor, which helps to enhance the infiltration of CD8 + T cells in the tumor. C@HPOC-mediated PDT can effectively inhibit tumor cell metastasis by stimulating systemic anti-tumor immunity in the 4T1 mTNBC murine model. The killing ability of C@HPOC on the tumor was investigated <span class="italic">in vitro</span>, with irradiation from a 660 nm laser (0.1 W cm<small><sup>−2</sup></small>, 2 min), indicating that C@HPOC + laser exhibited high phototoxicity against 4T1 cells compared with the control groups. To investigate the tumor cell-killing effect of C@HPOC + laser <span class="italic">in vitro</span>, they irradiated with a 660 nm laser (2 min, 0.1 W cm<small><sup>−2</sup></small>) in different groups (including the control group); the results revealed that the C@HPOC + laser group showed significant phototoxicity. To figure out whether C@HPOC-mediated PDT can trigger the emergence of ICD, they used 4T1 cells treated with C@HPOC + laser and then evaluated CRT exposure, HMGB1 release, and ATP secretion. Finally, it was shown that C@HPOC has the effect of oxygen-boosted PDT. In general, oxygen-enhanced immunogenic PDT, induced by C@HPOC, ablates the primary tumor and effectively inhibits distant tumor and lung metastasis.</p>
        <p class="otherpara">A new strategy that is a kind of bionic red blood cells (BRBCs) is prepared by the layer by layer assembly method, using Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>@CuO, an oxygen donor (oxy-Hb), an anti-cancer drug (ZnPc) and a photocrosslinking acrylate modified hyaluronic acid (HA) gel shell.<a title="Select to navigate to references" href="#cit259"><sup><span class="sup_ref">259</span></sup></a> The authors used Fe<small><sub>3</sub></small>O<small><sub>4</sub></small>@CuO as a specific recruiter for oxy-Hb, and the HA gel shell can prevent oxy-Hb from releasing O<small><sub>2</sub></small> in the blood, but when BRBCs enter the tumor and accumulate, the HA shell will be degraded by HAase, which triggers the release of O<small><sub>2</sub></small> to alleviate the hypoxia of the tumor. ZnPc consumed O<small><sub>2</sub></small> during PDT treatment, resulting in enhanced fluorescence of intracellular probes. The fluorescence signals of the BRBC and BRBC+ magnetic treatment groups were significantly stronger than those of other groups with HAase, indicating that BRBCs can simulate the adequate oxygen supply of erythrocytes in the PDT process in hypoxic tumors. Magnetic field-assisted tumor targeting was proved <span class="italic">in vivo</span>, and the accumulation of BRBCs <span class="italic">in vivo</span> with or without a magnetic field was studied and compared. With the same fluorescence excitation conditions, strong ZnPc fluorescence signals were detected in tumor tissues with or without a magnetic field, but the fluorescence signal intensity with BRBC + magnetism was significantly higher than that in the control group. The data show that a magnetic field can enhance tumor-targeting efficiency, and BRBCs have excellent performance in tumor targeting. Also, the publications about RBC or Hb as an O<small><sub>2</sub></small> vehicle were summaried in <a title="Select to navigate to table" href="#tab8">Table 8</a>.</p>
        
<div class="table_caption"><b>Table 8</b> <span id="tab8">Summary of publications about RBC or Hb as an O<small><sub>2</sub></small> vehicle</span>
		</div>

            <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="45.29pt"/><col align="left" width="43.06pt"/><col align="left" width="30.25pt"/><col align="left" width="188.21pt"/><col align="left" width="49.77pt"/><col align="left" width="54.54pt"/><col align="left" width="47.85pt"/><col align="left" width="37.64pt"/><col align="left" width="25.62pt"/></colgroup>
              
              
              
              
              
              
              
              
              
              <thead align="left">
                <tr align="left" valign="bottom">
                  <th align="left" valign="bottom" class="border_black">Application</th>
                  <th align="left" valign="bottom" class="border_black">PSs</th>
                  <th align="left" valign="bottom" class="border_black">ROS species</th>
                  <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                  <th align="left" valign="bottom" class="border_black">ROS indicator</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vitro</span> (cell lines)</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vivo</span> (tumour-bearing mice)</th>
                  <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> carrier</th>
                  <th align="left" valign="bottom" class="border_black">Ref.</th>
                </tr>
              </thead>
              <tfoot align="left">
                <tr align="left">
                  <th colspan="9">Abbreviations: 1,3-diphenylisobenzofuran (DPBF); man-made pseudo-RBCs (mmRBCs); Rose Bengal (RB); probe for reactive oxygen species (ABDA); acoustically powered and magnetically navigated red blood cell-mimicking micromotor (RBCM); hemoglobin (Hb)-linked conjugated polymer nanoparticles (CPNs); zinc phthalocyanine (ZnPc).</th>
                </tr>
              </tfoot>
              <tbody align="left">
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Rose Bengal</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 980 nm (0–30 min)</td>
                  <td rowspan="2" valign="top">DPBF</td>
                  <td rowspan="2" valign="top">U87MG</td>
                  <td rowspan="2" valign="top">U97-MG</td>
                  <td rowspan="2" valign="top">RBC</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit248">248</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 980 nm (2 W cm<small><sup>−2</sup></small>, 15 min) &amp; 808 nm (1.5 W cm<small><sup>−2</sup></small>, 15 min)</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">ICG</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 808 nm, 1 W cm<small><sup>−2</sup></small>, 1 min</td>
                  <td rowspan="2" valign="top">SOSG</td>
                  <td rowspan="2" valign="top">CT-26</td>
                  <td rowspan="2" valign="top">S180 and CT-26</td>
                  <td rowspan="2" valign="top">Hb</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit249">249</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 808 nm, 1.5 W cm<small><sup>−2</sup></small>, 3 min</td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT/PTT</td>
                  <td valign="top">ICG/Dox</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 808 nm, 2.0 W cm<small><sup>−2</sup></small>, 10 min</td>
                  <td valign="top">SOSG</td>
                  <td valign="top">4T1, HUVECs</td>
                  <td valign="top">4T1 and 4T1-Luc</td>
                  <td valign="top">Hb</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit250">250</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">MB</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span> (<span class="italic">vivo</span>): 808 nm, 2.0 W cm<small><sup>−2</sup></small>, 10 min</td>
                  <td valign="top">DCFH-DA, COS7</td>
                  <td valign="top">4T1</td>
                  <td valign="top">4T1</td>
                  <td valign="top">mmRBC</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit251">251</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">RB</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">800 nm, 390 mW</td>
                  <td valign="top">ABDA</td>
                  <td valign="top">MCF-7</td>
                  <td valign="top">MCF-7</td>
                  <td valign="top">Hb</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit252">252</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">BODIPY</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 635 nm, 25 mW cm<small><sup>−2</sup></small>, 10 min</td>
                  <td valign="top">DCFH-DA</td>
                  <td valign="top">HepG2</td>
                  <td valign="top">NO</td>
                  <td valign="top">Hb</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit253">253</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">ICG</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 808 nm, 0.35 W cm<small><sup>−2</sup></small>, 15 min</td>
                  <td valign="top">ABDA</td>
                  <td valign="top">HeLa and L02</td>
                  <td valign="top">NO</td>
                  <td valign="top">RBCM</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit254">254</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">NPs</td>
                  <td valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">Chemiluminescence of luminol</td>
                  <td valign="top">DCFH</td>
                  <td valign="top">HeLa and HCT-8</td>
                  <td align="left" valign="top">—</td>
                  <td valign="top">CPNs</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit257">257</a>
                  </td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">Ce6</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 660 nm, 0.1 W cm<small><sup>−2</sup></small>, 0.5 min</td>
                  <td rowspan="2" valign="top">SOSG</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">4T1</td>
                  <td rowspan="2" valign="top">Hb</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit258">258</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 660 nm, 0.1 W cm<small><sup>−2</sup></small>, 30 min</td>
                </tr>
                <tr align="left">
                  <td rowspan="2" valign="top">PDT</td>
                  <td rowspan="2" valign="top">ZnPc</td>
                  <td rowspan="2" valign="top">
                    <small><sup>1</sup></small>O<small><sub>2</sub></small></td>
                  <td valign="top">
                    <span class="italic">In vitro</span>: 665 nm LED, 5 min</td>
                  <td rowspan="2" valign="top">DCFH-DA, Ru(dpp)<small><sub>3</sub></small> Cl<small><sub>2</sub></small></td>
                  <td rowspan="2" valign="top">A549</td>
                  <td rowspan="2" valign="top">A549</td>
                  <td rowspan="2" valign="top">Oxy-Hb</td>
                  <td rowspan="2" valign="top">
                    <a title="Select to navigate to references" href="#cit259">259</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">
                    <span class="italic">In vivo</span>: 665 nm LED, 2 W, 30 min</td>
                </tr>
              </tbody>
            </table></div></div>
          <hr class="hrule"/><br/>
      
      
        
        <h3 id="sect2715"><span class="b_heading">3.4 Hyperbaric oxygen</span></h3>
        <span>Hyperbaric oxygen (HBO) as a clinical adjuvant therapy has been used to cure carbon monoxide poisoning, and in wound healing, soft tissue infection and other diseases.<a title="Select to navigate to reference" href="#cit18"><sup><span class="sup_ref">18,260,261</span></sup></a> As an adjuvant therapy, it has many advantages, such as the ability to deliver oxygen to tissues without hemoglobin and the ability to reduce tumor interstitial fluid pressure (IFP). HBO can solve the problem of the slow diffusion rate and short diffusion distance of oxygen in tissue.<a title="Select to navigate to references" href="#cit262"><sup><span class="sup_ref">262</span></sup></a> It can effectively oxygenate or even alleviate the anoxic area of the tumor.<a title="Select to navigate to references" href="#cit263"><sup><span class="sup_ref">263</span></sup></a> If the hypoxia environment is not changed, the therapeutic effect will be reduced. For tumor tissue hypoxia, hyperoxia to compensate for oxygen depletion is a good way to improve hypoxia. Hyperbaric oxygen can provide extra oxygen in tumor tissue by adding oxygen or substances or other molecules that can produce O<small><sub>2</sub></small>. Another way is by modifying the structure of photosensitizers, making light-dependent photosensitizers into light-independent photosensitizers (Type II to Type I).</span>
        <p class="otherpara">At present, there are few studies on the use of HBO combined with PDT in the treatment of human squamous cell carcinoma (SCC), aiming at the advantages of HBO combined with PDT. Hence, Fang <span class="italic">et al.</span> proposed a method using HBO combined with 5-aminolevulinic acid PDT to inhibit the proliferation of human squamous cell lines.<a title="Select to navigate to references" href="#cit264"><sup><span class="sup_ref">264</span></sup></a> It was found that the combination of HBO and PDT could not only inhibit the proliferation of A431 cells <span class="italic">in vitro</span> but also down-regulate Bcl-2 to significantly enhance PDT-induced apoptosis and autophagy. Autophagy plays a survival-promoting role in apoptosis. Therefore, the combination of HBO and PDT may be a promising treatment method for human squamous cell carcinoma. The combination of HBO and ALA-PDT cooperatively up-regulated the proteins Bax and active caspase 3, and down-regulated Bcl-2 in A431 cells. Western blot tests detected the expression of apoptosis-related proteins (Bax, Bcl-2, and caspase 3), and the results indicated that the expression of Bax and caspase in A431 cells increased cooperatively. In contrast, the expression of Bcl-2 decreased, indicating that apoptosis is an intrinsic pathway of mitochondria. The authors also reduced the production of ROS in A431 cells by dual ALA-HBO treatment, which was conducive to autophagy. In general, ALA-HBO is one of the promising methods for the treatment of human squamous cell carcinoma.</p>
        <p class="otherpara">Due to the hypoxia-related environment and the difficulty of photosensitizers penetrating tumor cells away from blood vessels, the therapeutic effect is limited in deep tumors. To address this problem, Yang's group proposed a therapeutic strategy of upconverting nano-sensitizers (UNPSs) and HBO to reshape the extracellular matrix to enhance PDT (<a title="Select to navigate to figure" href="#imgfig15">Fig. 15</a>).<a title="Select to navigate to references" href="#cit265"><sup><span class="sup_ref">265</span></sup></a> UNPSs are designed to have a Nd<small><sup>3+</sup></small>-sensitized sandwich structure, in which the up-conversion core acts as a light transducer to transfer energy to an adjacent photosensitizer to produce ROS. The hyperbaric oxygen-assisted PDT process promotes oxygen diffusion by decomposing collagen in the tumor extracellular matrix, and promotes the penetration of UNPSs to the deep tumor. They evaluated the <span class="italic">in vitro</span> PDT efficacy of UNPS using MTT analysis, and cell viability was significantly reduced with increasing UNPS concentration after 808 nm laser irradiation and HBO application. HBO adjuvant PDT with UNPSs can improve the efficacy of cancer treatment. HBO-assisted PDT with UNPS was used to carry out an experiment on the mouse model of xenotransplantation. Firstly, the metabolism of UNPSs was studied; after intravenous injection, fluorescence could be detected after 6 hours and disappeared after 48 hours. They classified different treatment groups, with the group exposed to the laser being exposed for 16 minutes at 24 and 48 hours after administration; by calculating the tumor volume, the therapeutic effect could be directly reflected according to the change of tumor volume. However, the UNPSs + NIR + HBO group had the most dramatic treatment effect. In short, HBO-enhanced PDT using UNPSs represents not only a promising choice for more efficient treatment of tumors, but also a new strategy. Also, the publications about HBO as an O<small><sub>2</sub></small> source were summaried in <a title="Select to navigate to table" href="#tab9">Table 9</a>.</p>
        <br/><div class="image_table"><table><tr><td colspan="3" class="imgHolder" id="imgfig15"><a href="/image/article/2022/BM/d1bm00317h/d1bm00317h-f15_hi-res.gif" title="Select to open image in new window" onclick="open(this.href, &#34;_blank&#34;, &#34;toolbar=1,scrollbars=yes,resizable=1&#34;); return false;"><img alt="image file: d1bm00317h-f15.tif" src="/image/article/2022/BM/d1bm00317h/d1bm00317h-f15.gif"/></a></td></tr><tr><td class="pushTitleRight"> </td><td class="image_title"><b>Fig. 15 </b> <span id="fig15"><span class="graphic_title">Schematic illustration of the PDT process with or without HBO; the synergistic therapy could relieve hypoxia and enhance the effect of PDT. Reproduced from ref. <a title="Select to navigate to references" href="#cit265">265</a> with permission from the American Chemical Society, copyright 2018.</span></span></td><td class="pushTitleLeft"> </td></tr></table></div>
        
<div class="table_caption"><b>Table 9</b> <span id="tab9">Summary of publications about HBO as an O<small><sub>2</sub></small> source</span>
		</div>

            <div class="rtable__wrapper"><div class="rtable__inner"><table class="tgroup rtable" border="0"><colgroup><col align="left" width="56.27pt"/><col align="left" width="29.94pt"/><col align="left" width="49.84pt"/><col align="left" width="159.53pt"/><col align="left" width="61.42pt"/><col align="left" width="48.63pt"/><col align="left" width="90.99pt"/><col align="left" width="25.62pt"/></colgroup>
              
              
              
              
              
              
              
              
              <thead align="left">
                <tr align="left" valign="bottom">
                  <th align="left" valign="bottom" class="border_black">Application</th>
                  <th align="left" valign="bottom" class="border_black">PSs</th>
                  <th align="left" valign="bottom" class="border_black">O<small><sub>2</sub></small> source</th>
                  <th align="left" valign="bottom" class="border_black">Excitation requirements (excitation wavelength, power density, time)</th>
                  <th align="left" valign="bottom" class="border_black">ROS indicator</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vitro</span> (cell line)</th>
                  <th align="left" valign="bottom" class="border_black">
                    <span class="italic">In vivo</span> (tumor-bearing mice)</th>
                  <th align="left" valign="bottom" class="border_black">Ref.</th>
                </tr>
              </thead>
              <tfoot align="left">
                <tr align="left">
                  <th colspan="8">Abbreviations: precursors of protoporphyrin IX (ALA).</th>
                </tr>
              </tfoot>
              <tbody align="left">
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">ALA</td>
                  <td valign="top">HBO</td>
                  <td valign="top">630 ± 15 nm, 5 J cm<small><sup>−2</sup></small>, 8 h</td>
                  <td valign="top">Detection kit</td>
                  <td valign="top">A431</td>
                  <td valign="top">NO</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit264">264</a>
                  </td>
                </tr>
                <tr align="left">
                  <td valign="top">PDT</td>
                  <td valign="top">RB</td>
                  <td valign="top">HBO</td>
                  <td valign="top">
                    <span class="italic">In vivo</span>: 808 nm, 0.75 W cm<small><sup>−2</sup></small>, 16 min</td>
                  <td valign="top">DCFH-DA</td>
                  <td valign="top">4T1</td>
                  <td valign="top">4T1</td>
                  <td valign="top">
                    <a title="Select to navigate to references" href="#cit265">265</a>
                  </td>
                </tr>
              </tbody>
            </table></div></div>
          <hr class="hrule"/><br/>
      
    
    
      
      <h2 id="sect2790"><span class="a_heading">4. Summary and outlook</span></h2>
      <span>PDT shows great potential in clinical research and application by improving treatment efficiency with minimal invasiveness through the precise management of laser irradiation compared with traditional oncology therapies. However, hypoxia seriously limits the efficiency of PDT and leads to tumor invasion and metastasis. Therefore, the presence of adequate molecular oxygen throughout the tumor volume is critical for effective PDT, the mechanism of using photosensitizers activated by light to produce cytotoxicity (biological reactive oxygen species).</span>
      <p class="otherpara">The maldistribution of blood vessels leads to highly uneven oxygen levels within the tumor, which in this case leads to the presence of severe hypoxia (deep tissue hypoxia). For drug therapy or PDT, tumor cells that lack adequate molecular oxygen are resistant to PDT in the presence of either drug therapy or photodynamic therapy. Therefore, tumor hypoxia limits the widespread clinical application of PDT to overcome the “Achilles’ heel”; so far, many strategies have been carried out to overcome hypoxia. This review paper summarizes methods for producing molecular oxygen <span class="italic">in situ</span> or carrying molecular oxygen into anoxic tumor areas through different carriers to improve tumor hypoxia, and this is systematically summarized and discussed. These oxygen replenishment strategies and <span class="italic">in situ</span> oxygen production strategies are described as follows.</p>
      <p class="otherpara">• Enhance tumor oxygen delivery by utilizing hemoglobin, red blood cells, and PFCs;</p>
      <p class="otherpara">• Oxygen is produced by catalyzing H<small><sub>2</sub></small>O<small><sub>2</sub></small> with different catalysts;</p>
      <p class="otherpara">• Light-driven water splitting increases <span class="italic">in situ</span> oxygen production;</p>
      <p class="otherpara">• Changing blood flow in different ways increases oxygen transport;</p>
      <p class="otherpara">• Oxygen is produced by photosynthesis near the tumor tissue.</p>
      <p class="otherpara">These strategies significantly alleviate the hypoxia of the tumor microenvironment and improve the efficacy of PDT, and the relief of hypoxia can also enhance the therapeutic effect of some drugs. However, there are still several issues that need to be noted in terms of the disadvantages of the supplementary oxygen strategy as described below:</p>
      <p class="otherpara">(1) Problems with low endogenous hydrogen peroxide content</p>
      <p class="otherpara">For the <span class="italic">in situ</span> generation of O<small><sub>2</sub></small> within tumors, the amount of endogenous H<small><sub>2</sub></small>O<small><sub>2</sub></small> is only 50–100 μM, so this will not achieve the goal of catalyzing endogenous hydrogen peroxide in tumor tissue with exogenous catalysts (commonly used metal ions). Therefore, this also makes the oxygen supplementation approach to PDT more difficult, which is a major drawback of the supplemental oxygen strategy. On a more optimistic note, the novel strategy of delivering exogenous H<small><sub>2</sub></small>O<small><sub>2</sub></small> into tumors and using catalysts to decompose exogenous H<small><sub>2</sub></small>O<small><sub>2</sub></small> into O<small><sub>2</sub></small> was used to solve the problem of low endogenous hydrogen peroxide content.</p>
      <p class="otherpara">(2) Toxicity of metal catalysts</p>
      <p class="otherpara">After solving the problem of a low content of endogenous hydrogen peroxide, another major disadvantage of the oxygen supplement strategy to improve the therapeutic effect of PDT is the toxicity of metal catalysts. MnO<small><sub>2</sub></small>, Pt and other catalysts are often used to catalyze hydrogen peroxide for oxygen production. In addition to catalysis, these catalysts will also produce some uncontrollable cytotoxicity, such as binding with some enzymes, resulting in enzyme inactivation. Therefore, it may bring a series of problems; moreover, metal ion metabolism is also difficult, which may bring some uncontrollable side effects.</p>
      <p class="otherpara">(3) The difficulty of synthesis of oxygen-delivery materials</p>
      <p class="otherpara">As a complementary strategy for exogenous oxygen delivery to the tumor system, the selection of materials should be more scientific, meet better biocompatibility, and target tumor cells. Therefore, materials with better properties need to be used. These materials include: biomaterials, such as fungi, white cell membranes, cell membranes, red blood cells and hemoglobin; and chemical materials: perfluorocarbons. For photosensitive bacteria hybridized with cyanobacteria and photosensitizers with different properties for PDT therapy of photosynthesis-enhanced tumors under light stimulation, this method of <span class="italic">in situ</span> generation of oxygen has been recently proposed as an effective method to alleviate tumor hypoxia, but the preparation process of cyanobacteria is tedious and takes a lot of time, and surgery is needed to implant photosensitive bacteria in biological applications. If this method leads to poor wound healing there will be large scars, so in later studies, photodynamic therapy can be used to remove scars and be combined with the treatment process, so as to shield some shortcomings. For the extraction of cell membranes, the process is also more tedious, therefore, to realize the engineering of extraction process will greatly promote the application of materials. Chemical materials can be difficult to synthesize, and some materials require multi-step synthesis, which will make it more difficult to supplement oxygen therapy strategies.</p>
      <p class="otherpara">(4) Excessive supplemental oxygen accelerates tumor blood vessel growth</p>
      <p class="otherpara">In the human body, blood vessels can provide O<small><sub>2</sub></small> and nutrition for the growth of all tissues, but tumors grow much faster than normal tissues, so the demand for nutrition is higher. In this state, tumor cells begin to produce growth factors that stimulate the growth of new blood vessels, resulting in abnormal vascular morphology. Abnormal vascular morphology leads to poor blood flow and reduced O<small><sub>2</sub></small> supply. The insufficient supply of oxygen will cause cancer cells to metastasize and eventually form a malignant tumor. In addition, abnormal vascular morphology also makes anticancer drugs unable to reach the focus, which greatly reduces the therapeutic effect. For an oxygen supplementation strategy, oxygen is directly transported into the tumor tissue through hyperbaric oxygen. Oxygen supplements should be in an appropriate range, otherwise excess oxygen on the one hand increases oxygen pressure and brings a lot of side effects in the process of PDT. On the other hand, excess oxygen will promote the rapid growth of tumor blood vessels. Then the biggest problem will be how to balance the appropriate amount of oxygen to alleviate tumor tissue hypoxia and oxygen to promote tumor growth. More and more research data reveal that direct delivery of oxygen has certain limitations. Therefore, for the application of this method of oxygen supplementation there is a need to constantly explore how to monitor the partial pressure of oxygen and supplement the effective concentration of oxygen in the tumor tissue. Once mastered, it will become easy to balance the above problems.</p>
      <p class="otherpara">Besides, other new strategies can be vigorously developed, including:</p>
      <p class="otherpara">(1) Chemotherapy in combination with PDT</p>
      <p class="otherpara">Nowadays, chemotherapy is still the main treatment for most cancers. However, during chemotherapy, cancer cells may develop resistance, which directly reduces the effectiveness of the treatment. Chemotherapy and PDT combined with adjuvant therapy can produce a synergistic effect, and the treatment results between them can complement each other; the combined effect can reduce the drug dose and systemic toxicity. At present, the most commonly used chemotherapy drugs are as follows: tipacamine (TPZ), Dox, AQ4N, platinum drugs, and so on.</p>
      <p class="otherpara">(2) Antiangiogenic PDT</p>
      <p class="otherpara">PDT also induces abnormal expression of VEGF, COX-2, and MMPs. The increased expression of HIF-1α in the tumor after PDT directly induces photodynamic drug resistance, with a high expression of VEGF. The combination of HIF-1α or VEGF inhibitors with PDT can prevent drug resistance and even improve therapeutic efficacy.</p>
      <p class="otherpara">(3) PTT/PDT</p>
      <p class="otherpara">PTT is targeted to tumor tissue by the photosensitizer. A low-power beam can be applied to tumor tissue to generate heat energy and use the heat to ablate the tumor. PDT and PTT both need to use irradiation and a photosensitizer, so the combined use of the photosensitizer can achieve dual functions simultaneously. The PTT process will also increase blood flow and alleviate the aggravation of hypoxia caused by the PDT process.</p>
      <p class="otherpara">(4) Immunotherapy combined with PDT</p>
      <p class="otherpara">Because an anti-tumor immune response can be initiated in the process of PDT, its effect on tumor ablation plays a very important role. Therefore, it has become a promising clinical model for cancer treatment. Multiple pathways have been reported for PDT to initiate anti-tumor immune responses, including:</p>
      <p class="otherpara">◆ up-regulation of the expression of transcription factor nuclear factor-kB (NF-kB) and molecular chaperone heat shock protein 70 (HSP-70);</p>
      <p class="otherpara">◆ promoting antigen presentation to cytotoxic T lymphocytes (CTL);</p>
      <p class="otherpara">◆ stimulating the immune response of the host by promoting the secretion of cytokines.</p>
    
    
      <h2 id="sect2839"><span class="a_heading">Author contributions</span></h2>
      <span>Shuheng Qin: conceptualization, data curation, investigation, writing – review &amp; editing; Yue Xu, Hua Li: supervision, visualization, formal analysis; Zhenwei Yuan, Haiyan Chen: supervision &amp; guidance, validation, reviewing &amp; editing.</span>
    
    
      <h2 id="sect2842"><span class="a_heading">Conflicts of interest</span></h2>
      <span>The author claims that they do not have competing interests for this paper.</span>
    
  
    <h2 id="sect2846"><span class="a_heading">Acknowledgements</span></h2>
      <span>This work was financially supported by Natural Science Foundation Committee of China (NSFC 82001891), the Post-doctoral Innovative Talent Support Program (BX20190389), China Postdoctoral science Foundation (2019M662009), and Postdoctoral Research Grant of Jiangsu Province.</span>
    
    <span id="sect2848"><h2 id="sect2845"><span class="a_heading">References</span></h2></span><ol type="1">
      <li><span id="cit1">A. P. Castano, T. N. Demidova and M. R. Hamblin, <span class="italic">Photodiagn. Photodyn. Ther.</span>, 2005, <span class="bold">2</span>, 1–23 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1572-1000(05)00030-X" title="DOI Link to resource 10.1016/S1572-1000(05)00030-X">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXmvValurc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25048553%5Buid%5D" title="PubMed Link to resource 25048553">PubMed</a>.</span></li>
      <li><span id="cit2">
          W. M. Sharman, C. M. Allen and J. E. van Lier, in <span class="italic">Singlet Oxygen, Uv-a, and Ozone</span>, ed. L. Packer and H. Sies,  2000, vol. 319, pp. 376–400 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Singlet%20Oxygen,%20Uv-a,%20and%20Ozone%5BJour%5D%20AND%20319%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202000%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit3">T. J. Dougherty, C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng, <span class="italic">JNCI, J. Natl. Cancer Inst.</span>, 1998, <span class="bold">90</span>, 889–905 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/jnci/90.12.889" title="DOI Link to resource 10.1093/jnci/90.12.889">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1cXktFOqsLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=9637138%5Buid%5D" title="PubMed Link to resource 9637138">PubMed</a>.</span></li>
      <li><span id="cit4">S. Pervaiz and M. Olivo, <span class="italic">Clin. Exp. Pharmacol. Physiol.</span>, 2006, <span class="bold">33</span>, 551–556 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1440-1681.2006.04406.x" title="DOI Link to resource 10.1111/j.1440-1681.2006.04406.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XlvFCmt7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16700893%5Buid%5D" title="PubMed Link to resource 16700893">PubMed</a>.</span></li>
      <li><span id="cit5">Z. Zhou, J. Song, L. Nie and X. Chen, <span class="italic">Chem. Soc. Rev.</span>, 2016, <span class="bold">45</span>, 6597–6626 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6CS00271D&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6CS00271D">RSC</a>.</span></li>
      <li><span id="cit6">Z. Lv, H. J. Wei, Q. Li, X. L. Su, S. J. Liu, K. Y. Zhang, W. Lv, Q. Zhao, X. H. Li and W. Huang, <span class="italic">Chem. Sci.</span>, 2018, <span class="bold">9</span>, 502–512 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7SC03765A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7SC03765A">RSC</a>.</span></li>
      <li><span id="cit7">R. C. Gilson, K. C. L. Black, D. D. Lane and S. Achilefu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2017, <span class="bold">56</span>, 10717–10720 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201704458" title="DOI Link to resource 10.1002/anie.201704458">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXht1eksbrL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28667692%5Buid%5D" title="PubMed Link to resource 28667692">PubMed</a>.</span></li>
      <li><span id="cit8">C. Zhang, K. L. Zhao, W. B. Bu, D. L. Ni, Y. Y. Liu, J. W. Feng and J. L. Shi, <span class="italic">Angew. Chem., Int. Ed.</span>, 2015, <span class="bold">54</span>, 1770–1774 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201408472" title="DOI Link to resource 10.1002/anie.201408472">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXitVChsrnK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25483028%5Buid%5D" title="PubMed Link to resource 25483028">PubMed</a>.</span></li>
      <li><span id="cit9">H. Y. Ding, H. J. Yu, Y. Dong, R. H. Tian, G. Huang, D. A. Boothman, B. D. Sumer and J. M. Gao, <span class="italic">J. Controlled Release</span>, 2011, <span class="bold">156</span>, 276–280 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2011.08.019" title="DOI Link to resource 10.1016/j.jconrel.2011.08.019">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXhsFGlt77O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21888934%5Buid%5D" title="PubMed Link to resource 21888934">PubMed</a>.</span></li>
      <li><span id="cit10">S. S. Lucky, K. C. Soo and Y. Zhang, <span class="italic">Chem. Rev.</span>, 2015, <span class="bold">115</span>, 1990–2042 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/cr5004198" title="DOI Link to resource 10.1021/cr5004198">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtFCms70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25602130%5Buid%5D" title="PubMed Link to resource 25602130">PubMed</a>.</span></li>
      <li><span id="cit11">M. Li, Y. Shao, J. H. Kim, Z. Pu, X. Zhao, H. Huang, T. Xiong, Y. Kang, G. Li, K. Shao, J. Fan, J. W. Foley, J. S. Kim and X. Peng, <span class="italic">J. Am. Chem. Soc.</span>, 2020, <span class="bold">142</span>, 5380–5388 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.0c00734" title="DOI Link to resource 10.1021/jacs.0c00734">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXjvFGisLs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32105455%5Buid%5D" title="PubMed Link to resource 32105455">PubMed</a>.</span></li>
      <li><span id="cit12">M. Li, J. Xia, R. Tian, J. Wang, J. Fan, J. Du, S. Long, X. Song, J. W. Foley and X. Peng, <span class="italic">J. Am. Chem. Soc.</span>, 2018, <span class="bold">140</span>, 14851–14859 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.8b08658" title="DOI Link to resource 10.1021/jacs.8b08658">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhvFeqs73L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30362735%5Buid%5D" title="PubMed Link to resource 30362735">PubMed</a>.</span></li>
      <li><span id="cit13">J. D. Chapman, C. C. Stobbe, M. R. Arnfield, R. Santus, J. Lee and M. S. McPhee, <span class="italic">Radiat. Res.</span>, 1991, <span class="bold">126</span>, 73–79 <a target="_blank" class="DOILink" href="https://doi.org/10.2307/3578173" title="DOI Link to resource 10.2307/3578173">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK3MXit1Cltro%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit14">J. E. Moulder and S. Rockwell, <span class="italic">Int. J. Radiat. Oncol., Biol., Phys.</span>, 1984, <span class="bold">10</span>, 695–712 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/0360-3016(84)90301-8" title="DOI Link to resource 10.1016/0360-3016(84)90301-8">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaL2c3jvFWgsg%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit15">M. Zhou, Y. Xie, S. Xu, J. Xin, J. Wang, T. Han, R. Ting, J. Zhang and F. An, <span class="italic">Eur. J. Med. Chem.</span>, 2020, <span class="bold">195</span>, 112274 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ejmech.2020.112274" title="DOI Link to resource 10.1016/j.ejmech.2020.112274">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXmsVOmsbg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32259703%5Buid%5D" title="PubMed Link to resource 32259703">PubMed</a>.</span></li>
      <li><span id="cit16">P. Vaupel, M. Hoeckel and A. Mayer, <span class="italic">Antioxid. Redox Signaling</span>, 2007, <span class="bold">9</span>, 1221–1235 <a target="_blank" class="DOILink" href="https://doi.org/10.1089/ars.2007.1628" title="DOI Link to resource 10.1089/ars.2007.1628">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXot1WktL4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17536958%5Buid%5D" title="PubMed Link to resource 17536958">PubMed</a>.</span></li>
      <li><span id="cit17">T. Maleki, N. Cao, S. H. Song, C. Kao, S.-C. A. Ko and B. Ziaie, <span class="italic">IEEE Trans. Biomed. Eng.</span>, 2011, <span class="bold">58</span>, 3104–3111 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=IEEE%20Trans.%20Biomed.%20Eng.%5BJour%5D%20AND%2058%5Bvolume%5D%20AND%203104%5Bpage%5D%20and%202011%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit18">I. Moen and L. E. B. Stuhr, <span class="italic">Target. Oncol.</span>, 2012, <span class="bold">7</span>, 233–242 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s11523-012-0233-x" title="DOI Link to resource 10.1007/s11523-012-0233-x">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23054400%5Buid%5D" title="PubMed Link to resource 23054400">PubMed</a>.</span></li>
      <li><span id="cit19">W. Zhang, S. Li, X. Liu, C. Yang, N. Hu, L. Dou, B. Zhao, Q. Zhang, Y. Suo and J. Wang, <span class="italic">Adv. Funct. Mater.</span>, 2018, <span class="bold">28</span>, 1706375 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201706375" title="DOI Link to resource 10.1002/adfm.201706375">CrossRef</a>.</span></li>
      <li><span id="cit20">M. R. Horsman and J. Overgaard, <span class="italic">J. Radiat. Res.</span>, 2016, <span class="bold">57</span>, I90–I98 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/jrr/rrw007" title="DOI Link to resource 10.1093/jrr/rrw007">CrossRef</a>.</span></li>
      <li><span id="cit21">E. B. Rankin and A. J. Giaccia, <span class="italic">Science</span>, 2016, <span class="bold">352</span>, 175–180 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.aaf4405" title="DOI Link to resource 10.1126/science.aaf4405">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XlsFSmu78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27124451%5Buid%5D" title="PubMed Link to resource 27124451">PubMed</a>.</span></li>
      <li><span id="cit22">A. P. Castano, P. Mroz and M. R. Hamblin, <span class="italic">Nat. Rev. Cancer</span>, 2006, <span class="bold">6</span>, 535–545 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrc1894" title="DOI Link to resource 10.1038/nrc1894">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XmtFehu7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16794636%5Buid%5D" title="PubMed Link to resource 16794636">PubMed</a>.</span></li>
      <li><span id="cit23">S. O. Gollnick, B. Owczarczak and P. Maier, <span class="italic">Lasers Surg. Med.</span>, 2006, <span class="bold">38</span>, 509–515 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/lsm.20362" title="DOI Link to resource 10.1002/lsm.20362">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16788921%5Buid%5D" title="PubMed Link to resource 16788921">PubMed</a>.</span></li>
      <li><span id="cit24">B. Karagoz, S. Suleymanoglu, G. Uzun, O. Bilgi, S. Aydinoz, A. Haholu, O. Turken, Y. Onem and E. G. Kandemir, <span class="italic">Basic Clin. Pharmacol. Toxicol.</span>, 2008, <span class="bold">102</span>, 287–292 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1742-7843.2007.00196.x" title="DOI Link to resource 10.1111/j.1742-7843.2007.00196.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXjt1Cmsbw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=18248515%5Buid%5D" title="PubMed Link to resource 18248515">PubMed</a>.</span></li>
      <li><span id="cit25">S. Guan, L. Wang, S.-M. Xu, D. Yang, G. I. N. Waterhouse, X. Qu and S. Zhou, <span class="italic">Chem. Sci.</span>, 2019, <span class="bold">10</span>, 2336–2341 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8SC05275A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8SC05275A">RSC</a>.</span></li>
      <li><span id="cit26">S. Kolemen, T. Ozdemir, D. Lee, G. M. Kim, T. Karatas, J. Yoon and E. U. Akkaya, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 3606–3610 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201510064" title="DOI Link to resource 10.1002/anie.201510064">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitFagtLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26845734%5Buid%5D" title="PubMed Link to resource 26845734">PubMed</a>.</span></li>
      <li><span id="cit27">X. Li, B.-D. Zheng, X.-H. Peng, S.-Z. Li, J.-W. Ying, Y. Zhao, J.-D. Huang and J. Yoon, <span class="italic">Coord. Chem. Rev.</span>, 2019, <span class="bold">379</span>, 147–160 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.ccr.2017.08.003" title="DOI Link to resource 10.1016/j.ccr.2017.08.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOhtLrJ" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit28">J. E. Moulder and S. Rockwell, <span class="italic">Cancer Metastasis Rev.</span>, 1987, <span class="bold">5</span>, 313–341 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/BF00055376" title="DOI Link to resource 10.1007/BF00055376">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaL2s7ovVSmtA%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=3552280%5Buid%5D" title="PubMed Link to resource 3552280">PubMed</a>.</span></li>
      <li><span id="cit29">J. Daruwalla and C. Christophi, <span class="italic">World J. Surg.</span>, 2006, <span class="bold">30</span>, 2112–2131 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00268-006-0190-6" title="DOI Link to resource 10.1007/s00268-006-0190-6">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17102915%5Buid%5D" title="PubMed Link to resource 17102915">PubMed</a>.</span></li>
      <li><span id="cit30">H. Cheng, J. Y. Zhu, S. Y. Li, J. Y. Zeng, Q. Lei, K. W. Chen, C. Zhang and X. Z. Zhang, <span class="italic">Adv. Funct. Mater.</span>, 2016, <span class="bold">26</span>, 7847–7860 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201603212" title="DOI Link to resource 10.1002/adfm.201603212">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsFenu77I" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit31">Q. Chen, L. Z. Feng, J. J. Liu, W. W. Zhu, Z. L. Dong, Y. F. Wu and Z. Liu, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Adv.%20Mater.%5BJour%5D%20AND%2030%5Bvolume%5D%20AND%201%5Bpage%5D%20and%202018%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit32">J. Kim, H. R. Cho, H. Jeon, D. Kim, C. Song, N. Lee, S. H. Choi and T. Hyeon, <span class="italic">J. Am. Chem. Soc.</span>, 2017, <span class="bold">139</span>, 10992–10995 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b05559" title="DOI Link to resource 10.1021/jacs.7b05559">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXht1Wmt73P" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28737393%5Buid%5D" title="PubMed Link to resource 28737393">PubMed</a>.</span></li>
      <li><span id="cit33">D. Zheng, B. Li, L. Xu, Q.-L. Zhang, J.-X. Fan, C.-X. Li and X.-Z. Zhang, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 6218–6227 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.8b02977" title="DOI Link to resource 10.1021/acsnano.8b02977">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtVShtrnF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29791792%5Buid%5D" title="PubMed Link to resource 29791792">PubMed</a>.</span></li>
      <li><span id="cit34">X. Cui, Q. Zhao, Z. Huang, Y. Xiao, Y. Wan, S. Li and C.-S. Lee, <span class="italic">Small</span>, 2020, <span class="bold">16</span>, 2004551 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.202004551" title="DOI Link to resource 10.1002/smll.202004551">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXit1alurrN" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit35">R. Kv, T.-I. Liu, I. L. Lu, C.-C. Liu, H.-H. Chen, T.-Y. Lu, W.-H. Chiang and H.-C. Chiu, <span class="italic">J. Controlled Release</span>, 2020, <span class="bold">328</span>, 87–99 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2020.08.038" title="DOI Link to resource 10.1016/j.jconrel.2020.08.038">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhslehs7rO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32858076%5Buid%5D" title="PubMed Link to resource 32858076">PubMed</a>.</span></li>
      <li><span id="cit36">Z. Y. Yang, J. F. Wang, S. Liu, X. H. Li, L. Y. Miao, B. Yang, C. L. Zhang, J. He, S. C. Ai and W. X. Guan, <span class="italic">Biomaterials</span>, 2020, <span class="bold">229</span>, 15 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2019.119580" title="DOI Link to resource 10.1016/j.biomaterials.2019.119580">CrossRef</a>.</span></li>
      <li><span id="cit37">Y.-T. Fan, T.-J. Zhou, P.-F. Cui, Y.-J. He, X. Chang, L. Xing and H.-L. Jiang, <span class="italic">Adv. Funct. Mater.</span>, 2019, <span class="bold">29</span>, 1806708 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201806708" title="DOI Link to resource 10.1002/adfm.201806708">CrossRef</a>.</span></li>
      <li><span id="cit38">R. Kumari, D. Sunil and R. S. Ningthoujam, <span class="italic">J. Controlled Release</span>, 2020, <span class="bold">319</span>, 135–156 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2019.12.041" title="DOI Link to resource 10.1016/j.jconrel.2019.12.041">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXis1yjsA%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31881315%5Buid%5D" title="PubMed Link to resource 31881315">PubMed</a>.</span></li>
      <li><span id="cit39">Y. Shao, B. Liu, Z. Di, G. Zhang, L.-D. Sun, L. Li and C.-H. Yan, <span class="italic">J. Am. Chem. Soc.</span>, 2020, <span class="bold">142</span>, 3939–3946 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.9b12788" title="DOI Link to resource 10.1021/jacs.9b12788">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhsFKgtLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31968933%5Buid%5D" title="PubMed Link to resource 31968933">PubMed</a>.</span></li>
      <li><span id="cit40">D. Wang, H. Wu, W. Q. Lim, S. Z. F. Phua, P. Xu, Q. Chen, Z. Guo and Y. Zhao, <span class="italic">Adv. Mater.</span>, 2019, <span class="bold">31</span>, 1901893 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201901893" title="DOI Link to resource 10.1002/adma.201901893">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31095804%5Buid%5D" title="PubMed Link to resource 31095804">PubMed</a>.</span></li>
      <li><span id="cit41">Z. Wang, T. Jia, Q. Sun, Y. Kuang, B. Liu, M. Xu, H. Zhu, F. He, S. Gai and P. Yang, <span class="italic">Biomaterials</span>, 2020, <span class="bold">228</span>, 119569 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2019.119569" title="DOI Link to resource 10.1016/j.biomaterials.2019.119569">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitVOgt7%252FJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31678845%5Buid%5D" title="PubMed Link to resource 31678845">PubMed</a>.</span></li>
      <li><span id="cit42">G. C. Dismukes, V. V. Klimov, S. V. Baranov, Y. N. Kozlov, J. DasGupta and A. Tyryshkin, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2001, <span class="bold">98</span>, 2170–2175 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.061514798" title="DOI Link to resource 10.1073/pnas.061514798">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXhslKnt70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11226211%5Buid%5D" title="PubMed Link to resource 11226211">PubMed</a>.</span></li>
      <li><span id="cit43">R. Y. Stanier and G. Cohen-Bazire, <span class="italic">Annu. Rev. Microbiol.</span>, 1977, <span class="bold">31</span>, 225–274 <a target="_blank" class="DOILink" href="https://doi.org/10.1146/annurev.mi.31.100177.001301" title="DOI Link to resource 10.1146/annurev.mi.31.100177.001301">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaE2sXlvFOhs74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=410354%5Buid%5D" title="PubMed Link to resource 410354">PubMed</a>.</span></li>
      <li><span id="cit44">Z. Hosseinidoust, B. Mostaghaci, O. Yasa, B. W. Park, A. V. Singh and M. Sitti, <span class="italic">Adv. Drug Delivery Rev.</span>, 2016, <span class="bold">106</span>, 27–44 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.addr.2016.09.007" title="DOI Link to resource 10.1016/j.addr.2016.09.007">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsFamtb7J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27641944%5Buid%5D" title="PubMed Link to resource 27641944">PubMed</a>.</span></li>
      <li><span id="cit45">T. Hasegawa, T. Matsuguchi, K. Noda, K. Tanaka, S. Kumamoto, Y. Shoyama and Y. Yoshikai, <span class="italic">Int. Immunopharmacol.</span>, 2002, <span class="bold">2</span>, 579–589 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S1567-5769(02)00002-4" title="DOI Link to resource 10.1016/S1567-5769(02)00002-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XivFyltLc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11962736%5Buid%5D" title="PubMed Link to resource 11962736">PubMed</a>.</span></li>
      <li><span id="cit46">K. Noda, N. Ohno, K. Tanaka, N. Kamiya, M. Okuda, T. Yadomae, K. Nomoto and Y. Shoyama, <span class="italic">Planta Med.</span>, 1996, <span class="bold">62</span>, 423–426 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/s-2006-957931" title="DOI Link to resource 10.1055/s-2006-957931">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK28XnsVyhsLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8923807%5Buid%5D" title="PubMed Link to resource 8923807">PubMed</a>.</span></li>
      <li><span id="cit47">K. Tanaka, A. Yamada, K. Noda, T. Hasegawa, M. Okuda, Y. Shoyama and K. Nomoto, <span class="italic">Cancer Immunol. Immunother.</span>, 1998, <span class="bold">45</span>, 313–320 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s002620050448" title="DOI Link to resource 10.1007/s002620050448">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1cXht12jtL0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=9490201%5Buid%5D" title="PubMed Link to resource 9490201">PubMed</a>.</span></li>
      <li><span id="cit48">W. B. Coley, <span class="italic">Clin. Orthop. Relat. Res.</span>, 1991, 3–11 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK3M%252FosFSktg%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit49">S.-B. Wang, X.-H. Liu, B. Li, J.-X. Fan, J.-J. Ye, H. Cheng and X.-Z. Zhang, <span class="italic">Adv. Funct. Mater.</span>, 2019, <span class="bold">29</span>, 1904093 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201904093" title="DOI Link to resource 10.1002/adfm.201904093">CrossRef</a>.</span></li>
      <li><span id="cit50">L. L. Liu, H. M. He, Z. Y. Luo, H. M. Zhou, R. J. Liang, H. Pan, Y. F. Ma and L. T. Cai, <span class="italic">Adv. Funct. Mater.</span>, 2020, <span class="bold">30</span>, 1910176 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201910176" title="DOI Link to resource 10.1002/adfm.201910176">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXht1GktLc%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit51">M. Huo, L. Wang, L. Zhang, C. Wei, Y. Chen and J. Shi, <span class="italic">Angew. Chem., Int. Ed.</span>, 2020, <span class="bold">59</span>, 1906–1913 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201912824" title="DOI Link to resource 10.1002/anie.201912824">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitlyhsr7J" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31721383%5Buid%5D" title="PubMed Link to resource 31721383">PubMed</a>.</span></li>
      <li><span id="cit52">Z. Zhang, J. Wang, X. Nie, T. Wen, Y. Ji, X. Wu, Y. Zhao and C. Chen, <span class="italic">J. Am. Chem. Soc.</span>, 2014, <span class="bold">136</span>, 7317–7326 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja412735p" title="DOI Link to resource 10.1021/ja412735p">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXntFChtrY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24773323%5Buid%5D" title="PubMed Link to resource 24773323">PubMed</a>.</span></li>
      <li><span id="cit53">Z. M. Li, P. Huang, X. J. Zhang, J. Lin, S. Yang, B. Liu, F. Gao, P. Xi, Q. S. Ren and D. X. Cui, <span class="italic">Mol. Pharm.</span>, 2010, <span class="bold">7</span>, 94–104 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/mp9001415" title="DOI Link to resource 10.1021/mp9001415">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXhsVWmurnN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19891496%5Buid%5D" title="PubMed Link to resource 19891496">PubMed</a>.</span></li>
      <li><span id="cit54">C. Lee, K. Lim, S. S. Kim, L. X. Thien, E. S. Lee, K. T. Oh, H.-G. Choi and Y. S. Youn, <span class="italic">J. Controlled Release</span>, 2019, <span class="bold">294</span>, 77–90 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2018.12.011" title="DOI Link to resource 10.1016/j.jconrel.2018.12.011">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXisFWiurfO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30543822%5Buid%5D" title="PubMed Link to resource 30543822">PubMed</a>.</span></li>
      <li><span id="cit55">A. Espinosa, R. Di Corato, J. Kolosnjaj-Tabi, P. Flaud, T. Pellegrino and C. Wilhelm, <span class="italic">ACS Nano</span>, 2016, <span class="bold">10</span>, 2436–2446 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b07249" title="DOI Link to resource 10.1021/acsnano.5b07249">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XnvFGjtw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26766814%5Buid%5D" title="PubMed Link to resource 26766814">PubMed</a>.</span></li>
      <li><span id="cit56">W. I. Choi, J.-Y. Kim, C. Kang, C. C. Byeon, Y. H. Kim and G. Tee, <span class="italic">ACS Nano</span>, 2011, <span class="bold">5</span>, 1995–2003 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn103047r" title="DOI Link to resource 10.1021/nn103047r">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXisVWqu7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21344891%5Buid%5D" title="PubMed Link to resource 21344891">PubMed</a>.</span></li>
      <li><span id="cit57">H. Chen, J. Tian, W. He and Z. Guo, <span class="italic">J. Am. Chem. Soc.</span>, 2015, <span class="bold">137</span>, 1539–1547 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja511420n" title="DOI Link to resource 10.1021/ja511420n">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXns1ymtg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25574812%5Buid%5D" title="PubMed Link to resource 25574812">PubMed</a>.</span></li>
      <li><span id="cit58">J. Zou, J. Zhu, Z. Yang, L. Li, W. Fan, L. He, W. Tang, L. Deng, J. Mu, Y. Ma, Y. Cheng, W. Huang, X. Dong and X. Chen, <span class="italic">Angew. Chem., Int. Ed.</span>, 2020, <span class="bold">59</span>, 8833–8838 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201914384" title="DOI Link to resource 10.1002/anie.201914384">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXitFCqtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31943602%5Buid%5D" title="PubMed Link to resource 31943602">PubMed</a>.</span></li>
      <li><span id="cit59">Z. Yu, P. Zhou, W. Pan, N. Li and B. Tang, <span class="italic">Nat. Commun.</span>, 2018, <span class="bold">9</span>, 5044 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-018-07197-8" title="DOI Link to resource 10.1038/s41467-018-07197-8">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30487569%5Buid%5D" title="PubMed Link to resource 30487569">PubMed</a>.</span></li>
      <li><span id="cit60">T.-J. Zhou, L. Xing, Y.-T. Fan, P.-F. Cui and H.-L. Jiang, <span class="italic">J. Controlled Release</span>, 2019, <span class="bold">307</span>, 44–54 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2019.06.016" title="DOI Link to resource 10.1016/j.jconrel.2019.06.016">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhtF2ntLnJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31202726%5Buid%5D" title="PubMed Link to resource 31202726">PubMed</a>.</span></li>
      <li><span id="cit61">S. Lamouille, J. Xu and R. Derynck, <span class="italic">Nat. Rev. Mol. Cell Biol.</span>, 2014, <span class="bold">15</span>, 178–196 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrm3758" title="DOI Link to resource 10.1038/nrm3758">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXivFagtrY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24556840%5Buid%5D" title="PubMed Link to resource 24556840">PubMed</a>.</span></li>
      <li><span id="cit62">A. Dongre and R. A. Weinberg, <span class="italic">Nat. Rev. Mol. Cell Biol.</span>, 2019, <span class="bold">20</span>, 69–84 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41580-018-0080-4" title="DOI Link to resource 10.1038/s41580-018-0080-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXit1GgtbfI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30459476%5Buid%5D" title="PubMed Link to resource 30459476">PubMed</a>.</span></li>
      <li><span id="cit63">H. Wang, Y. Guo, C. Wang, X. Jiang, H. Liu, A. Yuan, J. Yan, Y. Hu and J. Wu, <span class="italic">Biomaterials</span>, 2020, <span class="bold">269</span>, 120621–120621 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2020.120621" title="DOI Link to resource 10.1016/j.biomaterials.2020.120621">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33383301%5Buid%5D" title="PubMed Link to resource 33383301">PubMed</a>.</span></li>
      <li><span id="cit64">T. Sun, Y. Zhang, C. Zhang, H. Wang, H. Pan, J. Liu, Z. Li, L. Chen, J. Chang and W. Zhang, <span class="italic">Front. Bioeng. Biotechnol.</span>, 2020, <span class="bold">8</span>, 237 <a target="_blank" class="DOILink" href="https://doi.org/10.3389/fbioe.2020.00237" title="DOI Link to resource 10.3389/fbioe.2020.00237">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32266251%5Buid%5D" title="PubMed Link to resource 32266251">PubMed</a>.</span></li>
      <li><span id="cit65">J. A. Raven, M. C. W. Evans and R. E. Korb, <span class="italic">Photosynth. Res.</span>, 1999, <span class="bold">60</span>, 111–149 <a target="_blank" class="DOILink" href="https://doi.org/10.1023/A:1006282714942" title="DOI Link to resource 10.1023/A:1006282714942">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK1MXmt1Glu7c%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit66">I. Sakurai, J.-R. Shen, J. Leng, S. Ohashi, M. Kobayashi and H. Wada, <span class="italic">J. Biochem.</span>, 2006, <span class="bold">140</span>, 201–209 <a target="_blank" class="DOILink" href="https://doi.org/10.1093/jb/mvj141" title="DOI Link to resource 10.1093/jb/mvj141">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD28XhtVKns7jL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16822813%5Buid%5D" title="PubMed Link to resource 16822813">PubMed</a>.</span></li>
      <li><span id="cit67">Y. S. Ho, Y. Xiong, W. C. Ma, A. Spector and D. S. Ho, <span class="italic">J. Biol. Chem.</span>, 2004, <span class="bold">279</span>, 32804–32812 <a target="_blank" class="DOILink" href="https://doi.org/10.1074/jbc.M404800200" title="DOI Link to resource 10.1074/jbc.M404800200">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2cXmtVChtbk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15178682%5Buid%5D" title="PubMed Link to resource 15178682">PubMed</a>.</span></li>
      <li><span id="cit68">J. Li, K. Wei, S. Zuo, Y. Xu, Z. Zha, W. Ke, H. Chen and Z. Ge, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1702108 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201702108" title="DOI Link to resource 10.1002/adfm.201702108">CrossRef</a>.</span></li>
      <li><span id="cit69">J. Liu, T. Liu, P. Du, L. Zhang and J. Lei, <span class="italic">Angew. Chem., Int. Ed.</span>, 2019, <span class="bold">58</span>, 7808–7812 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201903475" title="DOI Link to resource 10.1002/anie.201903475">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXptFSrur4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30957318%5Buid%5D" title="PubMed Link to resource 30957318">PubMed</a>.</span></li>
      <li><span id="cit70">S. Gao, P. Zheng, Z. Li, X. Feng, W. Yan, S. Chen, W. Guo, D. Liu, X. Yang, S. Wang, X.-J. Liang and J. Zhang, <span class="italic">Biomaterials</span>, 2018, <span class="bold">178</span>, 83–94 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2018.06.007" title="DOI Link to resource 10.1016/j.biomaterials.2018.06.007">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtFCmtb3F" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29913389%5Buid%5D" title="PubMed Link to resource 29913389">PubMed</a>.</span></li>
      <li><span id="cit71">B. Wang, W. Lin, Z. Mao and C. Gao, <span class="italic">J. Mater. Chem. B</span>, 2018, <span class="bold">6</span>, 3145–3155 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8TB00476E&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8TB00476E">RSC</a>.</span></li>
      <li><span id="cit72">J. Zhu, T. Xiao, J. Zhang, H. Che, Y. Shi, X. Shi and J. C. M. van Hest, <span class="italic">ACS Nano</span>, 2020, <span class="bold">14</span>, 11225–11237 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.0c03080" title="DOI Link to resource 10.1021/acsnano.0c03080">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhs1SgtbvF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32809803%5Buid%5D" title="PubMed Link to resource 32809803">PubMed</a>.</span></li>
      <li><span id="cit73">P. Liu, X. Xie, X. Shi, Y. Peng, J. Ding and W. Zhou, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2019, <span class="bold">11</span>, 48261–48270 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.9b18112" title="DOI Link to resource 10.1021/acsami.9b18112">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXit1Wkt73L" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31763809%5Buid%5D" title="PubMed Link to resource 31763809">PubMed</a>.</span></li>
      <li><span id="cit74">J. Yin, H. Cao, H. Wang, K. Sun, Y. Li and Z. Zhang, <span class="italic">Acta Pharm. Sin. B</span>, 2020, <span class="bold">10</span>, 2246–2257 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.apsb.2020.06.004" title="DOI Link to resource 10.1016/j.apsb.2020.06.004">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXnslWqtA%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33304789%5Buid%5D" title="PubMed Link to resource 33304789">PubMed</a>.</span></li>
      <li><span id="cit75">L. Deng, D. Sheng, M. Liu, L. Yang, H. Ran, P. Li, X. Cai, Y. Sun and Z. Wang, <span class="italic">Biomater. Sci.</span>, 2020, <span class="bold">8</span>, 858–870 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9BM01126A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9BM01126A">RSC</a>.</span></li>
      <li><span id="cit76">J. Wang, X. Sun, W. Mao, W. Sun, J. Tang, M. Sui, Y. Shen and Z. Gu, <span class="italic">Adv. Mater.</span>, 2013, <span class="bold">25</span>, 3670–3676 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201300929" title="DOI Link to resource 10.1002/adma.201300929">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXovFaqt7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23740675%5Buid%5D" title="PubMed Link to resource 23740675">PubMed</a>.</span></li>
      <li><span id="cit77">J. Wang, W. Mao, L. L. Lock, J. Tang, M. Sui, W. Sun, H. Cui, D. Xu and Y. Shen, <span class="italic">ACS Nano</span>, 2015, <span class="bold">9</span>, 7195–7206 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b02017" title="DOI Link to resource 10.1021/acsnano.5b02017">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWqtLnE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26149286%5Buid%5D" title="PubMed Link to resource 26149286">PubMed</a>.</span></li>
      <li><span id="cit78">R. Cheng, F. Feng, F. Meng, C. Deng, J. Feijen and Z. Zhong, <span class="italic">J. Controlled Release</span>, 2011, <span class="bold">152</span>, 2–12 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2011.01.030" title="DOI Link to resource 10.1016/j.jconrel.2011.01.030">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmvFyksLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21295087%5Buid%5D" title="PubMed Link to resource 21295087">PubMed</a>.</span></li>
      <li><span id="cit79">C.-P. Liu, T.-H. Wu, C.-Y. Liu, K.-C. Chen, Y.-X. Chen, G.-S. Chen and S.-Y. Lin, <span class="italic">Small</span>, 2017, <span class="bold">13</span>, 1700278 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201700278" title="DOI Link to resource 10.1002/smll.201700278">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28509427%5Buid%5D" title="PubMed Link to resource 28509427">PubMed</a>.</span></li>
      <li><span id="cit80">Y. Liu, Z. Wang, Y. Liu, G. Zhu, O. Jacobson, X. Fu, R. Bai, X. Lin, N. Lu, X. Yang, W. Fan, J. Song, Z. Wang, G. Yu, F. Zhang, H. Kalish, G. Niu, Z. Nie and X. Chen, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 10539–10548 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b05908" title="DOI Link to resource 10.1021/acsnano.7b05908">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtLrN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28953351%5Buid%5D" title="PubMed Link to resource 28953351">PubMed</a>.</span></li>
      <li><span id="cit81">D. F. Stowe and A. K. S. Camara, <span class="italic">Antioxid. Redox Signaling</span>, 2009, <span class="bold">11</span>, 1373–1414 <a target="_blank" class="DOILink" href="https://doi.org/10.1089/ars.2008.2331" title="DOI Link to resource 10.1089/ars.2008.2331">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXkvVGnsbY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19187004%5Buid%5D" title="PubMed Link to resource 19187004">PubMed</a>.</span></li>
      <li><span id="cit82">N. Kavcic, K. Pegan, P. Vandenabeele and B. Turk, <span class="italic">Biol. Chem.</span>, 2019, <span class="bold">400</span>, 149–160 <a target="_blank" class="DOILink" href="https://doi.org/10.1515/hsz-2017-0317" title="DOI Link to resource 10.1515/hsz-2017-0317">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhsFygsrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30052510%5Buid%5D" title="PubMed Link to resource 30052510">PubMed</a>.</span></li>
      <li><span id="cit83">J. N. Moloney and T. G. Cotter, <span class="italic">Semin. Cell Dev. Biol.</span>, 2018, <span class="bold">80</span>, 50–64 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.semcdb.2017.05.023" title="DOI Link to resource 10.1016/j.semcdb.2017.05.023">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXpvVKht7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28587975%5Buid%5D" title="PubMed Link to resource 28587975">PubMed</a>.</span></li>
      <li><span id="cit84">M. A. O. Dawood, H. G. Abo-Al-Ela and M. T. Hasan, <span class="italic">Fish Shellfish Immunol.</span>, 2020, <span class="bold">97</span>, 268–282 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.fsi.2019.12.054" title="DOI Link to resource 10.1016/j.fsi.2019.12.054">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXisVGgur3M" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31863903%5Buid%5D" title="PubMed Link to resource 31863903">PubMed</a>.</span></li>
      <li><span id="cit85">E. Ju, K. Dong, Z. Chen, Z. Liu, C. Liu, Y. Huang, Z. Wang, F. Pu, J. Ren and X. Qu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 11467–11471 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201605509" title="DOI Link to resource 10.1002/anie.201605509">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhtlaisLvE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27504861%5Buid%5D" title="PubMed Link to resource 27504861">PubMed</a>.</span></li>
      <li><span id="cit86">H. Fan, G. Yan, Z. Zhao, X. Hu, W. Zhang, H. Liu, X. Fu, T. Fu, X.-B. Zhang and W. Tan, <span class="italic">Angew. Chem., Int. Ed.</span>, 2016, <span class="bold">55</span>, 5477–5482 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201510748" title="DOI Link to resource 10.1002/anie.201510748">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XkvVChs7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27010667%5Buid%5D" title="PubMed Link to resource 27010667">PubMed</a>.</span></li>
      <li><span id="cit87">J. Y. Cao and S. J. Dixon, <span class="italic">Cell. Mol. Life Sci.</span>, 2016, <span class="bold">73</span>, 2195–2209 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00018-016-2194-1" title="DOI Link to resource 10.1007/s00018-016-2194-1">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XlsValurw%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27048822%5Buid%5D" title="PubMed Link to resource 27048822">PubMed</a>.</span></li>
      <li><span id="cit88">L.-S. Lin, J. Song, L. Song, K. Ke, Y. Liu, Z. Zhou, Z. Shen, J. Li, Z. Yang, W. Tang, G. Niu, H.-H. Yang and X. Chen, <span class="italic">Angew. Chem., Int. Ed.</span>, 2018, <span class="bold">57</span>, 4902–4906 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201712027" title="DOI Link to resource 10.1002/anie.201712027">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXlslSiurY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29488312%5Buid%5D" title="PubMed Link to resource 29488312">PubMed</a>.</span></li>
      <li><span id="cit89">C. Liu, D. Wang, S. Zhang, Y. Cheng, F. Yang, Y. Xing, T. Xu, H. Dong and X. Zhang, <span class="italic">ACS Nano</span>, 2019, <span class="bold">13</span>, 4267–4277 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.8b09387" title="DOI Link to resource 10.1021/acsnano.8b09387">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXlvVSrsL0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30901515%5Buid%5D" title="PubMed Link to resource 30901515">PubMed</a>.</span></li>
      <li><span id="cit90">J.-J. Hu, Q. Lei and X.-Z. Zhang, <span class="italic">Prog. Mater. Sci.</span>, 2020, <span class="bold">114</span>, 100685 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.pmatsci.2020.100685" title="DOI Link to resource 10.1016/j.pmatsci.2020.100685">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtV2ksbrL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit91">Y.-H. Zhang, W.-X. Qiu, M. Zhang, L. Zhang and X.-Z. Zhang, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2018, <span class="bold">10</span>, 15030–15039 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b01818" title="DOI Link to resource 10.1021/acsami.8b01818">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXnt1amtb4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29633614%5Buid%5D" title="PubMed Link to resource 29633614">PubMed</a>.</span></li>
      <li><span id="cit92">T. Amann, U. Maegdefrau, A. Hartmann, A. Agaimy, J. Marienhagen, T. S. Weiss, O. Stoeltzing, C. Warnecke, J. Scholmerich, P. J. Oefner, M. Kreutz, A. K. Bosserhoff and C. Hellerbrand, <span class="italic">Am. J. Pathol.</span>, 2009, <span class="bold">174</span>, 1544–1552 <a target="_blank" class="DOILink" href="https://doi.org/10.2353/ajpath.2009.080596" title="DOI Link to resource 10.2353/ajpath.2009.080596">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXksVOrsrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19286567%5Buid%5D" title="PubMed Link to resource 19286567">PubMed</a>.</span></li>
      <li><span id="cit93">H. Bi, Y. Dai, P. Yang, J. Xu, D. Yang, S. Gai, F. He, G. An, C. Zhong and J. Lin, <span class="italic">Chem. Eng. J.</span>, 2019, <span class="bold">356</span>, 543–553 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.cej.2018.09.076" title="DOI Link to resource 10.1016/j.cej.2018.09.076">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhslehtbnE" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit94">J. Liu, L. Cui and D. Losic, <span class="italic">Acta Biomater.</span>, 2013, <span class="bold">9</span>, 9243–9257 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.actbio.2013.08.016" title="DOI Link to resource 10.1016/j.actbio.2013.08.016">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhsVOnsLbI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23958782%5Buid%5D" title="PubMed Link to resource 23958782">PubMed</a>.</span></li>
      <li><span id="cit95">X. Luan, Y.-Y. Guan, H.-J. Liu, Q. Lu, M. Zhao, D. Sun, J. F. Lovell, P. Sun, H.-Z. Chen and C. Fang, <span class="italic">Adv. Sci.</span>, 2018, <span class="bold">5</span>, 1800034 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.201800034" title="DOI Link to resource 10.1002/advs.201800034">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30128230%5Buid%5D" title="PubMed Link to resource 30128230">PubMed</a>.</span></li>
      <li><span id="cit96">H. Zhou, J. Ge, Q. Miao, R. Zhu, L. Wen, J. Zeng and M. Gao, <span class="italic">Bioconjugate Chem.</span>, 2020, <span class="bold">31</span>, 315–331 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.bioconjchem.9b00699" title="DOI Link to resource 10.1021/acs.bioconjchem.9b00699">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXit1Cku7%252FF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31765561%5Buid%5D" title="PubMed Link to resource 31765561">PubMed</a>.</span></li>
      <li><span id="cit97">P. Liu, X. Xie, M. Liu, S. Hu, J.-S. Ding and W.-H. Zhou, <span class="italic">Acta Pharm. Sin. B</span>, 2021, <span class="bold">11</span>, 823–834 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.apsb.2020.07.021" title="DOI Link to resource 10.1016/j.apsb.2020.07.021">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhtVOmsLfL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33777684%5Buid%5D" title="PubMed Link to resource 33777684">PubMed</a>.</span></li>
      <li><span id="cit98">V. Hirsch, J. Salaklang, B. Rothen-Rutishauser and A. Petri-Fink, <span class="italic">IEEE Trans. Magn.</span>, 2013, <span class="bold">49</span>, 402–407 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=IEEE%20Trans.%20Magn.%5BJour%5D%20AND%2049%5Bvolume%5D%20AND%20402%5Bpage%5D%20and%202013%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit99">T. L. Moore, L. Rodriguez-Lorenzo, V. Hirsch, S. Balog, D. Urban, C. Jud, B. Rothen-Rutishauser, M. Lattuada and A. Petri-Fink, <span class="italic">Chem. Soc. Rev.</span>, 2015, <span class="bold">44</span>, 6287–6305 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C4CS00487F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C4CS00487F">RSC</a>.</span></li>
      <li><span id="cit100">C. Yang, Y. Liu, S. Su, N. Gao, J. Jing and X. Zhang, <span class="italic">J. Mater. Chem. B</span>, 2020, <span class="bold">8</span>, 9943–9950 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0TB00529K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0TB00529K">RSC</a>.</span></li>
      <li><span id="cit101">K. Yang, G. Yu, R. Tian, Z. Zhou, H. Deng, L. Li, Z. Yang, G. Zhang, D. Liu, J. Wei, L. Yue, R. Wang and X. Chen, <span class="italic">Adv. Funct. Mater.</span>, 2021, <span class="bold">31</span>, 2008078 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.202008078" title="DOI Link to resource 10.1002/adfm.202008078">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXhvVSgs7o%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit102">S.-B. He, H.-H. Deng, A.-L. Liu, G.-W. Li, X.-H. Lin, W. Chen and X.-H. Xia, <span class="italic">ChemCatChem</span>, 2014, <span class="bold">6</span>, 1543–1548 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/cctc.201400011" title="DOI Link to resource 10.1002/cctc.201400011">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXmsVWhu7g%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit103">J. N. Rodriguez-Lopez, D. J. Lowe, J. Hernandez-Ruiz, A. N. P. Hiner, F. Garcia-Canovas and R. N. F. Thorneley, <span class="italic">J. Am. Chem. Soc.</span>, 2001, <span class="bold">123</span>, 11838–11847 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja011853+" title="DOI Link to resource 10.1021/ja011853+">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD3MXnvFaksrg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11724589%5Buid%5D" title="PubMed Link to resource 11724589">PubMed</a>.</span></li>
      <li><span id="cit104">P. Prasad, C. R. Gordijo, A. Z. Abbasi, A. Maeda, A. Ip, A. M. Rauth, R. S. DaCosta and X. Y. Wu, <span class="italic">ACS Nano</span>, 2014, <span class="bold">8</span>, 3202–3212 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn405773r" title="DOI Link to resource 10.1021/nn405773r">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXls12hu78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24702320%5Buid%5D" title="PubMed Link to resource 24702320">PubMed</a>.</span></li>
      <li><span id="cit105">J. Chen, H. Luo, Y. Liu, W. Zhang, H. Li, T. Luo, K. Zhang, Y. Zhao and J. Liu, <span class="italic">ACS Nano</span>, 2017, <span class="bold">11</span>, 12849–12862 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b08225" title="DOI Link to resource 10.1021/acsnano.7b08225">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvFOitbjJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29236476%5Buid%5D" title="PubMed Link to resource 29236476">PubMed</a>.</span></li>
      <li><span id="cit106">Y. Zhang, F. Wang, C. Liu, Z. Wang, L. Kang, Y. Huang, K. Dong, J. Ren and X. Qu, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 651–661 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.7b07746" title="DOI Link to resource 10.1021/acsnano.7b07746">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2itg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29290107%5Buid%5D" title="PubMed Link to resource 29290107">PubMed</a>.</span></li>
      <li><span id="cit107">J. Ouyang, Y. Deng, W. Chen, Q. Xu, L. Wang, Z. Liu, F. Tang, L. Deng and Y.-N. Liu, <span class="italic">J. Mater. Chem. B</span>, 2018, <span class="bold">6</span>, 2057–2064 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8TB00371H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8TB00371H">RSC</a>.</span></li>
      <li><span id="cit108">D. He, L. Hai, X. He, X. Yang and H.-W. Li, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1704089 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201704089" title="DOI Link to resource 10.1002/adfm.201704089">CrossRef</a>.</span></li>
      <li><span id="cit109">J. Liu, Y. Liu, W. Bu, J. Bu, Y. Sun, J. Du and J. Shi, <span class="italic">J. Am. Chem. Soc.</span>, 2014, <span class="bold">136</span>, 9701–9709 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja5042989" title="DOI Link to resource 10.1021/ja5042989">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhtVent7vF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=24956326%5Buid%5D" title="PubMed Link to resource 24956326">PubMed</a>.</span></li>
      <li><span id="cit110">X.-S. Wang, J.-Y. Zeng, M.-K. Zhang, X. Zeng and X.-Z. Zhang, <span class="italic">Adv. Funct. Mater.</span>, 2018, <span class="bold">28</span>, 1801783 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201801783" title="DOI Link to resource 10.1002/adfm.201801783">CrossRef</a>.</span></li>
      <li><span id="cit111">P. Zhang, W. Steelant, M. Kumar and M. Scholfield, <span class="italic">J. Am. Chem. Soc.</span>, 2007, <span class="bold">129</span>, 4526–4527 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/ja0700707" title="DOI Link to resource 10.1021/ja0700707">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXjsVaisLk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17385866%5Buid%5D" title="PubMed Link to resource 17385866">PubMed</a>.</span></li>
      <li><span id="cit112">Y. Li, X. Jian, S. Zhou, Y. Lu, C. Zhao, Z. Gao and Y.-Y. Song, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2019, <span class="bold">11</span>, 17215–17225 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.9b02484" title="DOI Link to resource 10.1021/acsami.9b02484">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXnvFCgsLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31007010%5Buid%5D" title="PubMed Link to resource 31007010">PubMed</a>.</span></li>
      <li><span id="cit113">Z. Xu, P. Sun, J. Zhang, X. Lu, L. Fan, J. Xi, J. Han and R. Guo, <span class="italic">Chem. Eng. J.</span>, 2020, <span class="bold">399</span>, 125797 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.cej.2020.125797" title="DOI Link to resource 10.1016/j.cej.2020.125797">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtFGhtLjL" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit114">Z. Gao, Y. Li, Y. Zhang, K. Cheng, P. An, F. Chen, J. Chen, C. You, Q. Zhu and B. Sun, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2020, <span class="bold">12</span>, 1963–1972 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.9b14958" title="DOI Link to resource 10.1021/acsami.9b14958">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXisVKkurvJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31873002%5Buid%5D" title="PubMed Link to resource 31873002">PubMed</a>.</span></li>
      <li><span id="cit115">Y. Peng, Y. Li, Y. Ban and W. Yang, <span class="italic">Angew. Chem., Int. Ed.</span>, 2017, <span class="bold">56</span>, 9757–9761 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201703959" title="DOI Link to resource 10.1002/anie.201703959">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhtFOlt7bO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28639729%5Buid%5D" title="PubMed Link to resource 28639729">PubMed</a>.</span></li>
      <li><span id="cit116">M. Xu, S.-S. Yang and Z.-Y. Gu, <span class="italic">Chem. – Eur. J.</span>, 2018, <span class="bold">24</span>, 15131–15142 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.201800556" title="DOI Link to resource 10.1002/chem.201800556">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhsVWhsbjJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30063265%5Buid%5D" title="PubMed Link to resource 30063265">PubMed</a>.</span></li>
      <li><span id="cit117">P. Kanoo, G. Mostafa, R. Matsuda, S. Kitagawa and T. K. Maji, <span class="italic">Chem. Commun.</span>, 2011, <span class="bold">47</span>, 8106–8108 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C1CC11416F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C1CC11416F">RSC</a>.</span></li>
      <li><span id="cit118">T. He, B. Ni, S. Zhang, Y. Gong, H. Wang, L. Gu, J. Zhuang, W. Hu and X. Wang, <span class="italic">Small</span>, 2018, <span class="bold">14</span>, 1703929 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201703929" title="DOI Link to resource 10.1002/smll.201703929">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29532997%5Buid%5D" title="PubMed Link to resource 29532997">PubMed</a>.</span></li>
      <li><span id="cit119">G. Zhan, L. Fan, F. Zhao, Z. Huang, B. Chen, X. Yang and S.-F. Zhou, <span class="italic">Adv. Funct. Mater.</span>, 2019, <span class="bold">29</span>, 1806720 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201806720" title="DOI Link to resource 10.1002/adfm.201806720">CrossRef</a>.</span></li>
      <li><span id="cit120">Y. Li, Z. Gao, F. Chen, C. You, H. Wu, K. Sun, P. An, K. Cheng, C. Sun, X. Zhu and B. Sun, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2018, <span class="bold">10</span>, 30930–30935 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b12800" title="DOI Link to resource 10.1021/acsami.8b12800">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Kht7nL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30183247%5Buid%5D" title="PubMed Link to resource 30183247">PubMed</a>.</span></li>
      <li><span id="cit121">W. Zhang, J. Lu, X. Gao, P. Li, W. Zhang, Y. Ma, H. Wang and B. Tang, <span class="italic">Angew. Chem., Int. Ed.</span>, 2018, <span class="bold">57</span>, 4891–4896 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201710800" title="DOI Link to resource 10.1002/anie.201710800">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXlslSiurk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29451722%5Buid%5D" title="PubMed Link to resource 29451722">PubMed</a>.</span></li>
      <li><span id="cit122">Y. Hao, Y. Chen, X. He, Y. Yu, R. Han, Y. Li, C. Yang, D. Hu and Z. Qian, <span class="italic">Adv. Sci.</span>, 2020, <span class="bold">7</span>, 2001853 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/advs.202001853" title="DOI Link to resource 10.1002/advs.202001853">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXitlWhtLnL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33101874%5Buid%5D" title="PubMed Link to resource 33101874">PubMed</a>.</span></li>
      <li><span id="cit123">W. Yang, G. Zhu, S. Wang, G. Yu, Z. Yang, L. Lin, Z. Zhou, Y. Liu, Y. Dai, F. Zhang, Z. Shen, Y. Liu, Z. He, J. Lau, G. Niu, D. O. Kiesewetter, S. Hu and X. Chen, <span class="italic">ACS Nano</span>, 2019, <span class="bold">13</span>, 3083–3094 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.8b08346" title="DOI Link to resource 10.1021/acsnano.8b08346">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXktFOmsL4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30835435%5Buid%5D" title="PubMed Link to resource 30835435">PubMed</a>.</span></li>
      <li><span id="cit124">X. Duan, X. Yang, C. Dai, T. Tong, C. Miao and J. Zheng, <span class="italic">Mater. Express</span>, 2019, <span class="bold">9</span>, 757–763 <a target="_blank" class="DOILink" href="https://doi.org/10.1166/mex.2019.1552" title="DOI Link to resource 10.1166/mex.2019.1552">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhtFWmtrc%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit125">R. Liu, M. Yu, X. Yang, C. S. Umeshappa, C. Hu, W. Yu, L. Qin, Y. Huang and H. Gao, <span class="italic">Adv. Funct. Mater.</span>, 2019, <span class="bold">29</span>, 1808462 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201808462" title="DOI Link to resource 10.1002/adfm.201808462">CrossRef</a>.</span></li>
      <li><span id="cit126">Y. Yao, H. Zhang, Z. Wang, J. Ding, S. Wang, B. Huang, S. Ke and C. Gao, <span class="italic">J. Mater. Chem. B</span>, 2019, <span class="bold">7</span>, 5019–5037 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9TB00847K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9TB00847K">RSC</a>.</span></li>
      <li><span id="cit127">S. Z. F. Phua, C. Xue, W. Q. Lim, G. Yang, H. Chen, Y. Zhang, C. F. Wijaya, Z. Luo and Y. Zhao, <span class="italic">Chem. Mater.</span>, 2019, <span class="bold">31</span>, 3349–3358 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.chemmater.9b00439" title="DOI Link to resource 10.1021/acs.chemmater.9b00439">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXnvFChsbY%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit128">X. Xia, X. Yang, P. Huang and D. Yan, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2020, <span class="bold">12</span>, 18301–18308 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.0c00650" title="DOI Link to resource 10.1021/acsami.0c00650">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXmt1eqtbY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32242653%5Buid%5D" title="PubMed Link to resource 32242653">PubMed</a>.</span></li>
      <li><span id="cit129">B. Wu, Z. Sun, J. Wu, J. Ruan, P. Zhao, K. Liu, C.-X. Zhao, J. Sheng, T. Liang and D. Chen, <span class="italic">Angew. Chem., Int. Ed.</span>, 2021, <span class="bold">60</span>, 9284–9289 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.202100752" title="DOI Link to resource 10.1002/anie.202100752">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXmslKmtbc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33586298%5Buid%5D" title="PubMed Link to resource 33586298">PubMed</a>.</span></li>
      <li><span id="cit130">D. N. Hanh, B. K. Rajbhandari and A. P. Annachhatre, <span class="italic">Environ. Technol.</span>, 2005, <span class="bold">26</span>, 581–589 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/09593332608618543" title="DOI Link to resource 10.1080/09593332608618543">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXlslCju7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15974276%5Buid%5D" title="PubMed Link to resource 15974276">PubMed</a>.</span></li>
      <li><span id="cit131">B. S. Harrison, D. Eberli, S. J. Lee, A. Atala and J. J. Yoo, <span class="italic">Biomaterials</span>, 2007, <span class="bold">28</span>, 4628–4634 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2007.07.003" title="DOI Link to resource 10.1016/j.biomaterials.2007.07.003">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2sXptFygurc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=17681597%5Buid%5D" title="PubMed Link to resource 17681597">PubMed</a>.</span></li>
      <li><span id="cit132">B. W. Bogan, V. Trbovic and J. R. Paterek, <span class="italic">Chemosphere</span>, 2003, <span class="bold">50</span>, 15–21 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/S0045-6535(02)00490-3" title="DOI Link to resource 10.1016/S0045-6535(02)00490-3">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XoslChsr0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12656224%5Buid%5D" title="PubMed Link to resource 12656224">PubMed</a>.</span></li>
      <li><span id="cit133">A.-C. Ndjou'ou and D. Cassidy, <span class="italic">Chemosphere</span>, 2006, <span class="bold">65</span>, 1610–1615 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.chemosphere.2006.03.036" title="DOI Link to resource 10.1016/j.chemosphere.2006.03.036">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16725177%5Buid%5D" title="PubMed Link to resource 16725177">PubMed</a>.</span></li>
      <li><span id="cit134">S. H. Oh, C. L. Ward, A. Atala, J. J. Yoo and B. S. Harrison, <span class="italic">Biomaterials</span>, 2009, <span class="bold">30</span>, 757–762 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2008.09.065" title="DOI Link to resource 10.1016/j.biomaterials.2008.09.065">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1cXhsFWrtr7O" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19019425%5Buid%5D" title="PubMed Link to resource 19019425">PubMed</a>.</span></li>
      <li><span id="cit135">J. Wang, Y. Zhu, H. K. Bawa, G. Ng, Y. Wu, M. Libera, H. C. van der Mei, H. J. Busscher and X. Yu, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2011, <span class="bold">3</span>, 67–73 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/am100862h" title="DOI Link to resource 10.1021/am100862h">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGltbvF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21155527%5Buid%5D" title="PubMed Link to resource 21155527">PubMed</a>.</span></li>
      <li><span id="cit136">E. Pedraza, M. M. Coronel, C. A. Fraker, C. Ricordi and C. L. Stabler, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2012, <span class="bold">109</span>, 4245–4250 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.1113560109" title="DOI Link to resource 10.1073/pnas.1113560109">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XkslCltbY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22371586%5Buid%5D" title="PubMed Link to resource 22371586">PubMed</a>.</span></li>
      <li><span id="cit137">L. Hu, P. Wang, M. Zhao, L. Liu, L. Zhou, B. Li, F. H. Albaqami, A. M. El-Toni, X. Li, Y. Xie, X. Sun and F. Zhang, <span class="italic">Biomaterials</span>, 2018, <span class="bold">163</span>, 154–162 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2018.02.029" title="DOI Link to resource 10.1016/j.biomaterials.2018.02.029">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXivFOhs78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29459324%5Buid%5D" title="PubMed Link to resource 29459324">PubMed</a>.</span></li>
      <li><span id="cit138">C.-C. Huang, W.-T. Chia, M.-F. Chung, K.-J. Lin, C.-W. Hsiao, C. Jin, W.-H. Lim, C.-C. Chen and H.-W. Sung, <span class="italic">J. Am. Chem. Soc.</span>, 2016, <span class="bold">138</span>, 5222–5225 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.6b01784" title="DOI Link to resource 10.1021/jacs.6b01784">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xls1KisL0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27075956%5Buid%5D" title="PubMed Link to resource 27075956">PubMed</a>.</span></li>
      <li><span id="cit139">Q. Yu, T. Huang, C. Liu, M. Zhao, M. Xie, G. Li, S. Liu, W. Huang and Q. Zhao, <span class="italic">Chem. Sci.</span>, 2019, <span class="bold">10</span>, 9091–9098 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9SC03161H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9SC03161H">RSC</a>.</span></li>
      <li><span id="cit140">L.-H. Liu, Y.-H. Zhang, W.-X. Qiu, L. Zhang, F. Gao, B. Li, L. Xu, J.-X. Fan, Z.-H. Li and X.-Z. Zhang, <span class="italic">Small</span>, 2017, <span class="bold">13</span>, 1701621 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/smll.201701621" title="DOI Link to resource 10.1002/smll.201701621">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28783253%5Buid%5D" title="PubMed Link to resource 28783253">PubMed</a>.</span></li>
      <li><span id="cit141">C. Liu, Y. Cao, Y. Cheng, D. Wang, T. Xu, L. Su, X. Zhang and H. Dong, <span class="italic">Nat. Commun.</span>, 2020, <span class="bold">11</span>, 1735 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-020-15591-4" title="DOI Link to resource 10.1038/s41467-020-15591-4">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXmvFGltLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32269223%5Buid%5D" title="PubMed Link to resource 32269223">PubMed</a>.</span></li>
      <li><span id="cit142">H. Fu, J. Fu, S. Ma, H. Wang, S. Lv and Y. Hao, <span class="italic">J. Mater. Chem. B</span>, 2020, <span class="bold">8</span>, 6059–6068 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0TB00859A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0TB00859A">RSC</a>.</span></li>
      <li><span id="cit143">H. Zhou, L. Xia, J. Zhong, S. Xiong, X. Yi, L. Chen, R. Zhu, Q. Shi and K. Yang, <span class="italic">Nanoscale</span>, 2019, <span class="bold">11</span>, 19823–19831 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C9NR06941K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C9NR06941K">RSC</a>.</span></li>
      <li><span id="cit144">P. F. A. Costa, A. P. Gerola, P. C. S. Pereira, B. S. Souza, W. Caetano, H. D. Fiedler, F. Nome and N. Hioka, <span class="italic">J. Mol. Liq.</span>, 2019, <span class="bold">274</span>, 393–401 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.molliq.2018.10.143" title="DOI Link to resource 10.1016/j.molliq.2018.10.143">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXitFCgt77M" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit145">H. Zhang, L. Huang, J. Zhai and S. Dong, <span class="italic">J. Am. Chem. Soc.</span>, 2019, <span class="bold">141</span>, 16416–16421 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.9b08046" title="DOI Link to resource 10.1021/jacs.9b08046">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhvVGgtLjF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31557008%5Buid%5D" title="PubMed Link to resource 31557008">PubMed</a>.</span></li>
      <li><span id="cit146">R. Song, B. Luo, J. Geng, D. Song and D. Jing, <span class="italic">Ind. Eng. Chem. Res.</span>, 2018, <span class="bold">57</span>, 7846–7854 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.iecr.8b00369" title="DOI Link to resource 10.1021/acs.iecr.8b00369">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXpvFGjsrg%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit147">G. Zhang, Z.-A. Lan and X. Wang, <span class="italic">Chem. Sci.</span>, 2017, <span class="bold">8</span>, 5261–5274 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7SC01747B&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7SC01747B">RSC</a>.</span></li>
      <li><span id="cit148">T. K. Fam, A. S. Klymchenko and M. Collot, <span class="italic">Materials</span>, 2018, <span class="bold">11</span>, 1768 <a target="_blank" class="DOILink" href="https://doi.org/10.3390/ma11091768" title="DOI Link to resource 10.3390/ma11091768">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30231571%5Buid%5D" title="PubMed Link to resource 30231571">PubMed</a>.</span></li>
      <li><span id="cit149">Y. Wang, S. Song, J. Liu, D. Liu and H. Zhang, <span class="italic">Angew. Chem., Int. Ed.</span>, 2015, <span class="bold">54</span>, 536–540 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2cXhvVGhtr7J" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit150">S. Cao, J. Low, J. Yu and M. Jaroniec, <span class="italic">Adv. Mater.</span>, 2015, <span class="bold">27</span>, 2150–2176 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201500033" title="DOI Link to resource 10.1002/adma.201500033">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXkvF2ns7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25704586%5Buid%5D" title="PubMed Link to resource 25704586">PubMed</a>.</span></li>
      <li><span id="cit151">L. Pan, S. Sun, Y. Chen, P. Wang, J. Wang, X. Zhang, J.-J. Zou and Z. L. Wang, <span class="italic">Adv. Energy Mater.</span>, 2020, <span class="bold">10</span>, 2000214 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/aenm.202000214" title="DOI Link to resource 10.1002/aenm.202000214">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXjvVKkur8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit152">Q. Dong, Y. Fang, Y. Shao, P. Mulligan, J. Qiu, L. Cao and J. Huang, <span class="italic">Science</span>, 2015, <span class="bold">347</span>, 967–970 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.aaa5760" title="DOI Link to resource 10.1126/science.aaa5760">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXjtF2qtLc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25636799%5Buid%5D" title="PubMed Link to resource 25636799">PubMed</a>.</span></li>
      <li><span id="cit153">S. M. Yin, J. Y. Han, T. H. Zhou and R. Xu, <span class="italic">Catal. Sci. Technol.</span>, 2015, <span class="bold">5</span>, 5048–5061 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5CY00938C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5CY00938C">RSC</a>.</span></li>
      <li><span id="cit154">H. Wan, Y. Zhang, W. Zhang and H. Zou, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2015, <span class="bold">7</span>, 9608–9618 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.5b01165" title="DOI Link to resource 10.1021/acsami.5b01165">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXms1Oms7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25893951%5Buid%5D" title="PubMed Link to resource 25893951">PubMed</a>.</span></li>
      <li><span id="cit155">R. Chen, J. Zhang, Y. Wang, X. Chen, J. A. Zapien and C.-S. Lee, <span class="italic">Nanoscale</span>, 2015, <span class="bold">7</span>, 17299–17305 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR04436G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR04436G">RSC</a>.</span></li>
      <li><span id="cit156">C.-J. Chen, C. K. Chen, T.-H. Lu, S.-F. Hu and R.-S. Liu, <span class="italic">RSC Adv.</span>, 2016, <span class="bold">6</span>, 103160–103168 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C6RA24563C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C6RA24563C">RSC</a>.</span></li>
      <li><span id="cit157">D. Yang, G. Yang, S. Gai, F. He, C. Li and P. Yang, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>, 6829–6838 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.6b15203" title="DOI Link to resource 10.1021/acsami.6b15203">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXit12ms74%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28170217%5Buid%5D" title="PubMed Link to resource 28170217">PubMed</a>.</span></li>
      <li><span id="cit158">D. Yang, G. Yang, J. Li, S. Gai, F. He and P. Yang, <span class="italic">J. Mater. Chem. B</span>, 2017, <span class="bold">5</span>, 4152–4161 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7TB00688H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7TB00688H">RSC</a>.</span></li>
      <li><span id="cit159">D.-W. Zheng, B. Li, C.-X. Li, J.-X. Fan, Q. Lei, C. Li, Z. Xu and X.-Z. Zhang, <span class="italic">ACS Nano</span>, 2016, <span class="bold">10</span>, 8715–8722 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.6b04156" title="DOI Link to resource 10.1021/acsnano.6b04156">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhtlKmsr7K" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27532320%5Buid%5D" title="PubMed Link to resource 27532320">PubMed</a>.</span></li>
      <li><span id="cit160">R.-Q. Li, C. Zhang, B.-R. Xie, W.-Y. Yu, W.-X. Qiu, H. Cheng and X.-Z. Zhang, <span class="italic">Biomaterials</span>, 2019, <span class="bold">194</span>, 84–93 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2018.12.017" title="DOI Link to resource 10.1016/j.biomaterials.2018.12.017">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXisFOrsb3P" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30583151%5Buid%5D" title="PubMed Link to resource 30583151">PubMed</a>.</span></li>
      <li><span id="cit161">R. Chen, J. Zhang, J. Chelora, Y. Xiong, S. V. Kershaw, K. F. Li, P.-K. Lo, K. W. Cheah, A. L. Rogach, J. A. Zapien and C.-S. Lee, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2017, <span class="bold">9</span>, 5699–5708 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.6b12469" title="DOI Link to resource 10.1021/acsami.6b12469">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGgs7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28121418%5Buid%5D" title="PubMed Link to resource 28121418">PubMed</a>.</span></li>
      <li><span id="cit162">X. Wang, W. Lu, Z.-Y. Gu, Z. Wei and H.-C. Zhou, <span class="italic">Chem. Commun.</span>, 2016, <span class="bold">52</span>, 1926–1929 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5CC08614K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5CC08614K">RSC</a>.</span></li>
      <li><span id="cit163">M. D. Brady, R. N. Sampaio, D. Wang, T. J. Meyer and G. J. Meyer, <span class="italic">J. Am. Chem. Soc.</span>, 2017, <span class="bold">139</span>, 15612–15615 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/jacs.7b09367" title="DOI Link to resource 10.1021/jacs.7b09367">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhs12mt7%252FN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29058884%5Buid%5D" title="PubMed Link to resource 29058884">PubMed</a>.</span></li>
      <li><span id="cit164">C. Zhang, W.-H. Chen, L.-H. Liu, W.-X. Qiu, W.-Y. Yu and X.-Z. Zhang, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1700626 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201700626" title="DOI Link to resource 10.1002/adfm.201700626">CrossRef</a>.</span></li>
      <li><span id="cit165">S. Gao, G. Wang, Z. Qin, X. Wang, G. Zhao, Q. Ma and L. Zhu, <span class="italic">Biomaterials</span>, 2017, <span class="bold">112</span>, 324–335 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2016.10.030" title="DOI Link to resource 10.1016/j.biomaterials.2016.10.030">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhslansbzE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27776285%5Buid%5D" title="PubMed Link to resource 27776285">PubMed</a>.</span></li>
      <li><span id="cit166">K. Yan, Y. Zhang, C. Mu, Q. Xu, X. Jing, D. Wang, D. Dang, L. Meng and J. Ma, <span class="italic">Theranostics</span>, 2020, <span class="bold">10</span>, 7287–7318 <a target="_blank" class="DOILink" href="https://doi.org/10.7150/thno.46288" title="DOI Link to resource 10.7150/thno.46288">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXitVWlsbrE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32641993%5Buid%5D" title="PubMed Link to resource 32641993">PubMed</a>.</span></li>
      <li><span id="cit167">P. Lee, N. S. Chandel and M. C. Simon, <span class="italic">Nat. Rev. Mol. Cell Biol.</span>, 2020, <span class="bold">21</span>, 268–283 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41580-020-0227-y" title="DOI Link to resource 10.1038/s41580-020-0227-y">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXksFCjs7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32144406%5Buid%5D" title="PubMed Link to resource 32144406">PubMed</a>.</span></li>
      <li><span id="cit168">
          G. Multhoff and P. Vaupel, in <span class="italic">Oxygen Transport to Tissue Xli</span>, ed. P. D. Ryu, J. C. LaManna, D. K. Harrison and S. S. Lee,  2020, vol. 1232, pp. 131–143 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Oxygen%20Transport%20to%20Tissue%20Xli%5BJour%5D%20AND%201232%5Bvolume%5D%20AND%20%5Bpage%5D%20and%202020%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit169">M. Najafi, B. Farhood and K. Mortezaee, <span class="italic">J. Cell. Physiol.</span>, 2019, <span class="bold">234</span>, 8381–8395 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/jcp.27740" title="DOI Link to resource 10.1002/jcp.27740">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXitFCgtbzK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30417375%5Buid%5D" title="PubMed Link to resource 30417375">PubMed</a>.</span></li>
      <li><span id="cit170">M. Najafi, B. Farhood, K. Mortezaee, E. Kharazinejad, J. Majidpoor and R. Ahadi, <span class="italic">J. Cancer Res. Clin. Oncol.</span>, 2020, <span class="bold">146</span>, 19–31 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00432-019-03080-1" title="DOI Link to resource 10.1007/s00432-019-03080-1">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31734836%5Buid%5D" title="PubMed Link to resource 31734836">PubMed</a>.</span></li>
      <li><span id="cit171">S. Pastorekova and R. J. Gillies, <span class="italic">Cancer Metastasis Rev.</span>, 2019, <span class="bold">38</span>, 65–77 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10555-019-09799-0" title="DOI Link to resource 10.1007/s10555-019-09799-0">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXlsVaktrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31076951%5Buid%5D" title="PubMed Link to resource 31076951">PubMed</a>.</span></li>
      <li><span id="cit172">B. Perillo, M. Di Donato, A. Pezone, E. Di Zazzo, P. Giovannelli, G. Galasso, G. Castoria and A. Migliaccio, <span class="italic">Exp. Mol. Med.</span>, 2020, <span class="bold">52</span>, 192–203 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s12276-020-0384-2" title="DOI Link to resource 10.1038/s12276-020-0384-2">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXjtlagsLo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32060354%5Buid%5D" title="PubMed Link to resource 32060354">PubMed</a>.</span></li>
      <li><span id="cit173">L. Yang, P. Shi, G. Zhao, J. Xu, W. Peng, J. Zhang, G. Zhang, X. Wang, Z. Dong, F. Chen and H. Cui, <span class="italic">Signal Transduction Targeted Ther.</span>, 2020, <span class="bold">5</span>, 8 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41392-020-0110-5" title="DOI Link to resource 10.1038/s41392-020-0110-5">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32296030%5Buid%5D" title="PubMed Link to resource 32296030">PubMed</a>.</span></li>
      <li><span id="cit174">C. E. Evans, K. Mattock, J. Humphries, P. Saha, A. Ahmad, M. Waltham, A. Patel, B. Modarai, L. Porter, S. Premaratne and A. Smith, <span class="italic">Angiogenesis</span>, 2011, <span class="bold">14</span>, 119–124 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10456-011-9205-5" title="DOI Link to resource 10.1007/s10456-011-9205-5">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXmslags78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21327472%5Buid%5D" title="PubMed Link to resource 21327472">PubMed</a>.</span></li>
      <li><span id="cit175">E. Eng, C. Holgren, S. Hubchak, P. Naaz and H. W. Schnaper, <span class="italic">Kidney Int.</span>, 2005, <span class="bold">68</span>, 695–703 <a target="_blank" class="DOILink" href="https://doi.org/10.1111/j.1523-1755.2005.00448.x" title="DOI Link to resource 10.1111/j.1523-1755.2005.00448.x">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXpt1Wmt7Y%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16014047%5Buid%5D" title="PubMed Link to resource 16014047">PubMed</a>.</span></li>
      <li><span id="cit176">C. W. Song, J. G. Rhee and S. H. Levitt, <span class="italic">Int. J. Radiat. Oncol., Biol., Phys.</span>, 1982, <span class="bold">8</span>, 851–856 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/0360-3016(82)90088-8" title="DOI Link to resource 10.1016/0360-3016(82)90088-8">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaL383msFWksw%253D%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit177">Q. Chen, H. Chen, H. Shapiro and F. W. Hetzel, <span class="italic">Radiat. Res.</span>, 1996, <span class="bold">146</span>, 293–297 <a target="_blank" class="DOILink" href="https://doi.org/10.2307/3579459" title="DOI Link to resource 10.2307/3579459">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaK28XlsFGit7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=8752307%5Buid%5D" title="PubMed Link to resource 8752307">PubMed</a>.</span></li>
      <li><span id="cit178">M. K. Kang, M. S. Kim and J. H. Kim, <span class="italic">Int. J. Hyperthermia</span>, 2011, <span class="bold">27</span>, 482–490 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/02656736.2011.563769" title="DOI Link to resource 10.3109/02656736.2011.563769">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21756045%5Buid%5D" title="PubMed Link to resource 21756045">PubMed</a>.</span></li>
      <li><span id="cit179">S.-Y. Lee, J.-H. Kim, Y.-H. Han and D.-H. Cho, <span class="italic">Int. J. Hyperthermia</span>, 2018, <span class="bold">34</span>, 953–960 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/02656736.2018.1423709" title="DOI Link to resource 10.1080/02656736.2018.1423709">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29297234%5Buid%5D" title="PubMed Link to resource 29297234">PubMed</a>.</span></li>
      <li><span id="cit180">G. Multhoff, G. Habl and S. E. Combs, <span class="italic">Int. J. Hyperthermia</span>, 2016, <span class="bold">32</span>, 455–463 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/02656736.2016.1152632" title="DOI Link to resource 10.3109/02656736.2016.1152632">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xlslenur4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27050781%5Buid%5D" title="PubMed Link to resource 27050781">PubMed</a>.</span></li>
      <li><span id="cit181">C. W. Song, H. J. Park, C. K. Lee and R. Griffin, <span class="italic">Int. J. Hyperthermia</span>, 2005, <span class="bold">21</span>, 761–767 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/02656730500204487" title="DOI Link to resource 10.1080/02656730500204487">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD2Mnls1yjsw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=16338859%5Buid%5D" title="PubMed Link to resource 16338859">PubMed</a>.</span></li>
      <li><span id="cit182">P. W. Vaupel and D. K. Kelleher, <span class="italic">Int. J. Hyperthermia</span>, 2010, <span class="bold">26</span>, 211–223 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/02656731003596259" title="DOI Link to resource 10.3109/02656731003596259">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXkslSjtLc%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20345270%5Buid%5D" title="PubMed Link to resource 20345270">PubMed</a>.</span></li>
      <li><span id="cit183">Z. Vujaskovic, E. L. Rosen, K. L. Blackwell, E. L. Jones, D. M. Brizel, L. R. Prosnitz, T. V. Samulski and M. W. Dewhirst, <span class="italic">Int. J. Hyperthermia</span>, 2003, <span class="bold">19</span>, 498–506 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/0265673031000121517" title="DOI Link to resource 10.1080/0265673031000121517">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD3svgsFKjuw%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=12944165%5Buid%5D" title="PubMed Link to resource 12944165">PubMed</a>.</span></li>
      <li><span id="cit184">R. Lima-Sousa, D. de Melo-Diogo, C. G. Alves, C. S. D. Cabral, S. P. Miguel, A. G. Mendonca and I. J. Correia, <span class="italic">Mater. Sci. Eng., C</span>, 2020, <span class="bold">117</span>, 111294 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.msec.2020.111294" title="DOI Link to resource 10.1016/j.msec.2020.111294">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhsF2ju7rM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32919655%5Buid%5D" title="PubMed Link to resource 32919655">PubMed</a>.</span></li>
      <li><span id="cit185">G. Ramirez-Garcia, M. Angel Honorato-Colin, E. De la Rosa, T. Lopez-Luke, S. S. Panikar, J. de Jesus Ibarra-Sanchez and V. Piazza, <span class="italic">J. Photochem. Photobiol., A</span>, 2019, <span class="bold">384</span>, 112053 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jphotochem.2019.112053" title="DOI Link to resource 10.1016/j.jphotochem.2019.112053">CrossRef</a>.</span></li>
      <li><span id="cit186">L. Hui, S. Qin and L. Yang, <span class="italic">ACS Biomater. Sci. Eng.</span>, 2016, <span class="bold">2</span>, 2127–2132 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsbiomaterials.6b00459" title="DOI Link to resource 10.1021/acsbiomaterials.6b00459">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yjtb7E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33465888%5Buid%5D" title="PubMed Link to resource 33465888">PubMed</a>.</span></li>
      <li><span id="cit187">K. Yue, J. Nan, X. Zhang, J. Tang and X. Zhang, <span class="italic">Appl. Therm. Eng.</span>, 2016, <span class="bold">99</span>, 1093–1100 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.applthermaleng.2016.01.077" title="DOI Link to resource 10.1016/j.applthermaleng.2016.01.077">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XisFOmtr8%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit188">P.-L. Chen, Q.-Y. Shi, T. Chen, P. Wang, Y. Liu and L.-H. Liu, <span class="italic">J. Mater. Sci.</span>, 2020, <span class="bold">55</span>, 7843–7856 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10853-020-04546-1" title="DOI Link to resource 10.1007/s10853-020-04546-1">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXlt1Srtrk%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit189">P. T. M. Phuong, H. J. Won, A. I. Robby, S. G. Kim, G.-B. Im, S. H. Bhang, G. Lee and S. Y. Park, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2020, <span class="bold">12</span>, 37929–37942 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.0c11979" title="DOI Link to resource 10.1021/acsami.0c11979">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhsVKnt7%252FM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32846494%5Buid%5D" title="PubMed Link to resource 32846494">PubMed</a>.</span></li>
      <li><span id="cit190">F. Yang, Q. Zhang, S. Huang and D. Ma, <span class="italic">J. Mater. Chem. B</span>, 2020, <span class="bold">8</span>, 7856–7879 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0TB01430C&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0TB01430C">RSC</a>.</span></li>
      <li><span id="cit191">S. Lee, R. G. Thomas, M. J. Moon, H. J. Park, I.-K. Park, B.-I. Lee and Y. Y. Jeong, <span class="italic">Sci. Rep.</span>, 2017, <span class="bold">7</span>, 2108 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41598-017-01108-5" title="DOI Link to resource 10.1038/s41598-017-01108-5">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28522841%5Buid%5D" title="PubMed Link to resource 28522841">PubMed</a>.</span></li>
      <li><span id="cit192">Y. Wu, W. Zhang, D. Xu, L. Ding, R. Ma, J.-Z. Wu and J.-H. Tang, <span class="italic">Lasers Med. Sci.</span>, 2018, <span class="bold">33</span>, 1601–1608 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10103-018-2532-7" title="DOI Link to resource 10.1007/s10103-018-2532-7">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29948451%5Buid%5D" title="PubMed Link to resource 29948451">PubMed</a>.</span></li>
      <li><span id="cit193">X.-S. Zhang, Y. Xuan, X.-Q. Yang, K. Cheng, R.-Y. Zhang, C. Li, F. Tan, Y.-C. Cao, X.-L. Song, J. An, X.-L. Hou and Y.-D. Zhao, <span class="italic">J. Nanobiotechnol.</span>, 2018, <span class="bold">16</span>, 42 <a target="_blank" class="DOILink" href="https://doi.org/10.1186/s12951-018-0367-9" title="DOI Link to resource 10.1186/s12951-018-0367-9">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29673352%5Buid%5D" title="PubMed Link to resource 29673352">PubMed</a>.</span></li>
      <li><span id="cit194">Y. Chen, Y. Gao, Y. Chen, L. Liu, A. Mo and Q. Peng, <span class="italic">J. Controlled Release</span>, 2020, <span class="bold">328</span>, 251–262 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2020.08.055" title="DOI Link to resource 10.1016/j.jconrel.2020.08.055">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXhslGht7rF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32889053%5Buid%5D" title="PubMed Link to resource 32889053">PubMed</a>.</span></li>
      <li><span id="cit195">H.-Y. Wang, Y. Zhang, X.-H. Ren, X.-W. He, W.-Y. Li and Y.-K. Zhang, <span class="italic">Nanoscale</span>, 2021, <span class="bold">13</span>, 886–900 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=D0NR07121H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/D0NR07121H">RSC</a>.</span></li>
      <li><span id="cit196">J.-J. Hu, M.-D. Liu, F. Gao, Y. Chen, S.-Y. Peng, Z.-H. Li, H. Cheng and X.-Z. Zhang, <span class="italic">Biomaterials</span>, 2019, <span class="bold">217</span>, 119303 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2019.119303" title="DOI Link to resource 10.1016/j.biomaterials.2019.119303">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXht1ymt7nI" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31271859%5Buid%5D" title="PubMed Link to resource 31271859">PubMed</a>.</span></li>
      <li><span id="cit197">T. W. H. Meijer, J. H. A. M. Kaanders, P. N. Span and J. Bussink, <span class="italic">Clin. Cancer Res.</span>, 2012, <span class="bold">18</span>, 5585–5594 <a target="_blank" class="DOILink" href="https://doi.org/10.1158/1078-0432.CCR-12-0858" title="DOI Link to resource 10.1158/1078-0432.CCR-12-0858">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XhsFahu7rM" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23071360%5Buid%5D" title="PubMed Link to resource 23071360">PubMed</a>.</span></li>
      <li><span id="cit198">L. Feng, D. Tao, Z. Dong, Q. Chen, Y. Chao, Z. Liu and M. Chen, <span class="italic">Biomaterials</span>, 2017, <span class="bold">127</span>, 13–24 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2016.11.027" title="DOI Link to resource 10.1016/j.biomaterials.2016.11.027">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXjvFagtr8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28279918%5Buid%5D" title="PubMed Link to resource 28279918">PubMed</a>.</span></li>
      <li><span id="cit199">X. Li, S. Kolemen, J. Yoon and E. U. Akkaya, <span class="italic">Adv. Funct. Mater.</span>, 2017, <span class="bold">27</span>, 1604053 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201604053" title="DOI Link to resource 10.1002/adfm.201604053">CrossRef</a>.</span></li>
      <li><span id="cit200">X.-S. Li, M.-R. Ke, W. Huang, C.-H. Ye and J.-D. Huang, <span class="italic">Chem. – Eur. J.</span>, 2015, <span class="bold">21</span>, 3310–3317 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/chem.201404514" title="DOI Link to resource 10.1002/chem.201404514">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXosFensg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25639348%5Buid%5D" title="PubMed Link to resource 25639348">PubMed</a>.</span></li>
      <li><span id="cit201">S. Xu, X. Zhu, C. Zhang, W. Huang, Y. Zhou and D. Yan, <span class="italic">Nat. Commun.</span>, 2018, <span class="bold">9</span>, 2053 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/s41467-018-04318-1" title="DOI Link to resource 10.1038/s41467-018-04318-1">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29795534%5Buid%5D" title="PubMed Link to resource 29795534">PubMed</a>.</span></li>
      <li><span id="cit202">Q. Chen, L. Feng, J. Liu, W. Zhu, Z. Dong, Y. Wu and Z. Liu, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1870051 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201870051" title="DOI Link to resource 10.1002/adma.201870051">CrossRef</a>.</span></li>
      <li><span id="cit203">W. Zhu, Z. Dong, T. Fu, J. Liu, Q. Chen, Y. Li, R. Zhu, L. Xu and Z. Liu, <span class="italic">Adv. Funct. Mater.</span>, 2016, <span class="bold">26</span>, 5490–5498 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201600676" title="DOI Link to resource 10.1002/adfm.201600676">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28Xot1Khtb0%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit204">H. Cheng, J.-Y. Zhu, S.-Y. Li, J.-Y. Zeng, Q. Lei, K.-W. Chen, C. Zhang and X.-Z. Zhang, <span class="italic">Adv. Funct. Mater.</span>, 2016, <span class="bold">26</span>, 7847–7860 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201603212" title="DOI Link to resource 10.1002/adfm.201603212">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsFenu77I" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit205">Y. Yong, X. Cheng, T. Bao, M. Zu, L. Yan, W. Yin, C. Ge, D. Wang, Z. Gu and Y. Zhao, <span class="italic">ACS Nano</span>, 2015, <span class="bold">9</span>, 12451–12463 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.5b05825" title="DOI Link to resource 10.1021/acsnano.5b05825">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhslSqu7%252FL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26495962%5Buid%5D" title="PubMed Link to resource 26495962">PubMed</a>.</span></li>
      <li><span id="cit206">G. Song, C. Liang, H. Gong, M. Li, X. Zheng, L. Cheng, K. Yang, X. Jiang and Z. Liu, <span class="italic">Adv. Mater.</span>, 2015, <span class="bold">27</span>, 6110–6117 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201503006" title="DOI Link to resource 10.1002/adma.201503006">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhsVOnu7nK" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26331476%5Buid%5D" title="PubMed Link to resource 26331476">PubMed</a>.</span></li>
      <li><span id="cit207">J. Du, Z. Gu, L. Yan, Y. Yong, X. Yi, X. Zhang, J. Liu, R. Wu, C. Ge, C. Chen and Y. Zhao, <span class="italic">Adv. Mater.</span>, 2017, <span class="bold">29</span>, 1701268 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201701268" title="DOI Link to resource 10.1002/adma.201701268">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28714110%5Buid%5D" title="PubMed Link to resource 28714110">PubMed</a>.</span></li>
      <li><span id="cit208">J. Wang, X. Tan, X. Pang, L. Liu, F. Tan and N. Li, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2016, <span class="bold">8</span>, 24331–24338 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.6b08391" title="DOI Link to resource 10.1021/acsami.6b08391">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XhsVKrtr%252FP" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27595856%5Buid%5D" title="PubMed Link to resource 27595856">PubMed</a>.</span></li>
      <li><span id="cit209">Y. Cheng, X. Kong, Y. Chang, Y. Feng, R. Zheng, X. Wu, K. Xu, X. Gao and H. Zhang, <span class="italic">Adv. Mater.</span>, 2020, <span class="bold">32</span>, 1908109 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201908109" title="DOI Link to resource 10.1002/adma.201908109">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXisVWns7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=32022983%5Buid%5D" title="PubMed Link to resource 32022983">PubMed</a>.</span></li>
      <li><span id="cit210">Z. Cui, K. Gao, S. Ge and W. Fa, <span class="italic">Mater. Res. Express</span>, 2017, <span class="bold">4</span>, 115032 <a target="_blank" class="DOILink" href="https://doi.org/10.1088/2053-1591/aa99f6" title="DOI Link to resource 10.1088/2053-1591/aa99f6">CrossRef</a>.</span></li>
      <li><span id="cit211">P. Cabrales and M. Intaglietta, <span class="italic">ASAIO J.</span>, 2013, <span class="bold">59</span>, 337–354 <a target="_blank" class="DOILink" href="https://doi.org/10.1097/MAT.0b013e318291fbaa" title="DOI Link to resource 10.1097/MAT.0b013e318291fbaa">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXhtVylu7zJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23820271%5Buid%5D" title="PubMed Link to resource 23820271">PubMed</a>.</span></li>
      <li><span id="cit212">C. I. Castro and J. C. Briceno, <span class="italic">Artif. Organs</span>, 2010, <span class="bold">34</span>, 622–634 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Artif.%20Organs%5BJour%5D%20AND%2034%5Bvolume%5D%20AND%20622%5Bpage%5D%20and%202010%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit213">D. R. Spahn, <span class="italic">Crit. Care</span>, 1999, <span class="bold">3</span>, R93–R97 <a target="_blank" class="DOILink" href="https://doi.org/10.1186/cc364" title="DOI Link to resource 10.1186/cc364">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BD3MzmslamtA%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11094488%5Buid%5D" title="PubMed Link to resource 11094488">PubMed</a>.</span></li>
      <li><span id="cit214">K. C. Lowe, <span class="italic">Blood Rev.</span>, 1999, <span class="bold">13</span>, 171–184 <a target="_blank" class="DOILink" href="https://doi.org/10.1054/blre.1999.0113" title="DOI Link to resource 10.1054/blre.1999.0113">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADyaK1MvlsVeqsQ%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=10527269%5Buid%5D" title="PubMed Link to resource 10527269">PubMed</a>.</span></li>
      <li><span id="cit215">B. A. Teicher and C. M. Rose, <span class="italic">Science</span>, 1984, <span class="bold">223</span>, 934–936 <a target="_blank" class="DOILink" href="https://doi.org/10.1126/science.6695191" title="DOI Link to resource 10.1126/science.6695191">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL2cXhtlGisrk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=6695191%5Buid%5D" title="PubMed Link to resource 6695191">PubMed</a>.</span></li>
      <li><span id="cit216">H.-Y. Lee, H.-W. Kim, J. H. Lee and S. H. Oh, <span class="italic">Biomaterials</span>, 2015, <span class="bold">53</span>, 583–591 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2015.02.117" title="DOI Link to resource 10.1016/j.biomaterials.2015.02.117">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXkt1Ort7s%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=25890754%5Buid%5D" title="PubMed Link to resource 25890754">PubMed</a>.</span></li>
      <li><span id="cit217">L. S. Chin, M. Lim, T. T. Hung, C. P. Marquis and R. Amal, <span class="italic">RSC Adv.</span>, 2014, <span class="bold">4</span>, 13052–13060 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C3RA47595F&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C3RA47595F">RSC</a>.</span></li>
      <li><span id="cit218">V. H. Fingar, T. S. Mang and B. W. Henderson, <span class="italic">Cancer Res.</span>, 1988, <span class="bold">48</span>, 3350–3354 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADyaL1cXks12mu78%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit219">A. M. Vezeridis, C. d. G. Lux, S. A. Barnhill, S. Kim, Z. Wu, S. Jin, J. Lux, N. C. Gianneschi and R. F. Mattrey, <span class="italic">J. Controlled Release</span>, 2019, <span class="bold">302</span>, 54–62 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.jconrel.2019.03.013" title="DOI Link to resource 10.1016/j.jconrel.2019.03.013">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXmt12is7g%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30928487%5Buid%5D" title="PubMed Link to resource 30928487">PubMed</a>.</span></li>
      <li><span id="cit220">M. Hubler, J. E. Souders, E. D. Shade, N. L. Polissar, J. U. Bleyl and M. P. Hlastala, <span class="italic">Crit. Care Med.</span>, 2002, <span class="bold">30</span>, 422–427 <a target="_blank" class="DOILink" href="https://doi.org/10.1097/00003246-200202000-00026" title="DOI Link to resource 10.1097/00003246-200202000-00026">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD38XislOis7k%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=11889323%5Buid%5D" title="PubMed Link to resource 11889323">PubMed</a>.</span></li>
      <li><span id="cit221">D. Haufe, K. G. Dahmen, O. Tiebel, M. Huebler and T. Koch, <span class="italic">Artif. Cells, Blood Substitutes, Biotechnol.</span>, 2011, <span class="bold">39</span>, 239–246 <a target="_blank" class="DOILink" href="https://doi.org/10.3109/10731199.2010.550264" title="DOI Link to resource 10.3109/10731199.2010.550264">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXosFahtL4%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21261566%5Buid%5D" title="PubMed Link to resource 21261566">PubMed</a>.</span></li>
      <li><span id="cit222">B. D. Spiess, <span class="italic">J. Appl. Physiol.</span>, 2009, <span class="bold">106</span>, 1444–1452 <a target="_blank" class="DOILink" href="https://doi.org/10.1152/japplphysiol.90995.2008" title="DOI Link to resource 10.1152/japplphysiol.90995.2008">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD1MXltVyhtb0%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=19179651%5Buid%5D" title="PubMed Link to resource 19179651">PubMed</a>.</span></li>
      <li><span id="cit223">C. Parrado, J. Nicolas, A. Juarranz and S. Gonzalez, <span class="italic">Photochem. Photobiol. Sci.</span>, 2020, <span class="bold">19</span>, 831–843 <a target="_blank" class="DOILink" href="https://doi.org/10.1039/D0PP00124D" title="DOI Link to resource 10.1039/D0PP00124D">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3cXptlKjsLY%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33856681%5Buid%5D" title="PubMed Link to resource 33856681">PubMed</a>.</span></li>
      <li><span id="cit224">X. Tang, Y. Cheng, S. Huang, F. Zhi, A. Yuan, Y. Hu and J. Wu, <span class="italic">Biochem. Biophys. Res. Commun.</span>, 2017, <span class="bold">487</span>, 483–487 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.bbrc.2017.03.142" title="DOI Link to resource 10.1016/j.bbrc.2017.03.142">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXmvFCntrs%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28359763%5Buid%5D" title="PubMed Link to resource 28359763">PubMed</a>.</span></li>
      <li><span id="cit225">R. A. Day, D. A. Estabrook, J. K. Logan and E. M. Sletten, <span class="italic">Chem. Commun.</span>, 2017, <span class="bold">53</span>, 13043–13046 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C7CC07038A&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C7CC07038A">RSC</a>.</span></li>
      <li><span id="cit226">K. Kolostova, J. Spicka, R. Matkowski and V. Bobek, <span class="italic">Am. J. Transl. Res.</span>, 2015, <span class="bold">7</span>, 1203–1213 <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXls1Gqu7c%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit227">H. Hu, X. Yan, H. Wang, J. Tanaka, M. Wang, W. You and Z. Li, <span class="italic">J. Mater. Chem. B</span>, 2019, <span class="bold">7</span>, 1116–1123 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8TB01844H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8TB01844H">RSC</a>.</span></li>
      <li><span id="cit228">C. Liu, H. Dong, N. Wu, Y. Cao and X. Zhang, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2018, <span class="bold">10</span>, 6991–7002 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b00112" title="DOI Link to resource 10.1021/acsami.8b00112">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXit1ylu70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29405051%5Buid%5D" title="PubMed Link to resource 29405051">PubMed</a>.</span></li>
      <li><span id="cit229">Y. Cheng, H. Cheng, C. Jiang, X. Qiu, K. Wang, W. Huan, A. Yuan, J. Wu and Y. Hu, <span class="italic">Nat. Commun.</span>, 2015, <span class="bold">6</span>, 8785 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/ncomms9785" title="DOI Link to resource 10.1038/ncomms9785">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXhslOns7bN" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26525216%5Buid%5D" title="PubMed Link to resource 26525216">PubMed</a>.</span></li>
      <li><span id="cit230">S. Ma, J. Zhou, Y. Zhang, B. Yang, Y. He, C. Tian, X. Xu and Z. Gu, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2019, <span class="bold">11</span>, 7731–7742 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b19840" title="DOI Link to resource 10.1021/acsami.8b19840">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitFGhs70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30694643%5Buid%5D" title="PubMed Link to resource 30694643">PubMed</a>.</span></li>
      <li><span id="cit231">Y. Wang, F. Zhang, H. Lin and F. Qu, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2019, <span class="bold">11</span>, 43964–43975 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.9b17237" title="DOI Link to resource 10.1021/acsami.9b17237">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXitVOhsbbJ" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31664811%5Buid%5D" title="PubMed Link to resource 31664811">PubMed</a>.</span></li>
      <li><span id="cit232">F. Guo, M. Yu, J. Wang, F. Tan and N. Li, <span class="italic">RSC Adv.</span>, 2016, <span class="bold">6</span>, 11070–11076 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5RA19521G&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5RA19521G">RSC</a>.</span></li>
      <li><span id="cit233">L. Zhang, H. Yi, J. Song, J. Huang, K. Yang, B. Tan, D. Wang, N. Yang, Z. Wang and X. Li, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2019, <span class="bold">11</span>, 9355–9366 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b21968" title="DOI Link to resource 10.1021/acsami.8b21968">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXisleqtL8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30734551%5Buid%5D" title="PubMed Link to resource 30734551">PubMed</a>.</span></li>
      <li><span id="cit234">S. Chen, B. Huang, W. Pei, L. Wang, Y. Xu and C. Niu, <span class="italic">Int. J. Nanomed.</span>, 2020, <span class="bold">15</span>, 8641–8658 <a target="_blank" class="DOILink" href="https://doi.org/10.2147/IJN.S281649" title="DOI Link to resource 10.2147/IJN.S281649">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BB3MXht1CksLo%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33177823%5Buid%5D" title="PubMed Link to resource 33177823">PubMed</a>.</span></li>
      <li><span id="cit235">D. C. Wallace, <span class="italic">Nat. Rev. Cancer</span>, 2012, <span class="bold">12</span>, 685–698 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nrc3365" title="DOI Link to resource 10.1038/nrc3365">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38Xhtlylsb%252FO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=23001348%5Buid%5D" title="PubMed Link to resource 23001348">PubMed</a>.</span></li>
      <li><span id="cit236">K. Hayashi, M. Nakamura, H. Miki, S. Ozaki, M. Abe, T. Matsumoto, T. Kori and K. Ishimura, <span class="italic">Adv. Funct. Mater.</span>, 2014, <span class="bold">24</span>, 503–513 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201301771" title="DOI Link to resource 10.1002/adfm.201301771">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3sXht12itbzI" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit237">D. Hu, L. Zhong, M. Wang, H. Li, Y. Qu, Q. Liu, R. Han, L. Yuan, K. Shi, J. Peng and Z. Qian, <span class="italic">Adv. Funct. Mater.</span>, 2019, <span class="bold">29</span>, 1806199 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adfm.201806199" title="DOI Link to resource 10.1002/adfm.201806199">CrossRef</a>.</span></li>
      <li><span id="cit238">P. Huang, Y. Zhang, Y. Liao, Q. Tang and J. Lin, <span class="italic">Angew. Chem., Int. Ed.</span>, 2021, <span class="bold">60</span>, 10647–10635 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.202015590" title="DOI Link to resource 10.1002/anie.202015590">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=33555085%5Buid%5D" title="PubMed Link to resource 33555085">PubMed</a>.</span></li>
      <li><span id="cit239">R. Liu, G. Spicer, S. Chen, H. F. Zhang, J. Yi and V. Backman, <span class="italic">J. Biomed. Opt.</span>, 2017, <span class="bold">22</span>, 025002 <a target="_blank" class="DOILink" href="https://doi.org/10.1117/1.JBO.22.2.025002" title="DOI Link to resource 10.1117/1.JBO.22.2.025002">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28157244%5Buid%5D" title="PubMed Link to resource 28157244">PubMed</a>.</span></li>
      <li><span id="cit240">D. J. Singel and J. S. Stamler, <span class="italic">Annu. Rev. Physiol.</span>, 2005, <span class="bold">67</span>, 99–145 <a target="_blank" class="DOILink" href="https://doi.org/10.1146/annurev.physiol.67.060603.090918" title="DOI Link to resource 10.1146/annurev.physiol.67.060603.090918">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BD2MXjsFelu70%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=15709954%5Buid%5D" title="PubMed Link to resource 15709954">PubMed</a>.</span></li>
      <li><span id="cit241">J. S. O'Neill and A. B. Reddy, <span class="italic">Nature</span>, 2011, <span class="bold">469</span>, 498–U470 <a target="_blank" class="DOILink" href="https://doi.org/10.1038/nature09702" title="DOI Link to resource 10.1038/nature09702">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21270888%5Buid%5D" title="PubMed Link to resource 21270888">PubMed</a>.</span></li>
      <li><span id="cit242">S. Wang, F. Yuan, K. Chen, G. Chen, K. Tu, H. Wang and L.-Q. Wang, <span class="italic">Biomacromolecules</span>, 2015, <span class="bold">16</span>, 2693–2700 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.biomac.5b00571" title="DOI Link to resource 10.1021/acs.biomac.5b00571">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2MXht1ajsLrO" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26207413%5Buid%5D" title="PubMed Link to resource 26207413">PubMed</a>.</span></li>
      <li><span id="cit243">H. Yi, P. Liu, N. Sheng, P. Gong, Y. Ma and L. Cai, <span class="italic">Nanoscale</span>, 2016, <span class="bold">8</span>, 5985–5995 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C5NR07348K&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C5NR07348K">RSC</a>.</span></li>
      <li><span id="cit244">L. Duan, X. Yan, A. Wang, Y. Jia and J. Li, <span class="italic">ACS Nano</span>, 2012, <span class="bold">6</span>, 6897–6904 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/nn301735u" title="DOI Link to resource 10.1021/nn301735u">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC38XptFSrurk%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=22732258%5Buid%5D" title="PubMed Link to resource 22732258">PubMed</a>.</span></li>
      <li><span id="cit245">C.-M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang and L. Zhang, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2011, <span class="bold">108</span>, 10980–10985 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.1106634108" title="DOI Link to resource 10.1073/pnas.1106634108">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3MXptV2ht78%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=21690347%5Buid%5D" title="PubMed Link to resource 21690347">PubMed</a>.</span></li>
      <li><span id="cit246">N. Doshi, A. S. Zahr, S. Bhaskar, J. Lahann and S. Mitragotri, <span class="italic">Proc. Natl. Acad. Sci. U. S. A.</span>, 2009, <span class="bold">106</span>, 21495–21499 <a target="_blank" class="DOILink" href="https://doi.org/10.1073/pnas.0907127106" title="DOI Link to resource 10.1073/pnas.0907127106">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC3cXltlGkug%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20018694%5Buid%5D" title="PubMed Link to resource 20018694">PubMed</a>.</span></li>
      <li><span id="cit247">G. Lippi, M. Franchini and G. Banfi, <span class="italic">Int. J. Sports Med.</span>, 2010, <span class="bold">31</span>, 75–76 <a target="_blank" class="DOILink" href="https://doi.org/10.1055/s-0030-1247540" title="DOI Link to resource 10.1055/s-0030-1247540">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ASTN%3A280%3ADC%252BC3c%252FovFahtg%253D%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=20135581%5Buid%5D" title="PubMed Link to resource 20135581">PubMed</a>.</span></li>
      <li><span id="cit248">P. Wang, X. Li, C. Yao, W. Wang, M. Zhao, A. M. El-Toni and F. Zhang, <span class="italic">Biomaterials</span>, 2017, <span class="bold">125</span>, 90–100 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2017.02.017" title="DOI Link to resource 10.1016/j.biomaterials.2017.02.017">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXjtlertLg%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28235648%5Buid%5D" title="PubMed Link to resource 28235648">PubMed</a>.</span></li>
      <li><span id="cit249">X. Guo, J. Qua, C. Zhu, W. Li, L. Luo, J. Yang, X. Yin, Q. Li, Y. Du, D. Chen, Y. Qiu, Y. Lou and J. You, <span class="italic">Drug Delivery</span>, 2018, <span class="bold">25</span>, 585–599 <a target="_blank" class="DOILink" href="https://doi.org/10.1080/10717544.2018.1435751" title="DOI Link to resource 10.1080/10717544.2018.1435751">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXjtVagur8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29461122%5Buid%5D" title="PubMed Link to resource 29461122">PubMed</a>.</span></li>
      <li><span id="cit250">G. Wan, B. Chen, L. Li, D. Wang, S. Shi, T. Zhang, Y. Wang, L. Zhang and Y. Wang, <span class="italic">Biomaterials</span>, 2018, <span class="bold">155</span>, 25–40 <a target="_blank" class="DOILink" href="https://doi.org/10.1016/j.biomaterials.2017.11.002" title="DOI Link to resource 10.1016/j.biomaterials.2017.11.002">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC2sXhvVentr%252FF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29161627%5Buid%5D" title="PubMed Link to resource 29161627">PubMed</a>.</span></li>
      <li><span id="cit251">W.-L. Liu, T. Liu, M.-Z. Zou, W.-Y. Yu, C.-X. Li, Z.-Y. He, M.-K. Zhang, M.-D. Liu, Z.-H. Li, J. Feng and X.-Z. Zhang, <span class="italic">Adv. Mater.</span>, 2018, <span class="bold">30</span>, 1802006 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/adma.201802006" title="DOI Link to resource 10.1002/adma.201802006">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30015997%5Buid%5D" title="PubMed Link to resource 30015997">PubMed</a>.</span></li>
      <li><span id="cit252">H. Cao, L. Wang, Y. Yang, J. Li, Y. Qi, Y. Li, Y. Li, H. Wang and J. Li, <span class="italic">Angew. Chem., Int. Ed.</span>, 2018, <span class="bold">57</span>, 7759–7763 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201802497" title="DOI Link to resource 10.1002/anie.201802497">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXpslSntb8%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29704295%5Buid%5D" title="PubMed Link to resource 29704295">PubMed</a>.</span></li>
      <li><span id="cit253">L. Liu, T. Li, Z. Ruan and L. Yan, <span class="italic">J. Mater. Sci.</span>, 2018, <span class="bold">53</span>, 9368–9381 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s10853-018-2276-6" title="DOI Link to resource 10.1007/s10853-018-2276-6">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXntV2ks7w%253D" title="Link to resource in CAS">CAS</a>.</span></li>
      <li><span id="cit254">C. Gao, Z. Lin, D. Wang, Z. Wu, H. Xie and Q. He, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2019, <span class="bold">11</span>, 23392–23400 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.9b07979" title="DOI Link to resource 10.1021/acsami.9b07979">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2lsL%252FE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31252507%5Buid%5D" title="PubMed Link to resource 31252507">PubMed</a>.</span></li>
      <li><span id="cit255">Y. Jiang and J. McNeill, <span class="italic">Chem. Rev.</span>, 2017, <span class="bold">117</span>, 838–859 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acs.chemrev.6b00419" title="DOI Link to resource 10.1021/acs.chemrev.6b00419">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC28XitFGht7nE" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=28029769%5Buid%5D" title="PubMed Link to resource 28029769">PubMed</a>.</span></li>
      <li><span id="cit256">J. Li, C. Xie, J. Huang, Y. Jiang, Q. Miao and K. Pu, <span class="italic">Angew. Chem., Int. Ed.</span>, 2018, <span class="bold">57</span>, 3995–3998 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201800511" title="DOI Link to resource 10.1002/anie.201800511">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXkt1Gqu7o%253D" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29417709%5Buid%5D" title="PubMed Link to resource 29417709">PubMed</a>.</span></li>
      <li><span id="cit257">L. Jiang, H. Bai, L. Liu, F. Lv, X. Ren and S. Wang, <span class="italic">Angew. Chem., Int. Ed.</span>, 2019, <span class="bold">58</span>, 10660–10665 <a target="_blank" class="DOILink" href="https://doi.org/10.1002/anie.201905884" title="DOI Link to resource 10.1002/anie.201905884">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXht1Oqt7zL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=31173456%5Buid%5D" title="PubMed Link to resource 31173456">PubMed</a>.</span></li>
      <li><span id="cit258">Z. Chen, L. Liu, R. Liang, Z. Luo, H. He, Z. Wu, H. Tian, M. Zheng, Y. Ma and L. Cai, <span class="italic">ACS Nano</span>, 2018, <span class="bold">12</span>, 8633–8645 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsnano.8b04371" title="DOI Link to resource 10.1021/acsnano.8b04371">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtlWgtbfF" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30005164%5Buid%5D" title="PubMed Link to resource 30005164">PubMed</a>.</span></li>
      <li><span id="cit259">X. Shi, Q. Zhan, X. Yan, J. Zhou, L. Zhou and S. Wei, <span class="italic">J. Mater. Chem. B</span>, 2020, <span class="bold">8</span>, 534–545 <a target="_blank" class="RSCLink" href="http://xlink.rsc.org/?doi=C8TB02430H&amp;newsite=1" title="Link to RSC resource DOI:10.1039/C8TB02430H">RSC</a>.</span></li>
      <li><span id="cit260">N. S. Al-Waili, G. J. Butler, J. Beale, R. W. Hamilton, B. Y. Lee and P. Lucas, <span class="italic">Med. Sci. Monit.</span>, 2005, <span class="bold">11</span>, RA279–RA289 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=Med.%20Sci.%20Monit.%5BJour%5D%20AND%2011%5Bvolume%5D%20AND%20RA279%5Bpage%5D%20and%202005%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit261">D. Devaraj and D. Srisakthi, <span class="italic">J. Clin. Diagn. Res.</span>, 2014, <span class="bold">8</span>, 263–265 <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;db=pubmed&amp;cmd=Search&amp;term=J.%20Clin.%20Diagn.%20Res.%5BJour%5D%20AND%208%5Bvolume%5D%20AND%20263%5Bpage%5D%20and%202014%5Bpdat%5D" title="Search PubMed for this citation">Search PubMed</a>.</span></li>
      <li><span id="cit262">K. Stepien, R. P. Ostrowski and E. Matyja, <span class="italic">Med. Oncol.</span>, 2016, <span class="bold">33</span>, 101 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s12032-016-0814-0" title="DOI Link to resource 10.1007/s12032-016-0814-0">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=27485098%5Buid%5D" title="PubMed Link to resource 27485098">PubMed</a>.</span></li>
      <li><span id="cit263">O. Thews and P. Vaupel, <span class="italic">Strahlenther. Onkol.</span>, 2015, <span class="bold">191</span>, 875–882 <a target="_blank" class="DOILink" href="https://doi.org/10.1007/s00066-015-0867-6" title="DOI Link to resource 10.1007/s00066-015-0867-6">CrossRef</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=26135917%5Buid%5D" title="PubMed Link to resource 26135917">PubMed</a>.</span></li>
      <li><span id="cit264">L.-H. Mei, G. Yang and F. Fang, <span class="italic">Biol. Pharm. Bull.</span>, 2019, <span class="bold">42</span>, 394–400 <a target="_blank" class="DOILink" href="https://doi.org/10.1248/bpb.b18-00611" title="DOI Link to resource 10.1248/bpb.b18-00611">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1MXhsVKkurjL" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=30587670%5Buid%5D" title="PubMed Link to resource 30587670">PubMed</a>.</span></li>
      <li><span id="cit265">J. Li, J. Huang, Y. Ao, S. Li, Y. Miao, Z. Yu, L. Zhu, X. Lan, Y. Zhu, Y. Zhang and X. Yang, <span class="italic">ACS Appl. Mater. Interfaces</span>, 2018, <span class="bold">10</span>, 22985–22996 <a target="_blank" class="DOILink" href="https://doi.org/10.1021/acsami.8b07090" title="DOI Link to resource 10.1021/acsami.8b07090">CrossRef</a> <a target="_blank" class="COILink" href="/en/content/coiresolver?coi=1%3ACAS%3A528%3ADC%252BC1cXhtFSgsr7E" title="Link to resource in CAS">CAS</a> <a target="_blank" class="PMedLink" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=29877702%5Buid%5D" title="PubMed Link to resource 29877702">PubMed</a>.</span></li>
    </ol>
    
    
    
    
    
  <table><tr><td><hr/></td></tr><tr><td><b>This journal is © The Royal Society of Chemistry 2022</b></td></tr></table></div></div></div></body><script src="/content/scripts/CrossMarkIE.js"> </script><SaxonLicenceTest result="pass" message="Licenced Enterprise Edition [ EE 9.3.0.4 ]"/></html>